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THE GENERALISED BONE TISSUE DAMAGE IN
OSTEOARTHRITIS PATIENTS
NM Shuba, OP Bortkevich, VM Kovalenko, AK Galitskaya, GA
Protsenko MO
StrazheskoInstituteof Cardiology,UkrainianRheumatologic
Centre, Kyiv, Ukraine
Aim of the study: to determine the incidence and peculiarities of
generalized bone tissue damage (osteopenia and for osteoporo-
sis) in OA pts by the data of bone mineral density (BMO),
measured by the bone densitometry.
Methods: There were observed 149 women with definite OA
(ACR, 1990) at the age of 19-82 yrs, avo 54,36±6,23yrs, duration of
disease aV.7,60±2,24 yrs. MonoOA of the large joint was diag-
nosed in 38 pts, olygoOA - 52, polyOA - 59; Rg-st.l - in 41 pts, II -
68, III - 40. We assessed clinical signs of osteopenialosteoporosis,
including anatomical changes etc. Single photon densitometry
(NK-364A densitometer, GAMMA Techn. Corp.) of the standard
parts of forearms was performed for assessment of BMO (WHO
Tech Rep, 1994). The BMO-Z index was determined for purpose of
dynamic analysis of bone tissue.
Results: BMO was reduced in 59,7% of OA pts of all age groups.
There were determined close relationships between the bone
mass loss and the age of pts, as well as relative risk of spon-
taneous fractures. The significant acceleration of bone loss was
observed in early menopause. One of the main clinical signs of in
pts without fractures was the pain syndrome, which was divided
into certain types. BMO was significantly lower in polyOA pts
(p<O,OI), especially those with involving of small joints than in
those with mono(olygo)OA. In 71% of pts with monoOAand 76,9%
those with olygoOA there were determined normal or increased
BMO. BMO was significantly lower also in the OA pts with chronic
course of disease and severe joints' functional state impairment.
Conclusions: There were determined the frequency of
osteopenialosteoporosis among OA pts, as well as peculiarities
and types of osteopenia syndrome' clinical manifestations.
PS02
MICRODAMAGE AND CYTOKINE MESSENGER RNA
EXPRESSION IN TRABECULAR BONE OF THE HUMAN
PROXIMAL FEMUR: A COMPARISON BETWEEN
OSTEOARTHRITIC AND CONTROL BONE
JS Kuliwaba,1.2 MR Forwood,3 OM FindlaY,4 NL Fazzalari1.2
1Div of Tissue Pathology, InstituteofMedical& Veterinary
Science, Adelaide, SA, Australia,2Dept ofPathologyand 4Dept
of Orthopaedics& Trauma, UniversityofAdelaide,Adelaide, SA,
Australia,and 3Dept ofAnatomy& DevelopmentalBiology,
Universityof Queensland, Brisbane, QLD, Australia.
Bone sustains microdamage (Mdx) as a result of fatigue loading.
Animal studies have demonstrated that Mdx is targeted for repair
by bone remodeling.
The aim of this study is to describe the incidence of Mdx in the
normal and osteoarthritic human proximal femur, and to present a
preliminary analysis of the relationship between in vivo Mdx and
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mRNA gene expression of factors involved in the regulation of
bone remodeling.
An intertrochanteric trabecular bone biopsy, of the proximal femur,
was taken from 33 patients with primary hip osteoarthritis (OA) (18
females, 15 males; median age 73 years) and 12 controls (C)
taken at autopsy (7 females, 5 males; median age 68 years). In
vivo Mdx was identified in 70~m sections using the basic fuchsin
en bloc staining technique. The following were measured: bone
volume fraction (BVITV), crack length (Cr.Le), crack density
(Cr. On), crack surface density (Cr.S.On), and damaged bone
fraction (OxV/BV). For 15 OA and 12 control cases total RNA was
isolated from half of each bone sample for semi-quantitative
RT-PCR analysis of mRNA expression of the osteotropic cytokines
interleukin (IL)-6 and IL-11, and the housekeeping gene GAPOH.
There was no difference between the OA and control groups for
BVITV, Cr.On or Cr.S.On. In OA, Cr.Le was significantly lower
(mean±SO, OA :51±18, C :63±13; p<0.03) and OxV/BV was
significantly increased (median, OA: 3.6(1.6-7.3), C: 0.47(0-2.11);
p<0.005). This may be indicative of an effective inhibition of crack
propagation, consistent with reported hypomineralised bone in OA.
In addition, the IL-6/GAPOH ratio was positively associated to
Cr.On (p<0.05), Cr.S.On (p<0.02) and OxV/BV (p<0.01) in OA. In
the pooled data sample, the IL-11/GAPOH ratio increased as
Cr.Le increased (p<0.02). Collectively these associations are con-
sistent with Mdx providing a stimulus for osteoclastic bone resorp-
tion, which may occur via Mdx altering the local osteocyte
environment, resulting in the stimulation of a bone remodeling
repair response.
PS03
TRABECULAR BONE ARCHITECTURE IN PRIMARY
OSTEOARTHRITIS
NL Fazzalari,1,2 JS Kuliwaba,1.2 MR Forwood,3 OM Findlay,4
1Div of Tissue Path, Instituteof Medical& VeterinaryScience,
Adelaide, SA, Australia,2Dept of Path and 4Dept of
Orthopaedics& Trauma, Uni ofAdelaide,Adelaide, SA,
Australia,and 3Dept ofAnatomy& DevelopmentalBiology,
Uni of Queensland, Brisbane, QLD, Australia.
Recent studies have shown that elevated bone mineral density is
associated with a subsequent accelerated joint space narrowing
rate. The aim of this study was to examine the trabecular bone
architecture and mRNA gene expression of factors involved in the
regulation of bone remodeling in osteoarthritis (OA). The study
group comprised of 28 patients operated on for severe primary hip
OA (9 males, 19 females, mean age 72 (60-83) years). Half of the
patients had vertical iliac crest biopsies taken during surgery. The
control group comprised of 69 normal proximal femora and a
wedge sample of iliac crest taken at autopsy. The controls were
divided into two groups; 32 subjects older than age 50 years (9
males, 23 females, 73 (57-95) years), and 37 subjects younger
than 50 years (20 males, 17 females, 27 (10-49) years). Undecal-
cified bone histology was prepared to histomorphometrically deter-
mine the trabecular bone volume fraction (BVITV) at three
proximal femoral sites and the iliac crest. For 15 OA and 12 control
cases total RNA was isolated from half of each bone sample for
semi-quantitative RT-PCR analysis of mRNA expression of the
osteotropic cytokines, Receptor Activator of NF-KB Ligand
(RANKL), its cognate receptor, RANK, and a naturally occurring
antagonist of RANKL, termed osteoprotegerin (OPG). At all four
sample sites, both the younger than 50 years and OA group had
BVITV values greater than the group older than 50 years. In
addition, by combining histomorphometric and molecular analyses,
'molecular histomorphometry', we have shown in the control bone
samples that the RANKL:OPG mRNA ratio correlates strongly with
trabecular bone volume (r = -0.67, p<0.05), erosion surface (r =
0.93, p<0.001), and osteoid surface (r = 0.80, p<0.001). Impor-
tantly, we have also shown that these associationsdo not holdin
OA bone, indicating that the regulation of bone turnover is different
in OA. Our data suggest that the cytokines we have measured,
using the experimental approach of 'molecular histomorphometry',
have the potential to elucidate the underlying molecular mecha-
nisms that lead to trabecular structures in primary OA, and provide
new diagnostic and treatment strategies. Treatments for OA are
currently limited and do not even consider the restoration of normal
bone architecture. A therapy that could restore normal bone
architecture would potentially have major clinical benefits and
broader application in the treatment of bone diseases, especially
adult onset bone diseases.
PS04
THE ROLE OF TYPE 1 HOMOTRIMER IN OA BONE
AJ Bailey, CA Miles, L Knott and TJ Sims
Collagen Research Group, UniversityofBristol,Bristol,UK
Aims: Our recent studies have re-emphasised the role of bone in
osteoarthritis by demonstrating increased metabolism of subchon-
dral bone collagen in osteoarthritic human femoral heads. The aim
of the present study is to determine whether there are any
phenotypic changes in the nature of this collagen.
Methods: The decalcified bone was solubilised and the chain
composition determined by SDS-PAGE. Collagen content, Iysyl-
hydroxylation and intermolecular cross-links were determined by
amino acid analyser. Electron microscopy was carried out on
uranyl acetate stained sections. Denaturation temperature and
enthalpy were determined by DSC. For comparison, type I homo-
trimer collagen was isolated from the aim model mouse in which
the a 2 chain is absent.
Results: The ratio of a1 to a2 varied from 6:1 to 17:1 in the OA
bone compared to 2:1 for the non-osteoarthritic bone indicating the
presence of a significant proportion of type I homotrimer. TEM
examination of OA bone showed thin, poorly organised collagen
fibrils. Comparative studies on the type I homotrimer from the aim
model revealed a significant reduction (27%) in intermolecular
cross-linking and mechanical strength (50%). The denaturation
temperature (Tm) of the homotrimer was 2.3?C higher than the
wild type. The Tfibre -Tmolecule was significantly lower for the
homotrimer indicating looser packing of the molecules in the fibre.
Calculation of the volume fraction of water confirmed an increased
separation (7%) of the molecules in the fibre this accounting for the
reduced cross-linking.
Conclusions: Newly synthesised human bone collagen in OA
clearly comprises a high proportion of type I homotrimer, which,
together with the increase in Iysyl hydroxylation, results in
weaker, poorly organised fibrils and consequently reduced mech-
anical properties of OAbone. Studies on type I homotrimer from
aim bone revealed an increased separation of the molecules in
the fibre due to a higher water content in the absence of the a2
chain. This indicates that the more hydrophobic a2 chain is
essential in the normal heterotrimer in driving out water to
achieve tighter packing of the molecules in the fibre. Changes in
the collagenous framework of the human femoral head clearly
playa role in the progression of OA and are worthy of further
investigation.
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PS05
THE PROTECTIVE EFFECTS OF CALCIUM PENTOSAN
POLYSULFATE ON ARTICULAR CARTILAGE AND
SUBCHONDRAL BONE IN THE MEDIAL COMPARTMENT OF
JOINTS OF AN OVINE MODEL OF OSTEOARTHRITIS
INDUCED BY LATERAL MENISCECTOMY
Su-Yang Hwa, Daniel Burkhardt, Susan M Smith,
Margaret M Smith, and Peter Ghosh'
InstituteofBone and JointResearch at the Royal North Shore
Hospital, DepartmentofSurgery, Sydney, Australia
Introduction: Calcium pentosan polysulfate (CaPPS) exhibits a
wide range of anabolic and anti-catabolic effects on articular
cartilage (AC) and synovium in animal models of arthritis. The aim
of the present study was to investigate the effects of CaPPS on the
medial compartment of osteoarthritic (OA) ovine joints.
Methods: Twelve of 18 aged ewes were subjected to bilateral
lateral meniscectomy to induce OA. Six of the OA ewes were
administered a dose of 20mg/kg of CaPPS orally twice a week for
24 weeks (OA+CaPPS). The fluorescent bone marker, calcein was
given two weeks before sacrifice at 26 weeks. The medial femoral
condyle (MFC) and medial tibial plateau (MTP) of joints were
prepared for the assessment of AC damage, histomorphometry,
bone mineral density (BMD), optical density (00) of collagen
birefringence. The subchondral bone (SCB) remodeling was
assessed by vascularity, and bone fluorescent labeling.
Results: The BMD of SCB in the MFC of OA ewes were signifi-
cantly decreased while the AC damage scores of MFC and MTP
were significantly increased. In contrast, the AC damage score of
OA+CaPPS animals were significantly decreased in the middle
zone of MTP. Moreover, the thickness of CC of MFC and MTP of
the OA+CaPPS group were significantly less than the untreated
OA group. The 00 values of collagen birefringence of MFC and
MTP of the OA+CaPPS group were significantly changed in the
superficial and deep zones of AC while the vascularity of MFC and
MTP of the OA+CaPPS group was significantly decreased com-
pared to the non-treated OA group. The extent of fluorochrome
labeling observed in sections of the MFC of the OA+CaPPS
animals was significantly decreased.
Conclusion: In this study, it was clearly shown that oral treatment
with CaPPS effectively retarded the progression of these OA
changes in the superficial and deep zones of AC and SCB of the
medial compartment of the laterally meniscectomised joints. These
studies therefore provide additional support for the use of CaPPS
as a structure-modifying osteoarthritic drug (SMOAD).
PS06
PROSTHESES CAUSE A DECREASE IN BONE GROWTH
FACTOR CONTENT
G Gibson, B Zhang and C Les Bone
JointCenter, Henry Ford Hospital, Detroit, MI, USA
The objective of these studies was to examine the influence of
prosthetic implants on the growth factor content of the surrounding
cortical bone.
METHODS: Under local IACUC approval, four groups of rats (15
per group) were anaesthetized. Groups 1 to 3 had cobalt-chrome,
titanium or polymethyl methacrylate (PMMA) prostheses placed in
the femur and one group four was reamed only. Animals were
sacrificed in groups of five 3, 7 or 14 days later. Femurs were
divided into equal segments. Blocks were fixed and cross-sections
stained for growth factors TGF-beta, TGF-beta 2, TGF--beta 1 and
VEGF after prior digestion with chondroitinase ABC and colla-
genase. Other segments of each femur were cleaned of soft
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tissues, powdered under liquid nitrogen and growth factors
extracted. The content of three growth factors TGF-beta 1, TGF-
beta 2 and VEGF were analyzed by specific ELISA. Growth factor
level in operated femur was compared with that of the unoperated
contralateral control.
RESULTS: The content of TGF-beta 2 in femoral cortical bone was
clearly influenced by implant insertion. Ti, CoCr and PMMA all
caused a 40 to 60% decline in TGF-beta 2 content by 7 days after
surgery. Reaming without implantation also caused loss of TGF-
beta 2 though it was not significant until two weeks after surgery.
No significant change in the level of TGF-bl or VEGF was seen.
Immunohistochemical detection showed a similar distribution of
the growth factors around osteocytes and vascular canals within
the bone. Studies completed to date showed no clear difference in
growth factor distribution with implantation.
CONCLUSION: Prosthesis implantation caused a loss of TGF-
beta 2 from the cortical bone matrix. This might be expected to
influence new bone growth around the prosthesis and contribute to
implant stability. A clearer understanding of the role of bone growth
factors in generation of new bone has the potential to provide a
greater understanding of the causes of implant stability and
loosening.
PS07
PICROSIRIUS RED CANNOT STAIN HUMAN COLLAGEN
NETWORK IN DEEP ARTICULAR CARTILAGE DUE TO
PROTEOGLYCAN HINDRANCE
1Hyttinen MM, 1Rieppo J, 2Hallikainen J, 1Helminen HJ
Departmentsof 1Anatomyand 2AppliedPhysics, Universityof
Kuopio, Kuopio, Finland.
Introduction: Collagen network of articular cartilage exhibits large
variation in local density, orientation, degree of anisotropy and
birefirengence. Picrosirius red (PSR) staining has been widely
used in the polarized light microscopy of healthy and osteoarthritic
collagen network. The aim was to find out if picrosirius red (PSR)
could be used for specific signal enhancement in quantitative
polarized light microscopy of articular cartilage collagen.
Materials and methods: Series of PSR-stained histological sec-
tions from human patellar articular cartilage were compared with
unstained sections. The effect of glycosaminoglycan (GAG)
removal by testicular hyaluronidase digestion on PSR staining was
studied as well. Staining was validated by a computerized polar-
ized light microscopy method capable for quantitative analysis of
birefringence, orientation and anisotropy of collagen fibrils. PSR
distribution in histological sections was measured by digital densi-
tometry. GAG residues after hyaluronidase treatment were stained
with safranin-O.
Results and conclusions: Unstained and PSR-stained sections
exhibited totally different distribution of birefringence in human
articular cartilage. PSR absorbance and enhanced birefringence
were highest in the superficial zone while in the unstained sections
the maximum was in the deep zones. Prolonged hyaluronidase
(1000U/ml, up to 48 h) did not completely remove cartilage GAGs
judged from safranin-O stained sections. This enzyme' resistant
GAG barrier very likely prevents stoichiometric PSR binding to
collagen.
PS08
CARTILAGE THICKENING OCCURS THROUGHOUT THE
OVINE STIFLE (KNEE) JOINT AFTER MEDIAL
MENISCECTOMY
Oakley SP+, Appleyard RC+, Szomor 2+, Portek 1+, Kirkham B#,
Lassere MN+
+ St George Hospital, Sydney, # Guy's and St. Thomas'
Hospital, London
Introduction: We have previously shown that "softening" (reduc-
tions in elastic modulus) occur throughout the ovine stifle under-
going arthroscopic assessments after medial meniscectomy. We
have also studied cartilage thickness in these joints.
Aim: To determine the extent and magnitude of changes in
cartilage thickness throughout the ovine stifle after medial
meniscectomy.
Methods: Twenty stifle joints were examined (4 normal, 4 at 4
weeks and 12 at 16 weeks post-medial-meniscectomy). Six carti-
lage surfaces (patella, trochlea, femoral condyles and tibial pla-
teaus) were evaluated in each stifle. A grid of 30-80 reference
points were marked on each surface using india ink. Cartilage
thickness was measured at each reference point using a needle
indentor and micrometer. Measurements were blind to stifle iden-
tity and duration of disease. Analysis was performed using oneway
ANOVA with multiple comparisons (Bonferroni method).
Results: Significant increases in cartilage thickness occurred after
medial meniscectomy at all surfaces except the lateral tibial
plateau. Further thickening occurred between 4 and 16 weeks at
the patellar, trochlear medial femoral and medial tibial surfaces.
Table: Thickness millimetres - Mean (Number of observations)
Time PAT TAO MFC LFC MTP LTP
oWeeks 1.00 0.83 1.07 0.84 1.02 0.98
(143) (275) (168) (136) (158) (199)
4 Weeks 1.18 1.09 1.22 1.12 1.24 1.16
(132) (2?9) (163) (150) (144) (198)
16 Weeks 1.39 1.38 1.55 1.17 1.46 1.37
(436) (763) (556) (446) (476) (625)
...### •••## •••### •••#
P<0.001 •••, p<0.01 ••, p<0.05 • for comparisons with 0 weeks.
P<0.001 # # #, p<0.01 # #, p<0.05 # for comparisons with 4 weeks.
Conclusions: There are widespread changes in the stifle in
response to localised insult. Thickening of similar magnitude
occurs in the medial and the patellofemoral compartments with
lesser changes in the lateral compartment. The mechanism for
these widespread changes is most likely altered biomechanical
stresses throughout the stifle although the effect of arthroscopic
procedure upon cartilage thickness is unknown.
PS09
CELLULAR AND MATRIX CHANGES EXIST THROUGHOUT
THE STIFLE JOINT AFTER MEDIAL MENISCECTOMY -
EVALUATION OF RESPONSIVENESS OF A NEW
HISTOLOGICAL METHOD OF ASSESSMENT
Oakley SP+, Ghosh P', Szomor 2+, Portek 1+, Kirkham B#,
Lassere MN+
+ St George Hospital, Sydney, • Royal North Shore Hospital,
Sydney, # Guy's Hospital, London.
Introduction: The use of chondroscopy to follow the progression
of joint changes in OA is gaining popularity but the diffiCUlty of
quantifying articular cartilage (AC) pathology has limited its appli-
cation.
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Conclusions: Stiffness decreases as structural damage and thick-
ness increase, consistent with evidence that collagen disruption is
i~portant in affecting this biomechanical parameter. Univariate analy-
SIS found that TB loss and structural damage had similar magnitude
of effect but multivariate p values reveal that correlation with TB loss
is weaker. "Total TB" loss appeared as sensitive as other methods of
TB grading. Number of tidemarks became significant (p<0.001) when
evaluated separately. These findings may not in themselves explain
the changes in shear modulus and may simply be co-phenomenae
that occur with or in response to collagen disruption.
(1) Little C et al J Rheumatol 1997,24; 2199.
(2) Oakley SP et ai, OARSI Sydney Congress, 2002 (submitted).
PS11
EVALUATION OF RELIABILITY OF A NEW HISTOLOGICAL
METHOD OF ASSESSMENT OF OSTEOARTHRITIC
CARTILAGE
Oakley SP+, Ghosh po, Szomor Z+, Portek 1+, Kirkham B#,
Lassere MN+
+ St George Hospital, Sydney, • Royal North Shore Hospital,
Sydney, # Guy's Hospital, London.
Introduction: Use of chondroscopy to evaluate joint changes in
OA is gaining popularity but the difficulty of quantifying articular
cartilage (AC) pathology has limited its application. The reference
standard for chondroscopy should be histopathology. Tne refer-
ence standard should be both reliable and responsive (able to
detect change). Measurement scales with greater detail are
responsive but reliability can be compromised.
Aim: Using an ovine model of OA we are examining this problem and
report here the reliability of a two methods of evaluating the histo-
logical changes which occur within joints following the induction of OA.
Methods: 20 stifles were examined (4 un-meniscectomised, 4 at 4
weeks and 12 at 16 weeks post-medial-meniscectomy). Six AC
surfaces (patella, trochlea, medial and lateral femoral condyles
and tibial plateaus) were evaluated at 5-7 reference points across
each AC surface. Sections were stained with toluidine blue (TB)
and photomicrographs taken at each reference point. These were
blinded, randomised and graded using the method of Little C et al
(J Rheumatol 1997,24;2199). The new method added grades for
slight increases in Cellularity and Territorial TB, divided the "Tide-
mark score" into "Tidemark number" and "Extent of vessel inva-
sion", and estimated "Total TB loss" and Inter-territorial TB loss on
a scale of 0-100. One observer graded 702 photo-micrographs
twice. Reproducibility was summarised as weighted kappa coeffi-
cients (Kw) and as intra-class correlation coefficients(ICC).
Regression Coefficient (p)
Older Method(1) New Method(2)
Kw 0.68
-0.01 (0.020)
-0.27 (0.001)
-0.13 (0.131)
0.2724
-0.95 (0.000)
-0.12 (0.000)
0.00 (0.965)
+0.10 (0.001)
New Method
Kw 0.61
ICC 0.82 (0-100 scale)
ICC 0.78 (0-100 scale)
Kw 0.59
Kw 0.55
0.2778
-1.00 (0.000)
-0.13 (0.000)
+0.07 (0.449)
+0.12 (0.000)
-0.10 (0.219)
-0.18 (0.046)
-0.10 (0.110)
Kw 0.84
Kw 0.68
Kw 0.71
Kw 0.61
Kw 0.76
Kw 0.54
-0.47
-0.50
-0.17
+0.22
-0.28
-0.40
-0.41
-0.17
-0.31
-0.02
Spearman
Rho
Method of Little
et al
Cartilage Thickness (mm)
Structural damage (0-10)
Cellularity (0-4)
Cloning (0-4)
Territorial T8 loss (0-4)
Inter-Territorial T8 loss (0-4)
Total T8 loss (0-100)
Tidemark Aggregate (0-3)
Tidemark Number (1-4)
Tidemark Vessels (0-3)
R-squared for model
Table:
Result
Structural damage
Cellularity
Cloning
Territorial T8 loss
Inter-Territorial T8 loss
Total T8 loss
Tidemark Aggregate
Tidemark Number
Tidemark Vessels
Results: 674 locations were evaluated. G ranged from 0.09-
6.71MPa (mean 1.97). Thickness ranged from 0.11-3.24 mm
(mean 1.24).
Aim: Using an ovine model of OA we are examining this problem
and report here the responsiveness of a new method of evaluating
the progression of histological changes which occur within joints
following the induction of OA.
Methods: 20 stifles were examined (4 normal, 4 at 4 weeks and 12
at 16 weeks post-medial-meniscectomy). Six AC surfaces, patella
(PAT), trochlea (TRO), medial (MFC) and lateral (LFC) femoral
condyles and tibial plateaus (MTP, LTP) were evaluated at 5-7
reference points across each AC surface. Sections were stained
with toluidine blue (TB) and photomicrographs taken at each
reference point. These were blinded, randomised and graded
using a modification of the method of Little C et al (J Rheumatol
1997,24;2199). The "tidemark score" was divided into "tidemark
number" and "extent of vessel invasion". A new method of
estimating "total TB loss on scale of 0-100" was trialled. Analyses
of changes over time at each cartilage surface were performed
using oneway ANOVA with mUltiple comparisons. The magnitude
of increase was expressed in proportion to baseline (e.g. "16x"
indicates 16 fold increase).
Results: 702 photomicrographs were graded. Increases in struc-
ture scores were greatest at the TRO (16x, p<0.001) and lowest at
the LTP (1.6x, p<0.05). Significant increases in cellularity (at all
surfaces) were greatest at LFC (8x, p<0.001). Increases in cloning
were seen only at the PAT (2x, p<0.001) and LFC (4x, p<0.001).
Inter-territorial TB scores did not increase. Territorial TB scores
increased significantly only at MTP (5x), LFC (4x) and MFC
(2x).Total TB scores increased dramatically at TRO (16x, p<0.001),
MTP (8x), MFC (6x) (p<0.001) and less so at LTP (1.7x) and LFC
(3.3x).~ Tidemark number decreased at the MFC and LTP
(p<0.001). Tidemark vessels increased at PAT, TRO, MFC and
LFC.
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Conclusions: This method for assessing tissue changes in OA
joints is responsive and easy to use. The better performance of
"total TB loss" at surfaces with less severe OA may be due to the
larger range of values on the scale. This has important implications
for histological measurement of outcome in trials. Similar improve-
ments might be seen with other domains of scoring with the
introduction of more detailed scales.
THE RELATIONSHIP BETWEEN STIFFNESS (SHEAR
MODULUS), THICKNESS AND HISTOLOGIC GRADING OF
CARTILAGE USING DIFFERENT SCORING METHODS
Oakley SP+, Appleyard RC+, Ghosh po, Szomor Z+, Portek 1+,
Kirkham B#, Lassere MN+
+ St George Hospital, Sydney, * Royal North Shore Hospital,
Sydney, # Guy's and St. Thomas'Hospital, London
Aim: To determine the relationship between shear modulus (G)
and different components of histological grading of normal and
osteoarthritic (OA) cartilages.
Methods: 20 ovine joints were examined (4 normal, 16 OA).
Cartilages from six joint regions were evaluated. Shear modulus
(G) was measured blindly at 5-7 points across each joint surface.
Photomicrographs of toluidine-blue (TB)-stained sections at each
reference point were histologically graded blind using an estab-
lished (1) and a new method (2). The relationships between the
histological evaluations and G were evaluated by Spearman
correlation and multiple linear regression with G as the outcome
variable.
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Observer Exact Reproducibility Average Range Median
reproducibility within 8 pts. difference
Average difference: Average difference between first and second
score for each observer, and between the first score of both
observer.
PS13
DETERMINATION OF CONCENTRATIONS OF HYALURONAN
AND AGGRECAN, AND HYALURONAN SIZE REQUIRED FOR
MAINTENANCE OF ELASTICITY OF JOINT FLUID AND
CARTILAGE
Conclusions: While there is often a trade-off between reliability
and responsiveness, the addition of grades and continuous scales
and the division of the tidemark domain did not the compromise the
reliability of these methods. Further work evaluating responsive-
ness of these methods is underway (Oakley SP et ai, Sydney
OARSI Congress 2002 - submitted).
VALIDATION OF AN APPARTATUS TO STUDY CONNECTIVE
TISSUE AND CELLS UNDER HYDROSTATIC PRESSURE
Methods: The elasticity of hyaluronan (1000, 3300 kDa) and the
aggrecan-hyaluronan complex was determined using an oscillat-
ing rheometer. Hyaluronan at 0.001-5 mg/ml and/or aggrecan at
10-50 mg/ml which included in the joint fluid and/or cartilage were
tested.
Results: The elasticity of 3300 kDa hyaluronan solution at 4-5
mg/ml was similar to that of cartilage matrix-like solution containing
3300 kDa hyaluronan (0.5 mg/ml) and aggrecan (50 mg/mi) at high
frequency, suggesting the cooperative role of joint fluid and carti-
lage during movement. Aggrecan solution (50 mg/ml) alone had
viscosity but not elasticity. However, the addition of 3300 kDa
hyaluronan at 0.001-0.1 mg/ml increased the elasticity, but addition
of higher concentrations of hyaluronan did not increase the elas-
ticity. The elasticity of the aggrecan-hyaluronan solution reached a
plateau at a 500:1 (w/w) ratio. 1000 kDa hyaluronan had far less
effect on the elasticity of the aggrecan solution than 3300 kDa
hyaluronan.
Conclusions: Only -50% reduction in hyaluronan concentration
«2 mg/ml) in joint fluid or aggrecan concentration «20 mg/ml) in
cartilage, or reduced hyaluronan size (1000 kDa) in the fluid or
cartilage, can abolish the elastic function of joint fluid or cartilage.
Intraarticular injections of large hyaluronan may have beneficial
effects on OA patients partly due to the increase in the elasticity of
joint fluid and damaged cartilage.
PS14
V Tasevski, JM Sorbetti, K Paulson, J-F Wang, NG Shrive, DA
Hart
Me Caig Centre for JointInjuryandArthritisResearch, Facultyof
Medicine, Universityof Calgary, Alberta, Canada.
Connective tissues such as cartilage, menisci and bone function in
a mechanically active environment and alterations in such environ-
ments can lead to tissue degeneration and osteoarthritis. The aim
of this study was to develop and validate an apparatus allowing the
analysis of large numbers of cells or explants under defined
mechanical loading in order to facilitate basic studies and drug
development through high throughput screening.
Methods: Cells were cultured either in monolayer or three
dimensional cultures in modified commercially available multi-well
plates containing sterile medium. Prior to an experiment, pre-
sterilized non-toxic oil is overlayed on top of the culture medium,
thereby creating a microenviroment where the cells remain
viable. Plates were then immersed into a purpose built apparatus
containing oil at the required temperature. A piston is inserted
into the apparatus with a tight seal. Motion of the piston is
computer controlled, and creates the hydrostatic pressure
required. By altering software parameters, either static or cyclic
hydrostatic pressure can be applied for various times. For the
validation experiments, both primary cells (porcine) and cell lines
(human) have been evaluated for loading effects +/- biological
modulators on gene expression (RT-PCR, gene arrays), cell
proliferation, and protein expression.
Results: Using this system, it has been shown that biologically
relevant loading protocols can up or down regulate mRNA (4-6
fold changes) for a subset of genes, modify responsiveness to
growth factors (TGFB) and hormones, alter cell morphology and
influence the differentiation state of cells using specific markers.
RNA, DNA, and protein have successfully been extracted from
cells following hydrostatic loading for up to 20 hrs using intermit-
tent cyclic loading protocols (0.5-1 MPa). Both primary cells, and
cell lines have been used in the proof of concept validation
studies.
2,6 (-31)-(36) 15
-1,4 (-24)-(36) 9,5
2,0 (-40)-(34) 12
84%
92%
80%
49%
49%
48%
A
B
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TOWARDS STANDARDIZATION OF OA CARTILAGE
HISTOPATHOLOGY; REPRODUCIBILITY OF PROPOSED
SYSTEM (THE BARCELONA DRAFT)
Hyllested, JL, Veje, K and Ostergaard, K
OsteoarthritisResearch Unit, Institutefor Inflammation,National
UniversityHospital, Copenhagen, Denmark.
Objective: The Histologic/Histochemical Grading System devel-
oped by Mankin and coworkers is neither adequately reproducible
nor sufficiently valid. At the OARSI congress 2000 in Barcelona,
Spain a new Histologic / Histochemical Grading System was
proposed. The objective of this study is to evaluate the intra- and
interobserver reproducibility of the proposed system.
Methods: Human articular cartilage was obtained from macro-
scopically normal and OA (Collins Mc-Elligot grade 0 and III/IV,
respectively) knee joints. Sections of central and peripheral
regions of normal samples and sections of OA samples containing
severe, moderate and mild OA changes were produced. A total of
88 sections were graded twice by two observers. The sections
were graded and staged, and a score calculated by multiplying the
grade with weighted stage.
Results: Intra- and interobserver reproducibilities
Range: Range of differences between first and second score for
each observer and between first score of both observers.
Median: Median of the first and second score for each observer
and for the first score of both observers.
95% Confidence Interval: The range of scores which contains the
true median with probability 0,95.
Conclusion: The proposed system is reproducible and could form
the basis of a new histologic/histochemical grading system.
M. Nishimura, M. Kawata', A. Okamoto', T. Hamada, Y. Kato
Graduate SchoolofBiomedicalSciences, HiroshimaUniversity,
Japan Research Center, Denki Kagaku Kogyo Co. Ltd., Japan
The aim of this study was to determine concentrations of
hyaluronan and aggrecan and hyaluronan size required for
maintenance of the elasticity of joint fluid and cartilage.
Conclusion: A unique loading apparatus has been developed and
validated which allows for multiple cells types, or multiples of a
given cell type under different biological conditions, to be subjected
to defined cyclic or static loading conditions. This system offers the
opportunity to evaluate more accurately the interplay between
biology and biomechanics in diseases where tissues and cells
such as cartilage, menisci and bone are affected.
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EFFECTS OF GLUCOSAMINE ON THE CATABOLISM OF
AGGRECAN IN ARTICULAR CARTILAGE
MZ lIic, B Martinac and CJ Handley
SchoolofHuman Biosciences,LaTrobe University,Melbourne,
Australia
Aim of study was to establish the outcome of the long-term
exposure of explant cultures of articular cartilage to glucosamine
(GlcN) on the stimulated aggrecan loss from the tissue.
Methods: The loss of 35S-labelled and chemical levels of aggre-
can, from the matrix of retinoic acid stimulated articular cartilage
explants maintained in the presence of GlcN at concentrations of
up to 10 mM for period of 9 days, was determined. The prophylac-
tic effect of (GlcN) on aggrecan degradation was investigated by
treating the articular cartilage cultures with 5 mM GlcN for 5 days
and then continuing the culture for further 10 days. The direct effect
of GlcN on aggrecanase acitvity was investigated using soluble
aggreGanase activity derived from cultures of synovial capsule to
digesf aggrecan monomer in the presence of GlcN. The effect of
GlcN on the metabolic activity of chondrocytes was assessed by
lactate production and protein synthesis.
Results: GlcN inhibited aggrecan degradation in explant cultures
of articular cartilage stimulated with retinoic acid in a dose depend-
ant manner. The withdrawal of GlcN from the cultures resulted in
an enhanced loss of aggrecan from the matrix similar to control
cultures. GlcN did not inhibit soluble aggrecanase activity. GlcN did
not have an adverse effect on the chondrocyte metabolism.
Conclusions: GlcN inhibited stimulated loss of aggrecan from
explant cultures of articular cartilage but this effect did not persist
when it was removed from the culture medium. The effect of GlcN
on the degradation on aggrecan is likely to be through the
regulation of aggrecanase activity and not through the direct
inhibition of aggrecanase activity.
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SINGLE MOLECULE STIFFNESS OF TYPE II COLLAGEN
AND HYALURONAN
YL Sun, T Fujii, A Fertala, KN An, ZP Luo
BaylorCollege of Medicine, Houston, TX, USA
Aim of study: To quantify mechanical properties of two important
molecules in cartilage, type II collagen and hyaluronan, at the
single molecule level.
Methods: The experiment was performed on a nano-mechanical
testing system, consisting of an optical tweezers and an interfer-
ometry system built in an inverted microscope. A piezo-stage with
a resolution of 1 nm was mounted on a motorized x-y stage. The
tested molecules were linked at one end to a large polystyrene
bead immobilized between two cover slips fixed on the piezo-
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stage, and at the other end by a small polystyrene bead trapped by
the optical tweezers and monitored by the interferometer. The
molecule was stretched slowly by moving the stage away from the
trapping center. The deformation of the molecule was determined
as the displacement difference between the large bead (or the
piezo-stage) and the trapped small bead. The force applied on the
molecule was equal to the trapping stiffness multiplied by the small
bead displacement. A LabVIEW''' program was created to control
/monitor the piezo-stage motion and to measure the trapped bead
displacement. The typical collagen molecule from recombinant
procollagen II was linked to two beads. Cystines in the propeptides
were reduced with dithiothreitol and biotinylated. The molecules
were then attached onto the streptavidin-coated beads. The
hyaluronan was attached to two amino-modified polystyrene beads
by covalent cross-links of the carboxyl group on the chain. The
force-extension relationship was fitted into the Marko-Siggia worm-
like chain model using a nonlinear least square method. The
molecule contour length and the persistence length, a measure of
bending rigidity, were then determined.
Results: The molecules were stretched to almost their entire
contour lengths by a force « 3 pN), which increased sharply as
they neared their contour lengths. The persistence lengths of
11.2±8.4 nm and 4.5±1.2 nm were obtained for single type II
collagen and hyaluronan molecules, respectively. The contour
lengths of type II collagen and hyaluronan molecules were
295.8±31.9 nm and 2.65±1.44 ~m, respectively.
Conclusions: Type II collagen shows significantly higher stiffness
(persistence length) than the hyaluronan, which supports our
general concept that collagen is the major structure in resisting
tension. More importantly, such information about single molecule
biomechanics may aid understanding of cell mechanotransduction
because it is at this level that the interactions of cells and
extracellular matrix occur. It also may address questions which
gross-level biomechanics cannot.
PS18
CULTURED CARTILAGE AND CHONDROCYTES ARE
REGULATED DIFFERENTLY BY CYCLIC COMPRESSION
AND TENSION
S Kamineni, G Heers, TJ Oegema Jr, KN An, ZP Luo
BaylorCollege ofMedicine, Houston, TX, USA
Aim of study: To test that cartilage matrix and chondrocytes are
highly sensitive to mechanical environments and, specifically, are
regulated differently by compression and tension.
Methods: Porcine chondrocytes from 3-month old piglets were
cultured on a flexible membrane (Flexcell International) for 10
weeks, to establish sheets of cartilage approximately 150 1m thick.
The sheets were subjected to cyclic compression (1.3KPa at 1Hz)
or tension (10% strain at 1 Hz), with an equivalent control for each
test condition for either 16 or 32 hours, after which the cells were
rested in an incubator for 16 hours. All the cartilage sheets were
then stained with alcian blue and examined under a confocal
microscope for quantification of proteoglycan content in the matrix.
Statistical analysis of ANOVA with a post-hOC test was used.
Results: Proteoglycan staining covered 46% (28%-61%) of the
membrane surface area following 32 hours of compression testing,
39% (26%-49%) following 16 hours of compression, 23% (15-49%)
for control samples, 19% (10%-29%) following 16 hours of tension,
and 16% following 32 hours of tension. Proteoglycan content
following cyclic compression, both 16 and 32 hours, was signifi-
cantly greater than with cyclic tension or control (p<0.0001).
Although the two time periods in compression visually increased,
this was not statistically significant. No statistical differences were
found between the control and tension groups, although the
staining density and the size of stained areas visibly decreased.
Conclusion: Our results suggest that cartilage is highly respon-
sive to the mechanical loading, with rapid and robust adaptation to
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the mechanical environment. The high sensitivity suggests that
subtle changes in the joint mechanical environment may alter the
cartilage matrix structure. Since poor content of proteoglycan has
been considered a detrimental factor in the integrity of cartilage
matrix, cartilage degradation and the possible formation of oste-
oarthritis may be the consequence of chondrocyte response to
altered joint loads.
PS19
THE EFFICACY OF SMALL MOLECULE MMP INHIBITORS IS
IMPACTED BY THE ABILITY TO PENETRATE CARTILAGE
EXTRACELLULAR MATRIX
X Yang, J Tillett, S Glasson, M Geck, N Mollova, Q Wang,
E Morris
Wyeth Research. Cambridge, Massachusetts.
Aim: To assist in creating a profile which would enable prediction
of therapeutic efficacy, we evaluated the ability of small mol-
ecules to prevent cartilage degradation ex vivo, and correlated
this with the ability of the compound to penetrate the cartilage
matrix
Methods: Two compounds (designated MPI-1 and MPI-2) with
similar in vitro potency against MMP-13, molecular weight, per-
meability, lipophilicity, and protein binding characteristics were
assayed for their ability to inhibit collagen degradation in an ex vivo
assay. YOJJng bovine articular cartilage explants were cultured with
or without human IL-1 a (5ng/ml) in the presence or absence of
inhibitor for 18 days. Conditioned media and explants were col-
lected for determination of collagen degradation by measurement
of hydroxyproline released and remaining in the explant. For the
inhibitor penetration study, explants were cultured with inhibitors
for 3 days. The explants were powdered and the inhibitors
extracted with acetonitrile. Liquid chromatography tandem mass
spectroscopy (LC-MS/MS) was used to determine the quantity of
inhibitors in the cartilage explants.
Results: After 18 days in the presence of IL-1a, bovine articular
cartilage explants released 32.7%±1.64% of their original collagen
content into the media. Addition of 10 ng/ml MPI-1 to those cultures
inhibited this collagen release by 70.5%. Addition of 1lJg/ml MPI-1
completely prevented IL-1 induced collagen degradation. In con-
trast, MPI-2 had no effect at 10 ng/ml and prevented only 41.5% of
IL-1 a induced collagen loss at 1lJg/ml. Analysis of the concen-
tration of inhibitor present within the cartilage extracellular matrix
after 3 days in culture revealed a 24-fold greater concentration of
the more effective inhibitor (4.34 ng MPI-1/mg cartilage compared
to 0.18 ng MPI-2/mg cartilage).
Conclusion: Since articular cartilage lacks a blood supply, deliv-
ery of systemic therapeutics must take place through penetration
of drug from the synovial fluid. Our work has demonstrated that the
ability of small molecule MMP inhibitors to penetrate into the
articular cartilage has a major impact on the ability to prevent
extracellular matrix degradation. This attribute should be evaluated
prior to initiating animal studies to evaluate efficacy in models of
osteoarthritis.
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HYDROSTATIC PRESSURE INDUCES APOPTOSIS OF
CHONDROCYTE CULTURED IN ALGINATE BEADS
R Terauchi, K Takahashi, Y Arai, T Ikeda, S Ohashi, *0 Mazda,
*J lmanishi, T Kubo
Departmentsof OrthopaedicSurgeryand *Microbiology,
KyotoPrefecturalUniversityofMedicine, Kyoto, Japan
Aim of the study was to investigate the influence of hydrostatic
pressure (HP) on apoptosis of chondrocytes cultured in alginate
beads.
Methods: Chondrocytes were isolated from articular cartilage of
rabbit joints and seeded in alginate beads. Beads were divided into
two groups. The first group (group A) was exposed immediately to
HP of 10 or 50 MPa for 12 or 24 hours using an apparatus that can
add pressure under sterile conditions. Chondrocytes in alginate
beads of the second group (group B) were cultured for two weeks
until abundant extracellular matrix accumulated around the cells,
then exposed to HP in the same manner. Apoptotic cells induced
by exposure to HP were quantified using the terminal deoxynucle-
otidyl transferase-mediated X-dUTP nick end labeling (TUNEL)
method.
Results: Apoptotic chondrocytes were not observed in the control
cells under atmospheric pressure, whereas apoptosis was
observed in group A cells and the number of apoptotic cells
increased with the duration and magnitude of HP. The apoptosis
rates were 11.0% (12 h) and 20.4% (24 h) when loaded with
10MPa of HP, which increased to 14.2% (12 h) and 59.8% (24 h)
when loaded with 50MPa of HP. On the other hand, there was no
significant population of apoptotic cells observed in group B.The
apoptosis rates were 0.9% (12 h) and 1.2% (24 h) when loaded
with 1OMPa of HP, 1.9% (12 h) and 2.0% (24 h) when loaded with
50MPa of HP.
Conclusions: The results indicated that excessively strong HP
can evoke apoptosis when the extracellular matrix surrounding the
chondrocytes is insufficient. These findings suggest the pathogen-
esis of cartilage degeneration in osteoarthritis.
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EFFECT OF DYNAMIC MECHANICAL STIMULATION AND
GROWTH FACTORS ON CHONDROCYTE MATRIX
SYNTHESIS
DO D'Lima1 ,2, A Bergula2 , PC Chen2 , S Patii2 , N Steklov2 ,
M Lotz1 , CW Colwell Jr.2
1 DivisionofArthritisResearch, The ScrippsResearch Institute,
La Jolla, CA, USA
2 ScrippsClinic, La Jolla CA, USA
Introduction: Surgical reconstruction of cartilage lesions is difficult
and without consistent results. Tissue engineering is a promising
approach to the replacement of cartilage defects with functioning
constructs developed in vitro. This study evaluated the effect of
combined mechanical stimulation and growth factors on chondro-
cyte matrix synthesis.
Methods: Cartilage was harvested from knee articular cartilage of
healthy human cadaver donors. Chondrocytes were isolated and
cultured as 3-dimensional agarose gel disk explants (5 mm x 2
mm). Explants were divided into Control, Dynamic, IGF, and
Dynamic-IGF groups. Dynamic explants were subjected to 10%
dynamic compression at 1Hz, 4 hours a day for 7 days. IGF
explants were cultured in media containing 50 ng IGF-1. Dynamic-
IGF explants were cultured in IGF-1 and also exposed to mechan-
ical stimulation. Cell density, glycosaminoglycan content, and
levels of 35S04 newly incorporated in glycosaminoglycan were
monitored.
Results: Cell density and viability was similar between the four
groups. Matrix synthesis e5S04 uptake) was increased in all three
experimental groups relative to Control: 42% in Dynamic, 70% in
IGF, and 98% in Dynamic-IGF explants. This was also reflected in
the increase in glycosaminoglycan content at the end of 7 days.
Discussion: The combination of biomechanical and biochemical
stimulation appeared to have an additive effect on matrix syn-
thesis. These results provide valuable information toward the
development of tissue engineered articular cartilage.
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Conclusion: AFM is a tool to measure the roughness of the
surface of the articular cartilage. The questions whether the load
induced lower roughness predisposes to osteoarthritis is unknown.
Results: All samples from the various areas showed that cartilage
surface were not smooth; the maximum distance difference
between the lowest and the highest point reached 132nm. The
irregularities varied between the tibia and the femur and according
to the area. Roughness was twice higher in NWB areas than in the
WB areas in both femoral condyle and tibial plateau and this
reached statistical significance,
PS24
ACCELERATION OF CARTILAGE REPAIR BY GENETICALLY
MODIFIED CHONDROCYTES OVER EXPRESSING BONE
MORPHOGENETIC PROTEIN·7
Chisa Hidaka. MD, Laurie R Goodrich, DVM, Chih-Tung Chen,
PhD, Russell F Warren, MD, Ronald G Crystal, MD and
Alan J Nixon, DVM
Hospitalfor SpecialSurgery, New York, NY, USA
Focal cartilage defects can lead to the development of premature
degenerative changes in the affected joint. Chondrocyte transplan-
tation is a promising approach for the repair of cartilage defects
that can lead to the formation of hyaline-like cartilage; however the
healing process can be lengthy. Previously we have shown that
over expression of bone morphogenetic protein-7 (BMP-7) in
chondrocytes by adenovirus-mediated gene transfer leads to
increased matrix synthesis and cartilage-like tissue formation in
vitro. In this context we hypothesized that implantation of geneti-
cally modified chondrocytes expressing BMP-7 would accelerate
the formation of hyaline-like repair tissue in an equine model of
cartilage defect repair. In this study chondrocytes treated with
adenovirus vector encoding BMP-7 (AdBMP-7) or as control, an
adenovirus vector encoding an irrelevant gene (E. coli cytosine
deaminase, AdCD) were implanted into extensive (15 mm diam-
eter) articular cartilage defects in the patello-femoral joints (equiva-
lent to the human knee) of 10 horses. Biopsies performed on 4 of
the 10 horses 4 wk after experimental cartilage repair showed a
high level of BMP-7 expression and markedly more hyaline-like
morphology than control. Cell survival and adenovirus gene per-
sistence were also assessed at the terminal time point 8 mo after
surgery by quantitative real-time polymerase chain reaction. Analy-
sis of repair tissue from 4 of 10 horses in which male donor
chondrocytes had been implanted into female hosts showed that
cell survival, as determined by the number of copies of the Y
chromosome marker SRY, ranged from less than 1% to 28% with
a mean of 4%. In 8 of 10 horses, a mean of 535 copies of CD per
100 cells were detected with a range of 0 to 3307 copies. With only
a very low number of implanted chondrocytes remaining in the
defect, healing in the controls was similar to the AdBMP-7-treated
defects, and no differences were detected in the morphologic,
biochemical or biomechanical properties of the repair tissues
between the two treatment groups 8 mo after surgery. These
studies suggest that genetic modification of chondroctyes to over
express BMP-7 may accelerate cartilage repair; but does not alter
the long term effects of chondrocyte-based repair, possibly
because of the loss of the implanted cells over time. The data also
show the persistence of adenovirus transgene 8 mo after genetic
modification of chondrocytes suggesting that if methods to improve
the persistence of implanted chondrocytes could be developed,
that the effect of Ad-mediated gene transfer in a cartilage defect
could persist for up to 8 mo.
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MATRIX SYNTHESIS IS DEPENDENT ON CHONDROCYTE
VIABILITY AFTER INJURY
DD D'Lima
,
,2, A Bergula2 , PC Chen2 , CW Colwell, Jr.2 , M Lotz1
1 DivisionofArthritisResearch, The ScrippsResearch Institute,
La Jolla, CA, USA
2 ScrippsClinic, La Jolla CA, USA
INTRODUCTION: Cartilage injury is a major risk factor for second-
ary osteoarthritis. Chondrocytes have been shown to undergo
apoptosis after mechanical trauma. This study investigates
measures that maintain cell viability and their effect on cartilage
matrix synthesis.
METHODS: Chondrocytes were isolated from normal human
articular cartilage and cultured in 3-dimensional agarose gel disk
explants (5 mm x 2 mm). Explants were subjected to injury (30%
strain for 500 msec) and treated with 100 micromolar z-VAD.fmk
(a broad spectrum caspase inhibitor which inhibits apoptosis).
Glycosaminoglycan synthesis was measured by 35S04 uptake.
RESULTS: A significant reduction in cell viability from 94 to 72%
was seen following injury. This was consistent with the 15%
decrease in glycosaminoglycan synthesis in injury explants. Treat-
ment with z-VAD increased viability to 88% and restored gly-
cosaminoglycan synthesis to control levels. z-VAD also reduced
the relative levels of newly synthesized glycosaminoglycans lost
from the explants into the media.
DISCU$SION & CONCLUSION: Chondrocyte apoptosis following
injury has significant impact on matrix degeneration and repair.
The present data supports the hypothesis that rescuing cells from
apoptosis restores glycosaminoglycan synthesis levels. This has
potential therapeutic use after acute cartilage injury.
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THE EFFECT OF LOAD ON ARTICULAR CARTILAGE
SURFACE MORPHOLOGY - AN ATOMIC FORCE
MICROSCOPY (AFM) STUDY
Nurith Ronen 1 Rachel Edrei 2 Alon Hoffman 2 and A. Menhem
Nahir 1
1 The H. SchussheimRheumatologyResearch Unit, Facultyof
Medicineand 2 ChemistryDepartment, Technion, Haifa, Israel.
Introduction: Although most scanning electron microscopy (SEM)
studies showed that the surface of the articular cartilage is not
smooth, the issue is still controversial as the preparation of the
tissue might introduce morphological bais. The aim of the current
project was to study cartilage surface by a different method, by
atomic force microscope (AFM). AFM enables also quantitative
measurements and this was used to,compare cartilage surface
from various areas of the joint.
Methods: Punches were taken from weight-bearing (WB) and non
weight bearing (NWB) areas of the femoral condyle and tibial
plateau of calves' knees, The immediately frozen unfixed samples
were ct in Bright's cryostat. Sections of cartilage surface were
studied by AFM. AFM measurements were performed by topome-
trix TMX2010 system using non=contact mode with silicon tips of
less than 10 nm in radius and with full cone angle less than 20?
The typical resonant frequency of the cantilever is f=200kHz with
normal force constants of k=48 N/m and atscan rate of 2 mm/s. A
single result represents the mean of 6 randomized fields 2x2 mm2
each, scanned in every sample. Roughness could be calculated
out of the individual measurements. SEM was done in parallel to
confirm that cartilage surface was studied.
Femoral condyle
Tibial plateau
NWB
13.5-3.3 (n=12)
9.6-2.4 (n=18)
WB
7.0-2.8 (n=25)
3.4-2.8 (n=6)
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AUTOLOGUS CHONDROCYTE IMPLANTATION VERSUS
MICROFRACTURE A PROSPECTIVE RANDOMISED
NORWEGIAN MULTICENTER-TRIAL
Gunnar Knutsen,!, Lars Engebretsen", Tom C Ludvigsen",
Jon Olav Drogsetl, Torbjorn Grontvedtl, Eirik Solheim·,
Torbjorn Strand·, Vidar Isaksen,!, Oddmund Johansen!!.
UniversityHospitalTromsO'l, Oslo OrthopaedicUniversity-clinid,
UniversityHospitalTrondheiml,DeaconessUniversityHospital
Bergen'. Norwayemail:ortod;unn.no
Introduction: New methods have been used with promising
results to treat full-thickness cartilage defects. In order to compare
the modern principle of autologous chondrocyte transplantation
with microfracture, the present randomised controlled study was
done.
Method: During the period from January 1999 to February 2000,
80 patients between 18 and 45 years of age with single sympto-
matic defects on the femoral condyle were treated with either ACI
(40 patients) or microfracture (40 patients). The randomisation was
done in the operating theatre after inclusion criteria were met. The
size of the defect was between 2 and 10 em". They all had stable
knees with no general osteoarthritis. Trauma was the aetiology in
64,5% and 28% had OCD. The two groups followed identical
rehabilitation protocol after surgery. Follow up examination of an
independent observer was done after 12 and 24 Months, and
second-look arthroscopy with biopsy for histological evaluation
was carried out at 24 months.
Results and discussion: There were four failures (reoperations
with non-healing) in the ACI-group, and two in the microfracture-
group. Reoperations to trim and debride were done in ten cases in
the ACI-group and four in the microfracture-group. Significant
clinical improvement (Lysholm and VAS painscore) was found in
both groups after two years. Histological evaluation of biopsies
from repair tissue after two years showed significantly better
quality of the cartilage in the ACI group, with more patients with
hyaline like cartilage and fewer with fibrocartilage than in the
microfracture group. Microfracture results in acceptable short
time results and have less failures and reoperations than ACI.
Autologus chondrocyte transplantation results in better qualilty
repair tissue, which probably will be important for the long time
outcome.
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MRI OF TISSUE ENGINEERED NEOCARTILAGE:
CORRELATION OF MRI RESULTS WITH BIOCHEMICAL AND
BIOMECHANICAL PROPERTIES OF NORMAL AND
CHONDROITINASE TREATED BIOREACTOR-DERIVED
CARTILAGE
COT Chen%, PA Torzilli%, KW Fishbein#, WE Horton Jr, and
RGS Spencer#
%Hospitalfor SpecialSurgery, New York, USA; #National
Instituteon Aging, Baltimore,USA; NEOUCOM, Rootstown,USA
AIM OF STUDY: To test the hypothesis that magnetic resonance
imaging (MRI) of engineered cartilage correlates with its biochemi-
cal and biomechanical properties, and that MRI can therefore be
used to evaluate cartilage matrix material properties during tissue
development and degradation.
METHODS: Chondrocytes from Day 16 embryonic chick sterna
were inoculated into a hollow fiber bioreactor and allowed to
grow for up to 4 weeks with and without exposure to chondroiti-
nase ABC. Spin-spin relaxation times (T2's) and negative fixed
charged density (FCD) of the cartilage was measured using MR
microimaging at 9.4 Tesla (400 MHz for protons). Water, prote-
oglycan and collagen contents were determined biochemically
according to standard methods. Dynamic and equilibrium moduli
were measured for each sample using unconfined rapid load
deformation and equilibrium stepped-relaxation tests, respect-
ively.
RESULTS: In control samples, tissue mass, solid matrix content,
chondroitin sulfate and collagen content, and equilibrium modulus
of the tissue increased with development time over 4 weeks
(typical n=7, p < 0.05), while FCD was statistically unchanged over
4 weeks (p = 0.25), and T2 decreased from 6574 msec to 5273
msec (p< 0.05). Exposure of the neocartilage to chondroitinase
ABC resulted in less tissue growth (typical n = 15, p<0.001) and a
significant decrease in FCD, proteoglycan content and dynamic
and equilibrium moduli (p < 0.01), while T2 was increased (p<
0.05), consistent with the observed increase in water content seen
with chondroitinase treatment. Regression analysis revealed good
correlations between FCD, proteoglycan content, and biomechani-
cal properties.
CONCLUSIONS: These results support our hypothesis that MR
imaging can be used as a non-invasive method to monitor neocar-
tilage formation and biochemical and biomechanical properties of
engineered cartilage. The MRI-compatible hollow fiber bioreactor
system used in this study permits the formation of neocartilage
from isolated chondrocytes in a highly reproducible manner, and
provides a flexible modality for detailed investigations of cartilage
formation, maintenance, and therapeutics.
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MAGNETIC RESONANCE IMAGING CHARACTERIZATION OF
OSTEOCHONDRAL DEFECT REPAIR
HK Gahunia' A Kangarlu2 P Schmalbrock2 D Chakeres2
Departmentof Orthobiologics,DePuy Orthopaedics,Warsaw,
Indiana USA 1 and Departmentof Radiology,Ohio State
University,Columbus,Ohio, USA2
Aims: The aims of this study were to 1) visualize, characterize and
compare osteochondral (OC) repair in ex vivo goat stifles using
1.5T and 8T MRI scanner and 2) compare the MR morphologic
appearance with histology.
Method: Mature, neutered male goats were assigned to an 8 (n=4)
or 16 weeks (n=4) study period. Two cylindrical OC defects (7mm
diameter, full cartilage thickness and 1mm into subchondral bone)
were surgically created in the right stifle: one in the medial femoral
condyle (MFC) and the other in the trochlear groove (TG). A
biocompatible, biodegradable polymer-based matrix attached to a
resorbable polymer anchor was implanted in the OC defect. At the
day of necropsy, the stifles were disarticulated and MR scanned
(1.5T and 8T) within 24 hrs. At 1.5T MR images were acquired
using 2D fast spin echo sequence (FOV=10xIOcm;
Matrix=512x256; ST=2mm; TRfTE=1500/20). At 8T MR images
were acquired using 2D spin echo sequence (FOV=15 em;
Matrix=1 024x1 024; ST=1 mm; TRfTE=1000/20). The stifles were
dissected, evaluated grossly, and OC blocks were excised for
histology. Five-micron sections along the mid-sagittal plane of OC
defect were stained with H&E.
Results: MR images of encapSUlated goat stifles, along the
mid-saggital plane of the OC defect, acquired at 1.5T and 8T were
capable of visualizing cartilage and bone integrity surrounding the
implant and delineated the margins of repair tissue with implant
matrix from the fixation device. The extent of OC repair and
adjacent bone lesions (8 or 16 weeks), corresponded with the
histology findings. Compared to the 1.5T images, the high-
resolution, high-contrast 8T images showed better signal to noise
ratio, delineation of the joint tissues/repair tissue margins, visuali-
zation of tissue microstructure, and better correlation with the
histologic morphology. At 1.5T and 8T the implant matrix and repair
tissue showed high to intermediate MR signal, whereas the fixation
device appeared as low MR signal. Areas of fibrotic tissue
appeared as intermediate to low MR signal.
Conclusions: The 1.5T and 8T MR images of ex vivo encapsu-
lated goat stifles could determine the extent/morphology of OC
repair tissue and the surrounding bone. More detail is observed at
8T. MRI assessment criteria for OC repair will be useful for future
animal and human cartilage repair studies.
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QUANTITATIVE EVALUATION OF REPAIR TISSUE BIOPSIES
AP Hollander1 ), SC Dickinson 1 ), T Sims1), C Soranzo,2)
P Brun3 ), G Abatangel03 )
l)UniversityofBristol,UK; 2)Fidia AdvancedBiopolymerss.r.i.,
Italy;3)Universityof Padova, Italy
AIM: To quantify the quality of repair cartilage as an outcome
measure in patients treated with chondrocytes implanted on HA
scaffolds.
METHODS: Chondrocytes isolated from low weight-bearing carti-
lage of patients were expanded in monolayer culture, seeded onto
Hyalograft C scaffolds and cultured for a further 14 days. The
cell-loaded scaffold was implanted into traumatic cartilage lesions
in the knee. Follow-up biopsies were harvested at arthroscopy
12-30 months after implantation and were processed for histologi-
cal analysis by standard techniques and for quantitative evaluation
using immunoassays for specific collagens, colorimetric assays for
prote0l;llycan and hydroxyproline and amino acid analysis for
mature and immature collagen crosslink content.
RESULTS: On histological analysis there was evidence of both
hyaline-like tissue and fibrocartilage. Most biopsies showed posi-
tive immunostaining for both type II collagen (hyaline) and type I
collagen (fibrocartilage) as well as staining for proteoglycan, using
toluidine blue and in some cases there was evidence of chondro-
cyte alignment. In light of these positive results we went on to
determine the repair tissue phenotype more accurately. Total
collagen content, measured as hydroxyproline, was very high in all
samples. Proteoglycan content was more variable, as was the type
II collagen concentration relative to total collagen, indicating that
some repair tissue biopsies were predominantly fibrocartilage in
nature whilst others were clearly hyaline-like. We also measured
the content of mature and immature collagen crosslinks as these
can provide an index of tissue turnover. In most cases there was
an excess of mature over immature crosslinks, indicating that the
repair tissue was stable, but still turning over.
CONCLUSIONS: Our study demonstrates for the first time that for
analysis of repair tissue biopsies, it is possible to both cut tissue
sections for histological analysis and quantify the quality of carti-
lage using sensitive assays. This new quantitative data demon-
strates a high total collagen content and maturation of the collagen
crosslinks. These observations suggest that an organized collagen
network has formed in most repair sites. It should now be possible
to determine with accuracy the potential for improvement in
cartilage quality with time following implantation.
PS29
AUTOLOGOUS CHONDROCYTE IMPLANTATION IN THE
TREATMENT OF ARTICULAR CARTILAGE DEFECTS OF THE
KNEE USING TYPE 1/111 COLLAGEN MEMBRANE: A NOVEL
APPROACH
WB Robertson, R Salleh, MH Zheng & DJ Wood
Departmentof Surgery(Orthopaedics),UWA, Perth, Australia.
Aim: The aim of this study was to use biological, functional and
radiographic evaluation to investigate the use of a type 1/111
collagen patch in autologous chondrocyte implantation (ACI).
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Introduction: Damage to the hyaline articular cartilage in the knee
may lead to the accelerated onset of osteoarthritis. A variety of
surgical procedures designed to promote fibrous repair of cartilage
defects have been tried and found to be ineffective. ACI in
combination with periosteal grafts have been employed to treat
cartilage defects since 1987 with successful results. However, the
use of periosteal flap has several drawbacks including the fact that
periosteum contains pluripotential cells, which can produce fibrous
reparative tissue as opposed to differentiated hyaline articular
cartilage. To address these problems a biodegradable type 1/111
collagen membrane has been developed for use in conjunction
with ACI. The membrane is composed of highly purified porcine
collagen and exhibits excellent biocompatibility and low immuno-
genicity. It was designed to reproduce the physiological barrier
functions of the periosteum. Definitive evidence regarding the role
of the membrane in enhancing chondrocyte-mediated cartilage
regeneration is lacking.
Methods: This series consists of a total of 31 patients who had
failed surgical treatment prior to definitive ACI using type 1/111
collagen membrane. MRI scans, KOOS scores and 6-minute walk
tests were conducted preoperatively, and postoperatively in order
to determine the success of integration of implanted chondrocytes
and restoration of knee joint function. Biological examination of the
cultured chondrocytes was conducted prior to implantation in order
to determine cellular phenotype.
Results: Postoperative MRI scans at three months showed oede-
matous tissue at the defect sites, contrasting with the fluid filled
defects seen preoperatively. MRI scans at one and two years
showed normal cartilage signal. Apopototic testing of chondrocytes
before implantation showed that viability of chondrocytes was over
85%. Analysis of 6-minute walk test (pO.05) and KOOS (pO.05)
results at one year postsurgery indicate improved functional
capacity compared to presurgery values.
Conclusions: Symptomatic articular cartilage lesions affect mil-
lions of people worldwide. This unilateral clinical series indicates
that ACI using type 1/111 collagen membrane is a promising new
treatment for this patient population. Longer clinical follow-up and
comprehensive perioperative assessment of cellular phenotype of
repair tissue is required.
P30
NEOCARTILAGE FORMATION BY PORCINE CHONDROCYTE
AND CHONDRON MULTILAYERS
RD Graff, A Parikh, I Tchivilev, and GM Lee
ThurstonArthritisResearch Centerand Dept. of Orthopedics,
UNC-Chapel Hill, USA
AIM: Development of a neocartilage construct readily amenable to
microscopy and biomechanical studies.
METHODS: Porcine articular cartilage was digested with a mixture
of dispase and collagenase for chondrons or pronase followed by
collagenase in DMEM for chondrocytes as previously described.
Chondrons or chondrocytes were plated at 2x105 cells/well in 96
well plates and maintained in Opti-MEM with 2.7 mM Ca2 +, 25
~g/ml ascorbate-2-P04, 2% FBS and pencillin/streptomycin. At 3
or 4, 7 and 11 days of culture, cultures were fixed and immunola-
beled in situ for fluorescence microscopy. RNA was isolated from
chondrocytes using a Clontech kit and prepared for rt-PCR. Cell
numbers were analyzed by MTT assay.
RESULTS: The multilayers could be picked up and transferred at
day 3 with little tearing and by day 11 with none. Some cell division
occurred between days 4 and 7 in both cultures. Chondron
multilayers were thicker with more layers of cells than the chondro-
cyte multilayers. In both, the chondrocytes were surrounded by a
thin rim of type VI collagen. Type II collagen, aggrecan and
tenascin were abundant throughout. Osteopontin was found only
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on the cell surface and intracellularly. By phalloidin staining, at day
3 almost all cells were rounded but by day 11 flattened cells were
predominant in the layer nearest the substratum. Few cells had
stress fibers. Chondrocyte cultures had more substratum-
associated cells than chondron cultures. In both, chondrocytes
could be found extending processes up through the multilayers.
mRNA analysis showed continued synthesis of type II collagen.
Some type I transcripts were also detectable.
CONCLUSION: Chondrons and chondrocytes plated at high den-
sity in a 96 well format produce a neocartilage that can be handled
within 3 to 4 days of culture and continues to accumulate matrix.
The chondrocyte phenotype is maintained as demonstrated by the
ample production of type II collagen and aggrecan. The neocarti-
lage was easy to immunolabel in situ without the need for section-
ing, and individual cells were readily observed by microscopy.
These constructs are suitable for immunolocalization of ECM
components and for mechanotransduction experiments, and could
also be ideal for cell deformation studies.
Supported by NIAMS AR54833 and AR08592.
PS31
INDEPENDENT ATP RELEASE AND CALCIUM SIGNALING
BY MECHANICALLY STIMULATED CHONDROCYTE
CULTURES
RD Graff and GM Lee
Dept. Orthopedics,Universityof North Carolina, Chapel Hill, NC,
USA
AIM: Determine the relationship of ATP release and calcium
mobilization in the chondrocyte response to mechanical stimu-
lation.
METHODS: Porcine articular cartilage was digested in a mixture of
dispase and collagenase for chondron isolation, or pronase fol-
lowed by collagenase for chondrocytes as previously described.
Multilayer neocartilage constructs were prepared by plating 2x105
cells/well in 96-well plates, and cultured in Opti-MEM with 2%FBS,
2.7 mM CaCI2, and 25?g/ml ascorbyl-2-P04. Cultures were stimu-
lated by fluid injection in a luminometer/fluorometer in a novel
microplate mechanotransduction assay. ATP release (by luciferase
assay) and intracellular calcium concentration (using Fluo-3) were
measured at days 3, 5, 7, and 11.
RESULTS: Fluid stimulation resulted in a rapid (within 1 second)
4-8-fold increase in ATP release above baseline at day 3. But
both baseline and stimulated ATP concentrations declined by
approximately 90% by day 11. ATPase activity was unchanged in
day 3 vs. day 11 cultures. In contrast, mechanically stimulated
calcium signaling, nearly absent at day 3, increased steadily with
time in culture (0-20% increase at day 3; 125-250% increase at
day 11). The calcium response was also extremely rapid (less
than 1 second) and was characterized by a transient peak
followed by sustained increase in intracellular concentrations.
Chondrocyte cultures showed greater Ca2+-responsiveness than
chondron cultures, and had more flattened cells by phalloidin
staining.
Genistein and LY294002 (tyrosine kinase and PI-3 kinase inhibi-
tor~, respectively) reduced basal and mechanically stimulated
Ca + concentrations. 18?-glycyrrhetinic acid (gap junction inhibitor)
and removal of extracellular Ca2+ each reduced basal Ca2+ con-
centrations and completely eliminated the response to fluid flow.
Interruption of cell-cell communication by cutting through the
multilayers did not decrease the Ca2+ response.
CONCLUSIONS: ATP release and calcium mobilization are very
early responses of chondrocytes to mechanical stimulation, and
display a similar time course. The inverse relationship of ATP and
Ca2+ signaling with time in culture and matrix accumulation sug-
gest that they are independent responses, as part of different
mechanotransduction pathways. Use of the chondrocyte multilayer
neocartilage constructs with the microplate mechanotranduction
assay will allow further characterization of the early responses of
chondrocytes to mechanical stimulation.
Supported by NIAMS AR54833 and AR08592.
PS32
COMBINED IGF-I AND OP-I STIMULATION OF NORMAL AND
OA CHONDROCYTES
RF Loeser, C Pacione, A Hakimiyan, S Chubinskaya
Rush MedicalCollege, Chicago, IL.
OA chondrocytes respond poorly to IGF-I while OP-I has not been
tested.
The aim of the current study was to compare the ability of IGF-I
and OP--1 , alone and in combination, to stimulate normal human
and OA chondrocytes.
METHODS: Chondrocytes isolated by enzymatic digestion of
cartilage obtained from subjects undergoing knee replacement for
OA (n=4) or from normal ankle joints of tissue donors (n=5) were
cultured in alginate beads in serum-free medium supplemented
with "mini-ITS" and 25ug/ml ascorbate and treated for 21 days
with 100 ng/ml IGF-I, 100 ng/ml OP-1 or both (IGF+OP). Controls
(C) were treated with vehicle alone. Fresh IGF-I or OP-1 was
added with media changes every 48 hours. The cultures were
evaluated for: 1) cell survival, 2) cell number by DNA analysis, 3)
matrix production by the particle exclusion assay and histology,
and 4) the level of accumulated proteoglycan (PG) by DMB
analysis. Results were analyzed by ANOVA.
RESULTS: After 21 days in serum-free alginate culture, survival of
OA cells decreased to 63±4% (C). Both IGF-I and OP-1 improved
survival but it was only statistically significant for IGF+OP (85±1%;
p=O.005). Survival of normal chondrocytes was 80±2% (C) and
was improved by either growth factor alone or in combo (p<O.05)
ranging from 86% with IGF alone to 94% with IGF+OP. Cell
proliferation was noted in the IGF+OP group which was significant
for normal cells (2-fold increase in DNA; p=0.002). Matrix produc-
tion assessed by particle exclusion and by Safranin 0 staining was
greatest in the cells treated with IGF+ OP in normal and OA
cultures. Likewise PG production was greatest in the combo group.
PG levels corrected for cell numbers (ug PG/ngDNA) are shown
below.
Normal p value OA p value
Control 3.1±0.4 3.1±0.1
IGF-I 3.7±0.6 NS 3.4±0.3 NS
OP-I 7.3±1.4 0.003 6.7±1.2 0.03
IGF+OP 8.6±0.8 0.0003 8.7±1.5 0.004
CONCLUSIONS: Survival of normal and OA cells in long-term
serum-free culture was best with IGF+OP. Neither IGF-I nor OP-1
alone stimulated proliferation but when combined an increase in
proliferation was noted, particularly in normal cells. OP-I was
clearly more potent than IGF-I in stimulating PG production in
both normal and OA cells. When normalized for cell numbers,
IGF+OP resulted in more matrix PG production and much more
matrix when assessed histologically. These results suggest that
combined therapy with IGF-I and OP-1 may be more effective than
either GF alone in treating OA cartilage damage.
PS33
CHARACTERIZATION OF ASCORBIC ACID TRANSPORT
MECHANISMS IN HUMAN CHONDROCYTES
AL Rohrbaugh and VB Kraus
Departmentsof Pathologyand Medicine, Duke University
MedicalCenter, Durham, NC USA
The aim of this study was to characterize ascorbic acid transport
mechanisms in human chondrosarcomas and primary human
chondrocytes.
Methods: We analyzed the expression of the two types of ascor-
bate transporters that have been identified thus far, the glucose
transporters (GLUT1 &GLUT3) and the sodium-dependent vitamin
C transporters (SVCT1 & SVCT2) in human chondrosarcomas
(1 05KC cells) and primary human chondrocytes. The regulation of
these transporters and their relative contributions to ascorbic acid
transport were evaluated using L- -ascorbic acid (L_14C-Asc) to
monitor ascorbic acid uptake into cells under various conditions
designed to differentially inhibit or augment the function of each
transporter.
Results and Conclusions: The 105KC cells expressed partial
transcripts for SVCT2, but not SVCT1. Previous studies have
shown that human chondrocytes express GLUT1 and GLUT3. We
found that transport of the reduced form of ascorbic acid (AA) into
105KC cells required sodium, suggesting that AA uptake by these
cells may be mediated by SVCT2. The transport of AA was
independent of the presence of glucose. However, the uptake of
the oxidized form of ascorbic acid (dehydroascorbate ) was sup-
press~d by approXimately 40% in the presence of 10mM glucose
(p < 0.01), suggesting that GLUT1 (IC50 = 10mM O-glucose) may
be the predominant transporter of OHA. Competition experiments
with reduced and unlabeled AA forms revealed that only the L-form
of ascorbic acid was able to significantly suppress the uptake of
L_14C-Asc (p < 0.01). This stereoselectively was consistent with the
specificity of uptake reported previously for the SVCTs. However,
all of the unlabeled and oxidized forms of ascorbic acid (L-AA,
O-isoascorbic acid, sodium L-ascorbate, and ascorbyl-2-
phosphate) were able to compete with 14C-OHA transport (p <
0.05), suggesting that this transport mechanism was not stereose-
lective. Work is ongoing to elucidate the physiological role of these
transporters in chondrocytes. In the future, these transporters
could be exploited to concentrate small molecules in chondrocytes.
PS34
PROLOGATION OF C-JUN N-TERMINAL KINASE
POTENTIATES APOPTOSIS INDUCED BY TUMOR NECROSIS
FACTOR ALPHA IN HUMAN CHONDROCYTES
HAKim
Departmentof InternalMedicine, Hallym UniversitySchoolof
Medicine, KangdongSacred Heart Hospital, Seoul, Korea
Aim of study: To elucidate the signaling pathway involved in tumor
necrosis factor-alpha (TNF-a)-induceddeath of chondrocytes
Methods: Primary chondrocyte cultures were obtained from
human knee osteoarthritis cartilages at the time of joint replace-
ment surgery. First passage chondrocytes were treated with TNF-a
and various potentiators, and cell death was measured with MTT
assay. C-Jun N terminal kinase (JNK) activation was investigated
by in gel JNK assay. In order to differentiate the role of ERK
activation from that of JNK activation, ERK kinase inhibitor PO
98059 was pretreated before addition of TNF-aipotentiators, and
its effect on ERK , JNK activity and cell death was evaluated by
Western blot, in-gel kinase assay and MIT assay, respectively.
Results: Chondrocytes were resistant to TNF-a-induced cell
death, and incubation for up to 96 hours at a concentration as high
as 100ng/ml of TNF-a did not induce significant cell death.
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Two-hour-pretreatment with actinomycin 0, the phosphatase
inhibitor vanadate or MAP kinase phosphatase -1 inhibitor
R0318220 invariably led to chondrocyte apoptosis. TNF-alpha
alone stimulated a single, brief JNK activity which disappeared
after 15 minutes. However, when the cells were pretreated with
actinomycin, TNF-alpha stimulated a second JNK activity peak
starting from 90 minutes after TNF-a treatment. When the cells
were pretreated with vanadate or R0318220, TNF-alpha-induced
JNK activation was greatly prolonged, and virtually no attenuation
of JNK activity was observerd for as long as 2 hours. In all three
cases, a sustained JNK activation was associated with the induc-
tion of apoptosis. Treatment of chondrocytes with TNF-a also led
to brief activation of ERK lasting about 15 minutes, which was
slightly prolonged by vanadate and Ro 318220. Pretreatment with
P098059 before TNF-aipotentiators led to quenching of ERK
without affecting JNK activation, but cell death was unaffected,
suggesting that prolonged JNK activation rather than ERK acti-
vation is related to chondrocyte apoptosis mediated by TNF-a.
Conclusions: Our data suggest that a sustained activation of JNK
induced by phosphatase inhibitors or actinomycin 0 after TNF-a
treatment is associated with chondrocyte apoptosis. This effect
may be due to blocking the expression of a TNF-a induced
phosphatase that inactivates JNK.
PS35
SIMILARITIES OF INTERLEUKIN-1 (IL-1), IL-17 AND TNF-A
SIGNAL TRANSDUCTION MECHANISMS IMPLICATED IN
UP-REGULATION OF MATRIX METALLOPROTEINASES IN
CHONDROCYTES
A Liacini, J Sylvester, WQ Li, M Zafarullah
CHUM Notre-Dame Hospital,Montreal, Quebec, Canada
H2L 4M1
Aim: Interleukin-1 (IL-1), IL-17 and tumor necrosis factor alpha
(TNF-a), the major proinflammatory cytokines induce arthritic joint
inflammation and promote cartilage breakdown by matrix metallo-
proteinases, such as MMP-13. We investigated the signaling
mechanisms of this induction.
Methods: Primary human osteoarthritic (OA) femoral head or
bovine chondrocytes or chondrosarcoma cells were pre-treated
with the potential inhibitors of IL-1, IL-17 and TNF-a signal trans-
duction and downstream target transcription factors followed by
stimulation with cytokines, and RNA/protein analyzed by Northern
and Western blotting.
Results: RNA for MMP-13 is increased in human arthritic femoral
cartilage compared to non-arthritic tissues. IL-1, IL-17 and TNF-a
rapidly activated phosphorylation of extracellular signal-regulated
kinase (ERKs), p38 and c-Jun N-terminal kinase (JNK) mitogen-
activated protein kinases (MAPKs) in human or bovine chondro-
cytes. Inhibitors of ERK (U0126 and P098059), JNK (SB203580
and curcumin) and p38 (SB203580 and SB202190) pathways
down-regulated the cytokine-stimulated expression of MMP-13.
Inhibitors of transcription factors, activating protein-1 or AP-1
(nordihydroguaiaretic acid, NOGA) and nuclear factor kappa B or
NF-eB (curcumin, sodium salicylate, pyrrolidine dithiocarbamate,
and proteasome inhibitors) suppressed cytokine-induced MMP-13
expression in primary chondrocytes and SW1353 cells.
Conclusions: These results suggest that MMP-13 gene induction
by the three cytokines is mediated by common mediators such as
MAP kinases, AP-1 and NF-eB factors. Blockade of these cytokine
signaling and their target transcription factors by the approaches
tested here may be beneficial for reducing cartilage breakdown by
MMP-13 in arthritis.
Supportedby The ArthritisSociety (Canada), Canadian Arthritis
Network (CAN) and Canadian Institutes of Health Research
(CIHR).
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DIFFERENTIAL EFFECTS OF FIBROBLAST GROWTH
FACTOR-18 (FGF18) ON THE EPIPHYSEAL GROWTH PLATE
AND HYALINE CARTILAGE IN VIVO.
JL Ellsworth, R Garcia, K Waggie, H Ren, SO Hughes,
EE Moore
ZymoGenetics,Inc., Seattle, WA, USA 98102
In previous studies we demonstrated that FGF18 was a growth
factor for mature chondrocytes and their progenitors. The aim of
the present study was to compare the effects of FGF18 on
chondrocyte proliferation and matrix deposition in the epiphyseal
growth plate and hyaline cartilage of adult rats in vivo.
Methods: Male 8-week old Sprague-Dawley rats received a single
intravenous injection of either vehicle or recombinant human
FGF18 (10 or 40 mg/kg). Subjects were euthanized 14 days later,
tissues were taken, fixed in buffered formalin and paraffin embed-
ded for histologic analysis. Cartilage formation was assessed in
the trachea, sternum/rib, vertebrae, and the femoral articular
surface and growth plate by staining of serial tissue sections with
H&E. Selected tissue sections were also stained with safranin-O,
and with antibodies to type II collagen. H&E stained sections of the
kidney, liver, lung, and spleen were also evaluated.
Results: Systemic administration of FGF18 increased the number
of basophilic cells with the morphology of chondrocytes on H&E
stained sections of the trachea, sternum/rib, vertebrae, and articu-
lar surface of the femur. Deposition of extracellular matrix was also
increased at these tissue sites as evidenced by increased staining
with safranin-O and anti-type II collagen antibodies. In contrast,
chondrocyte numbers and extracellular matrix were greatly dimin-
ished in the growth plate cartilage of rats injected with FGF18.
Cartilage was largely replaced at this site by increased numbers of
osteoblasts and by increased formation of lamellar bone. Relative
to rats treated with vehicle, no treatment-related changes in the
kidney, liver, lung, or spleen were observed.
Conclusion: These data show that FGF18 has opposite effects on
the epiphyseal growth plate and hyaline cartilage in vivo. FGF18
appeared to induce endo-chondral bone formation at the expense
of growth plate cartilage. In contrast, FGF18 stimulated the expan-
sion of hyaline cartilage with enhanced expression of type II
collagen and increased deposition of extracellular matrix.
Stryker Biotech. As a control, non-specific goat anti-mouse IgG
antibody was used at the same concentrations. The cultures were
analyzed for PGs remaining in the matrix or released into the
culture media (DMMB assay), cell survival assay, DNA content,
and PG synthesis eSS04-2 incorporation). Levels of endogenous
OP-1 were monitored by OP-1 ELISA.
Results: The treatment of human chondrocytes with two doses of
anti-OP-1 and goat anti-mouse IgG antibodies for 24 and 48 hours
did not affect cell survival and DNA content. After 24 and 48 hours
1 IJg/ml of anti-OP-1 antibody led to 20-30% inhibition of PG
synthesis; the higher dose of this antibody (5 IJg/ml) induced
further decline in PG synthesis (up to 40%, p<0.01). Studies of
PGs released into the media showed a more pronounced
response to 1 IJg/ml dose. After 24 hours of culture, there was a
25% increase in PG release in the presence of anti-OP-1 antibody
compared to both control groups (p<0.01). At the same time, the
levels of PGs remaining in the cell-associated matrix were
decreased up to 23% (p<0.01). Concentration of OP-1 in the matrix
was reduced in the presence of neutralizing anti-OP-1 antibody.
Conclusions: The results presented here illustrate the first
attempt to delineate directly the function of endogenous OP-1 in
human adult articular cartilage. Our novel findings suggest an
important role for endogenous OP-1 in regulation of matrix integ-
rity. The inhibition of endogenous OP-1 protein affected both
anabolic and catabolic processes by down-regulation of PG syn-
thesis and promotion of PG degradation in human adult articular
cartilage.
P38
PROTEIN BINDING IMPACTS THE ABILITY OF SMALL
MOLECULE MMP INHIBITORS TO PENETRATE CARTILAGE
EXTRACELLULAR MATRIX
J Tillett, N Mollova, E Collins, M Geck, J Brooks, S Glasson,
E Morris
Wyeth Research. Cambridge,Massachusetts
Aim: We evaluated the ability of exogenous protein to decrease
the potency of an MMP inhibitor in vitro and compared this to
inhibitor concentrations within cultured bovine articular cartilage
(BAC).
Biacore analysis found the MMP inhibitor to be 98% protein bound.
Ex vivo:In separate studies of compound penetration, the concen-
trations were 4340 ng/g in BAC cultured in serum-free media and
Methods: In vitro: Fluorescence resonance energy transfer
(FRET) assays were carried out to determine IC50 values of the
inhibitor against MMP-13 in the absence or presence of human
serum (HS), fetal bovine serum (FBS), or bovine serum albumin
(BSA) using a 6 amino acid peptide of type II collagen (CoI2).
Protein binding of the MMP inhibitor was determined using a
Biacore surface plasmon resonance system.
Ex vivo:Explants of BAC were collected from metacarpalphalan-
geal joints of calves and cultured in DMEM, with human IL-1 alpha
(5ng/ml) and the MMP inhibitor (11g/ml), with and without FBS for
3 days. The explants were powdered in a freezer mill and recon-
stituted into buffer. Mass spectrometry (LC-MS/MS) was used to
determine the quantity of inhibitor (ng/gram cartilage) in the
explants.
ResUlts: In vitro: FRET IC50 values for the inhibitor in the
presence of:
P37
INHIBITION OF OSTEOGENIC PROTEIN-1 IN HUMAN ADULT
ARTICULAR CARTILAGE LEADS TO THE DECREASE IN
PROTEOGLYCAN CONTENT AND SYNTHESIS
S Chubinskaya, A Hakimiyan, DC Rueger.
Rush MedicalCollege, Chicago, IL, USA.
Osteogenic Protein-1 (OP-1) is a member of the bone morphoge-
netic protein family. While recombinant human OP-1 has been
shown to induce the synthesis of cartilage extracellular matrix
components, we reported its endogenous expression in human
adult articular cartilage. Although OP-1 is present in adult tissue,
the mechanisms of its function remain to be elucidated.
The goal of the current study was to block or inhibit endogenous
OP-1 protein via neutralizing OP-1 antibody, and to investigate the
effect on proteoglycan (PG) synthesis and degradation as well as
cell viability and proliferation.
Methods: Cartilage was obtained from femoral condyles of normal
human organ donors. Chondrocytes isolated by enzymatic diges-
tion were cultured in alginate in serum-free medium supplemented
with "mini-ITS" and 25 IJg/ml ascorbate for 24 and 48 hours in the
presence of 1 and 5 IJg/ml of neutralizing antibody obtained from
Human (HS)
0% 2.5 ± 0.1
25%17±3
Bovine (FBS)
2.4 ± 0.1
13 ± 1
Bovine (BSA)
omg/ml 1.4 ±0.04
25 mg/ml 7.4 ± 0.7
602 ng/g in BAC cultured with 30% FBS in media. This suggests
that the penetration of this inhibitor is reduced 7.2 fold in the
presence of 30% FBS.
Conclusions: In vitro assays indicate that this inhibitor binds
highly to serum proteins and their presence lowers the IC50
against MMP-13 by 5-7 fold in the FRET assay. While protein
binding may serve to prolong exposure in vivo, serum proteins also
decrease the amount of inhibitor available to penetrate cartilage.
The effects of physiological levels of proteins on in vitro inhibitor
efficacy and cartilage penetration should be evaluated, in conjunc-
tion with pharmacokinetic data, in order to determine appropriate
doses for in vivo studies.
PS39
FACTORS CONTRIBUTING TO SIGNAL TRANSDUCTIONS IN
CULTURED CHONDROCYTES
T Nishikori*, K Enomoto**, H Kataoka**, Y Uchio*, S Maniwa*,
T Kohno*, M Ochi*
*DepartmentofOrthopaedics,**Departmentof Physiology,
Shimane MedicalUniversity,Izumo, Japan
Introduction: Mechanical stress is always applied to articular
cartilage, and signal transductions frequently occur among
chondrocytes. However, the mechanism underlying signal trans-
duction is unclear. It was reported that when uridine triphosphate
(UTP) is applied to mammary tumor cells, it connects with the
P2Y2 receptor on the plasma membrane, causing the release of
intracellular adenosine triphosphate (ATP) into the extracellular
space via chloride channels on the plasma membrane. However, it
is unclear whether or not this phenomenon is induced in articular
cartilage.
Aim of study: To investigate the factors contributing to signal
transductions in cultured chondrocytes.
Methods: Articular cartilage was obtained from the knees of
Japanese white rabbits. Chondrocytes were isolated and cultured
in a monolayer. After the culture medium was removed at 3 days
post-culture, 0.5 ml of 100 ~M UTP solution was added to each
well. In a control group, 0.5ml of Ringer's solution (Ringer) was
added. After 5 min incubation at 37, luciferase-Iuciferin was added,
and the released ATP concentration was measured. Moreover, a
P2 receptor inhibitor (suramin) and a Cl'channel inhibitor (niflumic
acid, DIDS) were added respectively before UTP was added, and
the extent of resulting inhibition of ATP release was examined for
each inhibitor.
Results: Each ATP concentration (nM) was 5.5 ± 2.0 in Ringer
only, 15.4 ±8.5 in Ringer + UTP, 2.1 ±0.1 in suramin only, 2.2 ±0.1
in suramin + UTP, 3.6 ± 0.9 in niflumic acid only, 4.7 ± 0.6 in
niflumic acid + UTP, 5.5 ± 3.9 in DIDS only, and 5.3 ± 1.2 in DIDS
+ UTP. These findings suggested that UTP stimulates ATP release
from chondrocytes whereas the P2 receptor inhibitor and the
Cl'channel inhibitor significantly inhibit ATP release.
Conclusions: P2 receptors and CI' channels contributed to signal
transductions in cultured chondrocytes.
PS40
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 &
FIBRONECTIN CO-LOCALIZE IN HUMAN ARTICULAR
CARTILAGE
JA Martin & JA Buckwalter
Universityof Iowa, Iowa City, IA USA
Aim: Several lines of evidence suggest that the anabolic cytokine
insulin-like growth factor I (IGF-I) has a major role in maintaining
articular cartilage and in cartilage repair. Insulin-like growth factor
binding proteins (IGFPBs) interact with IGF-I and modify its activity.
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The role of IGFPBs in human articular cartilage has not been
studied, but these molecules could create reservoirs of IGF-I within
the articular cartilage matrix that released IGF-I in response to
tissue injury or osteoarthritis. We hypothesized that IGFBPs bind to
other matrix molecules in the pericellular matrix creating a store of
IGF-I in the immediate vicinity of chondrocytes.
Method: To test this hypothesis we used quantitative immunohis-
tological measures of the matrix location and concentration of
IGFBP-3, -4, -5, fibronectin, tenascin C, and type VI collagen in
osteoarthritic and normal human articular cartilage. We also used
purified proteins to measure the binding of IGFBPs to fibronectin,
tenascin C and type VI collagen.
Results: IGFPB-3 co-localized with fibronectin, but not with
tenascin or type VI collagen (p < 0.05). The other IGFBPs did not
co-localize with the matrix molecules (p < 0.05). In agarose
diffusion assays IGFBP-3 interacted strongly with fibronectin but
not with tenascin C or type VI collagen.
Conclusions: The evidence for direct binding between purified
IGFPB-3 and fibronectin and the co-localization of the two proteins
in the pericellular matrix strongly supports the hypothesis that this
molecular complex functions as a matrix reservoir for IGF-1. This
matrix reservoir may have important roles in maintaining articular
cartilage and in stimulating the chondrocyte anabolic response to
tissue damage. Specifically, release of IGF-I from the matrix
reservoir in the early stages of osteoarthritis would stimulate
chondrocyte synthetic activity and help maintain or restore the
tissue. Loss of this cell-matrix interaction may be one of the
important factors in the progression of osteoarthritis.
PS41
OSTEOARTHRITIS AND CHONDROCYTE SENESCENCE
JA Martin & JA Buckwalter
Universityof Iowa, Iowa City, IA USA
Aim: Osteoarthritis is not an inevitable consequence of aging, but
a strong association exists between age and increasing incidence
of osteoarthritis. We hypothesized that in vivo articular cartilage
chondrocyte senescence impairs the ability of the cells to maintain
or restore articular cartilage and thereby increases the risk of
osteoarthritis.
Methods: To test this hypothesis we measured senescence
markers in human articular cartilage chondrocytes from 27 donors
ranging in age from one to 87 years. The markers included
expression of the senescence associated enzyme beta galactosi-
dase, mitotic activity and telomere length. We also examined
mitochondrial DNA and mitochondrial numerical density per cell.
To determine if chondrocyte age changes are reversible we
transfected human articular cartilage chondrocytes with human
telomerase gene and human oncogenes.
Results: B-galactosidase expression increased with age (r = .84,
P = .0001) while mitotic activity and telomere length declined
(r =- .77, P = .001 and r =- .71, P = .0004 respectively). Decreasing
telomere length was strongly correlated with increasing expression
of beta-galactosidase and decreasing mitotic activity. With increas-
ing numbers of cell divisions mitochondrial DNA was degraded and
the numerical density of mitochondria per cell declined. Transfec-
tion of human articular cartilage chondrocytes from a 47 year old
donor with human telomerase and oncogenes created a cell line
that has completed more than 300 population doublings as com-
pared with an upper limit of 20 population doublings for normal
cells. Telomere length increased in the transfected cells.
Conclusions: These findings help explain the previously reported
age related declines in chondrocyte synthetic activity and
response to anabolic cytokines and indicate that in vivo chondro-
cyte senescence may contribute to the age related increase in the
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incidence of osteoarthritis. The creation of an immortal line and
increased telomere length by transfection of human chondrocytes
suggests that it may be possible to alter the progression of human
chondrocytes toward senescence.
P542
REGULATION BY REACTIVE OXYGEN SPECIES OF
PRO-INFLAMMATORY GENES IN CHONDROCYTES
Y Henrotin1 , M Mathy-Hartere, C Sanchez1, G Martin2,
K Boumediene2, J-P Pujol2, J-Y L Reginster1
1 Bone and CartilageResearch Unit, Liege, Belgium;
2 Laboratoryof ConnectiveTissue Biochemistry,Universityof
Caen, France.
AIM OF STUDY: Reactive oxygen species (ROS) were identified
as potent mediators in cartilage tissue destruction and synovial
membrane inflammation. These ROS, mainly produced by poly-
morphonuclear leukocytes and macrophages, were essentially
superoxide anion (02:), hydrogen peroxide (H202) and nitric oxide
(NO). NO and 02: react together to form peroxynitrite (ONOO') a
powerful oxidant. Chondrocytes exposed to soluble factor such as
interleukin-1 B (IL-1 B) or lipopolysaccharide (LPS) are also capable
to produce ROS. This research work was designed to investigate
the effect of ROS on the expression by chondrocytes of pro-
inflammatory genes such as interleukin (IL)-1 B, -6, -8,
cyclooxygenase-2 (COX-2) and nitric oxide synthase (iNOS).
METHODS: Human chondrocytes were enzymatically isolated
from osteoarthritic knee cartilage and then submitted to exogenous
ROS produced by a 3 hours incubation in HBSS with S-nitroso-N-
acetyl-D,L-penicillamine (SNAP) (10'4M) a NO donor,
3-Morpholinosydnonimine (SIN-1) (lO'4M) a ONOO' generating
molecule, ONOO' chemically synthesised (10-5 M) or H202 (10-
4M). After washings, the cells were cultured for the next 24 hours
with or without lipopolysaccharide (LPS) (10 IJg/ml) or IL-1 B
(lO'11M). IL-1 B, IL-6, IL-8, iNOS and COX-2 gene expressions
were analysed by real time and quantitative RT PCR. NF-eB
activation in chondrocytes was studied by gel retardation assay.
RESULTS: The inflammatory genes were highly expressed in
response to LPS and IL-1 B. This over-expression was
accompanied by NF-eB activation. SNAP significantly down-
regulated LPS-induced IL-1 B, IL-6, IL-8 and COX-2 gene expres-
sion, whereas SIN-1 and ONOO' were inefficient. SNAP fully
blocked iNOS gene expression while SIN-1 and ONOO' partially
decreased LPS-induced iNOS mRNA. H202 decreased the
expression of all the genes with the exception of IL-1 B.
When chondrocytes were treated with IL-1 B, gene expressions
were drastically decreased by SIN-1, ONOO- and H202 while
SNAP has no effect.
CONCLUSION: LPS and IL-1 B-induced gene expressions are
differently regulated by ROS. The LPS signalling pathway was
down regulated by NO whereas IL-1 B signalling pathway was
sensitive to ONOO-.
P43
AVOCADO/SOYBEAN UNSAPONIFIABLES INCREASE
AGGRECAN SYNTHESIS AND REDUCE CATABOLIC AND
PRO-INFLAMMATORY MEDIATORS PRODUCTION BY
HUMAN OSTEOARTHRITIC CHONDROCYTES
C Sanchez, MA Deberg, N Piccardi, P Miska,
J-YL Reginster, YE Henrotin
Bone and CartilageResearch Unit, Liege, Belgium
AIM OF STUDY: To investigate the long-term effects (12 days) of
avocado/soybean unsaponifiables (ASU) on the metabolism of
human osteoarthritic (OA) chondrocytes cultured in alginate
beads.
METHODS: Enzymatically isolated OA chondrocytes were cul-
tured in alginate beads in a well-defined culture medium for 12
days, in the presence or not of IL-1 B 10'10 M. The DNA content was
measured according to a fluorimetric method. Aggrecan (AGG),
stromelysin-1 (MMP-3), tissue inhibitor of metalloproteinases-1
(TIMP-1), macrophage inflammatory protein-1 beta (MIP-1 B),
interleukin (IL)-6, -8 and TGF-?1 production were assayed by
specific enzyme amplified sensitivity immunoassays (EASIA).
Prostaglandin (PG) E2 was measured by a specific radioimmu-
noassay and nitrite by a spectrophotometric method based upon
the Griess reaction. Avocado and soybean unsaponifiable residues
were mixed in the ratio 1:2 (A1S2) or tested separately in a range
of concentrations between 0.625 and 40 IJg/ml.
RESULTS: After twelve days of incubation, A1S2 increased in a
dose- and time-dependent manner AGG synthesis and accumula-
tion in alginate beads. Furthermore, A1S2 promoted the recovery
of aggrecan synthesis after a three days period of IL-1 Btreatment.
ASU were potent inhibitors of both basal and IL-1 B-stimulated
MMP-3 productions, and stimulators of TGF-B1 synthesis. They
also partially reversed the inhibitory effect of IL-1 B ?on TIMP-1
production. Furthermore, ASU inhibited MIP-1 B, IL-6, IL-8, NO
and PGE2 basal production by OA chondrocytes and partially
counteracted the IL-1-stimulating effect on PGE2. In A1S2 mixture,
A and S had an additive effect on AGG synthesis and acted in
synergy to inhibit NO production.
CONCLUSIONS: From this work, we can conclude that ASU
stimulated aggrecan production and recovered aggrecan produc-
tion after IL-1 B treatment by stimulating TGF- B 1 and decreasing
catabolic cytokines synthesis. In parallel, ASU decreased MMP-3
production and stimulated TIMP-1 production. Taken together,
these findings give an explanation to the recently demonstrated
structure-modifying effects of ASU in hip osteoarthritis.
P544
CHARACTERIZATION OF THE METABOLISM OF
OSTEOARTHRITIC CHONDROCYTES CULTURED IN
ALGINATE BEADS
C Sanchez, M Mathy-Hartert, MA Deberg, J-YL Reginster,
YE Henroitin
Bone and CartilageResearch Unit, Liege, Belgium
AIM OF STUDY: To investigate the production of aggrecan,
stromelysin-1 (MMP-3), tissue inhibitor of metalloproteinases
(TIMP)-1, interleukin (IL) -6, -8, macrophage inflammatory protein
(MIP)-1 B, nitric oxide (NO), prostaglandin (PG)E2 and TGF-B1 by
human osteoarthritic (OA) chondrocytes cultured for a long-term in
alginate beads. This work gives also new informations on the
distribution of these agents in the different compartments of the
alginate culture: the cell-associated matrix (CM), that corresponds
to the pericellular and territorial matrix in cartilage, and the further-
removed matrix (FRM), the equivalent of the interterritorial matrix
in this tissue. Finally, we have investigated the long-term effects of
interleukin (IL)-1 B on the OA chondrocytes metabolism.
METHODS: Human articular OA chondrocytes were cultured for
12 days in alginate beads (n=10), in the absence or the presence
of IL-1 B 10,10 M. The culture supernatant is changed every three
days. The production of aggrecan, MMP-3, TIMP-1, IL-6, IL-8,
MIP-1 Band TGF-B1 were investigated in the different matrix
compartments and in the culture supernatant by specific ELISA.
The PGE2 released into the supernatant was also quantified by
RIA and NO by a spectrophotometric assay based upon the
GRIESS reaction.
RESULTS: As shown by the table I, cytokines, metalloproteinases
and aggrecan are differently distributed in the different compart-
ments of the alginate culture. Aggrecan was primarily found in the
CM and FRM, whereas PGE2, NO, MMP-3 and TIMP-1 were
almost exclusively found in the supernatant. In contrast to other
cytokines (MIP-1 Band IL-6), IL-8 and TGF-B1 were accumulated
in the extracellular matrix. At the end of the 12 days of incubation,
IL-1 B strongly stimulated IL-6, IL-8, MIP-1 B, PGE2 and NO pro-
duction but dramatically inhibited aggrecan, TIMP-1 and TGF-B1
synthesis. After 6 days of culture, AGG amount increased in the
FRM and decreased in the CM whereas total production remained
stable suggesting that newly synthetized AGG migrate to the FRM
The IL-1 B?-induced MMP-3 production showed a particular profile.
Indeed IL-1 B increased MMP-3 during the first three days of
culture, but inhibited the production for longer incubation periods.
PS45
AG-041R, A NOVEL INDOLlN-2-0NE DERIVATIVE,
STIMULATES CARTILAGE MATRIX SYNTHESIS WITHOUT
PROMOTING TERMINAL DIFFERENTIATION OF RAT
ARTICULAR CHONDROCYTES
M Okazaki, Y Higuchi and H Kitamura
Fuji Gotemba Research Labs., ChugaiPharmaceuticalCo., Ltd.,
Gotemba, Japan
Objectives: AG-041 R, originally synthesized as a CCK2 /gastrin
receptor antagonist, has recently been demonstrated to induce
systemic cartilage hyperplasia in rats. The aim of this study was to
characterize its anabolic actions on chondrocytes.
Methods: Articular chondrocytes were isolated from knee joints of
5 week-old SO rats. Effects of AG-041 R on cartilage matrix
synthesis in the cultures were examined by measuring sulfate
incorporation into proteoglycans and accumulation of Alcian blue
stainable matrices. The expression of genes encoding cartilage
matrix proteins was examined by Northern blotting. ALP activity,
histochemical staining of mineralization, as well as the expression
of markers for hypertrophic chondrocytes, were assessed for
terminal differentiation of chondrocytes. Roles of endogenous
TGF-B/BMPs in the anabolic action of AG-041 R were also
investigated with respective neutralizing soluble receptors.
Results: AG-041 R stimulated synthesis of proteoglycans
assessed by both sulfate incorporation and accumulation of Alcian
blue stainable matrices in the monolayer cultures of rat articular
chondrocytes. The maximum effect was seen at 2 lmol/L. The
promotion of cartilage matrix synthesis was also confirmed by the
up-regulation of the gene expression of matrix proteins including
type II collagen and aggrecan, as well as tenascin, a unique matrix
protein preferentially localized in articular cartilage. In contrast,
AG-041 R profoundly inhibited ALP activity, mineralization and the
gene expression of type X collagen and Cbfa1 at the same
concentration. RT-PCR analysis showed increase in BMP-2 mRNA
after AG-041 R treatment. Studies using neutralizing soluble recep-
tors for TGF-B/BMPs revealed that the soluble BMP receptor
blocked both sulfate incorporation and Alcian blue stainable matrix
accumulation stimulated by AG-041 R.
Conclusions: AG-041 R is a unique low molecular weight com-
pound that stimulates cartilage matrix synthesis without promoting
chondrocyte terminal differentiation. Its anabolic effects on
chondrocytes are mediated at least in part by endogenous BMPs.
AG-041 R may be a valuable agent in autologous chondrocyte
transplantation to maintain the permanent phenotype of articular
chondrocytes.
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PS46
INHIBITION OF MITOCHONDRIAL RESPIRATORY CHAIN
INDUCES APOPTOSIS IN HUMAN ARTICULAR
CHONDROCYTES
E Maneiro, MC de Andres, A Bonilla, MJ Lopez-Armada,
B Carames, I Fuentes, B Lema, M Medin, JL Fernandez-Sueiro,
JA Pinto, FJ de Toro, F Galdo and FJ Blanco
Unidadde Investigaci6n.CHU Juan Canalejo. A Coruna. SPAIN
Introduction: Osteoarthritis (OAl. an articular degenerative dis-
ease, is characterized by an increase in both chondrocyte death
and NO production. Activity of mitochondrial respiratory chain is
altered in OA and it has been noted that loss of mitochondrial
membrane potential is related to apoptosis.
Objective: This study was aimed to evaluate the effect of mito-
chondrial respiratory chain inhibitors on the induction of apoptosis
in human chondrocytes.
Methods: Human cartilages were obtained from patients with joint
replacement surgery and from normal autopsy cases. Chondro-
cytes were incubated at 3?OC in a humidified gas mixture contain-
ing 5% C02 balanced with air after digestion of cartilage. Cells
were analyzed by flow cytometry using the probe JC-1 to measure
the mitochondrial membrane potential and propidium iodure to
assess apoptosis. Apoptosis also was assessed by TUNEL.
Results: The inhibitor of mitochondrial respiratory complex II
(NPA, 5mM) induced a 10% of cells with depolarization in compa-
ration with unstimulated cells, the inhibitor of complex III (antimycin
A, 50lJg/ml) induced a 18% and the inhibitor of complex V
(oligomycin) 12% at 5 hours in culture. NPA cause apoptosis in 8%
of chondrocytes comparation with unstimulated cells, Actinoycin in
18 % and Oligomycin in 18% of chondorcytes at 24h.
Conclusion: Inhibition of complex III and V induce chondrocyte
apoptosis.
Supported by FIS 01/5401
PS47
INTERLEUKIN 1 AND TUMOUR NECROSIS FACTOR
REGULATE THE MITOCHONDRIAL TRANSMEMBRANE
POTENTIAL, THE BCL-2 FAMILY AND CASPASES
ACTIVATION IN HUMAN NORMAL CHONDROCYTE CELLS
MJ Lopez-Armada, B Carames, I Fuentes, B Lema, M Medin,
E Maneiro, MC de Andres, A Bonilla, JA Pinto, FJ de Toro,
JL Sueiro, F Galdo, FJ Blanco-Garda.
Unidadde Investigaci6n.HospitalJuan Canalejo. La Coruna.
Spain.
Death of chondrocyte cells by apoptosis is a hallmark of degen-
erative joint diseases such as osteoarthritis (OA). Loss of the
mitochondrial transmembrane potential (A1jfl. regulation of Bcl-2
family and caspases activation play an important role in apoptosis.
In this work, we studied the effects of interleukin 1~ (IL-1~) and
tumour necrosis factor a (TNFa) , two potent proinflammatory
agents, on mitochondrial A1jf, expression of Bcl-2 family compo-
nents and caspases activation in healthy human chondrocyte cells.
Variation on mitochondrial membrane potential was measured by
5,5',6,6'-tetrachloro-1 ,1 ',3,3'-tetraethylbenzimidazolyl carbocya-
nine iodide using flow cytometry. As a control, mitochondrial
depolarization was induced by valinomycin (1 IJM).
When chondrocyte cells were incubated for 12 hours with various
concentrations of IL-1 ~ (0.5, 5 and 50 ng/ml) and TNFa (1, 10 and
100 ng/ml), both citokines decreased, in a dose-dependent man-
ner the mitochondrial membrane potential (5 ng/mIIL-1~: 40 % and
10 ng/ml TNFa: 35 % vs control; p < 0.05). We also found that
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Bcl-2 (antiapoptotic) and Bax (proapoptotic), members of the Bcl-2
family, were induced in a dose- and time-dependent manner by
IL-1j3 and TNFa (by western-blot). There was a light rise by 24
hours after stimulation which increased at 72 hours and peaked
expression after 6 days of incubation (BcI-2: IL-1j3 750% and TNFa
820 % vs basal, p<0.05; Bax: IL-1j3 430% and TNFa 400 % vs
basal, p < 0.05).
We also investigated the participation of caspases (proteases) in
the effects apoptosis induced by IL-1j3 and TNFa (by western-blot).
We evaluated the executioner caspases 3 and 7. Procaspase 3
and 7 processing was enhaced by the two citokines in a time- and
dose-dependent manner. This response started as early as 24 h,
reaching maximun levels between 48-72 h of incubation (caspase
3: IL-1j3 320 % and TNFa 420 % vs basal, p<0.05; caspase 7:
IL-1j3 830% and TNFa 750 % vs basal, p < 0.05) and sustaining
highest levels to 6 days.
These results show that TNFa and IL-1j3 regulate the mitochon-
drial membrane potential, the Bcl-2 family protein and caspases
activation in human normal chondrocyte cells. These data could be
important for a better understanding of the participation of TNFa
and IL-1j3 in the pathogenesis of OA cartilage.
PS48
SELECTIVE REGULATION OF PROLIFERATION AND
PHENOTYPE EXPRESSION OF HUMAN CHONDROCYTES
BY FIBROBLAST GROWTH FACTOR 9 (FGF9)
OA Perez, AV Polotsky, DS Hungerford, CG Frondoza
JohnsHopkinsUniversity,Departmentof OrthopaedicSurgery,
The Good SamaritanHospital, Baltimore, USA
The aim of this study was to evaluate the effect of FGF9 on human
chondrocy1e proliferation and phenotypic expression.
Methods: Human nasal osteoblasts, synovial fibroblasts, nasal
and articular chondrocy1es (1 x1 05/ml) were incubated with heparin
(2~g/ml) and 100 ng/ml FGF9, or heparin and control media alone,
in 24 well plates for 0.5 to 9 days. Proliferative capacity was
evaluated by 3H-thymidine uptake and the expression of cyclin D1
and CDK4 at the message and protein levels. Viable cells were
enumerated using trypan blue uptake. The production of cartilage-
specific extracellular matrix components (ECM: collagen type II,
aggrecan) was determined by the reverse transcriptase polym-
erase chain reaction (RT-PCR), electrophoretic mobility shift assay
(EMSA), and immunostaining. Statistical analysis was performed
using Student's paired t tests with the Intercooled Stata 6.0
software.
Results: FGF9 induced time-dependent chondrocyte proliferation
(230% increase in cell number by day 9, p<0.01). Exposure to
FGF9 was not mitogenic for osteoblasts or synovial fibroblasts.
The mitogenic effect correlated with increased mRNA and protein
levels of: (a) cyclin D1 (mRNA, p<0.05 at all time points) and CDK4
(mRNA, p<0.05 at 0.5 and 1-day time points). Compared to control
medium alone, FGF9 enhanced the expression of collagen-type-II
and aggrecan at the message and protein levels by 12 hours
(p<0.05). The FGF9 receptor (FGFR3) transcript and protein were
also elevated by 12 hours (p<0.05). Chondrocytes incubated with
growth factor showed augmented FGFR3 protein levels by DNA
binding. These cells also displayed intense FGFR3 membrane
immunostaining patterns compared to chondrocy1es incubated in
control media alone. In contrast, incubation with FGF9 inhibited
collagen-type-I expression through day 9 at the message (p<0.05)
and protein levels.
Conclusions: Our discovery that FGF9 preferentially enhances
chondrocyte proliferation and phenotype expression demonstrates
its utility as a growth and differentiation factor. FGF9 would be
helpful in amplifying chondrocyte numbers while promoting syn-
thesis of ECM components.
PS49
INHIBITORY EFFECT OF NSAIDS AND GINGER EXTRACT
ON THE EXPRESSION OF TNF-?, NF-?B AND I?B-? IN
HUMAN SYNOVIOCYTES AND CHONDROCYTES
A Sohrabi, AV Polotsky, DS Hungerford, L. Lindmark,
CG Frondoza
JohnsHopkinsUniversity,DepartmentofOrthopaedicSurgery,
The Good SamaritanHospital, Baltimore,USA, Ferrosan,
Denmark
The aim of this study was to compare the effect of NSAIDs such as
aspirin and ginger extract on the expression of TNF-a and its
transcription regulators NF-KB, and IKB-a in human synoviocy1es
and chondrocy1es.
Methods: Human synovial fibroblasts and articular chondrocytes
(1 x1 05/ml) were incubated with 100:g/ml NSAIDs-aspirin; ginger
extract (EXVT.77, Zinaxin) containing hydroxyalkoxyphenol com-
pounds (HAPC); or control medium alone for up to 1 hr. and then
activated with TNF-a (1 ng/ml) for another hour. Expression of
TNF-a, and its transcription regulators NF-eB, and leB-a were
determined by reverse transcriptase polymerase chain reaction
(RT-PCR), electrophoretic mobility shift assay (EMSA), and
Western blot.
Results: Aspirin inhibited cellular expression of TNF-a to less than
50% of controls indicated by RT-PCR. In contrast, ginger extract
-HAPC reduced mRNA levels to less than 15 % of controls. Both
aspirin and ginger extract-HAPC suppressed TNF- 'v'induced acti-
vation of NF-KB in a time dependent fashion as shown by EMSA.
Within five minutes, aspirin and ginger extract-HAPC dramatically
inhibited NF-KB activation with a recovery by 45 minutes and 60
minutes, respectively. This inhibition correlated with inhibition of
IKB-a degradation which persisted for 30 minutes.
Conclusion: Our studies demonstrate that similar to NSAIDs,
ginger extract blocks cytokine expression which parallels suppres-
sion of NF-KB activation and IKB-a degradation. The observation
that ginger extract disrupts the inflammatory cascade suggests
clues as to the possible mode of action which could help modify the
pathogenesis of osteoarthritis. Ginger extracts as dietary supple-
ment may provide an alternative or complementary approach to
modulate cytokine mediated cartilage degradation.
PSSO
DYNAMIC MICROCARRIER SPINNER CULTURE SYSTEM
ENHANCES CHONDROCYTE PROLIFERATION AND
EXPRESSION OF CARTILAGE-SPECIFIC EXTRACELLULAR
MATRIX (ECM) COMPONENTS
CG Frondoza, A Sohrabi, AV Polotsky, DS Hungerford
JohnsHopkinsUniversity,DepartmentofOrthopaedicSurgery,
The Good SamaritanHospital, Baltimore,USA
The aim of this study was to determine the effect of propagating
human chondrocytes in a dynamic microcarrier spinner culture
system on the production of cartilage ECM components.
Methods: Human chondrocytes retrieved from: knee, nasal sep-
tum and ankle cartilage (3x104/cc) were seeded onto collagen
microcarriers and maintained in spinner culture at 37°C, 5% C02
for 2 to 4 weeks. 3H-Thymidine uptake and enumeration of
viable cells determined proliferative capacity. Expression of colla-
gen types II, I, aggrecan at the message and reverse tran-
scriptase polymerase chain reaction (RT-PCR), 35S04
incorporation-gel electrophoresis and immunostaining determined
protein levels.
Results: Chondrocy1es from three different tissue sites multiplied
in dynamic microcarrier spinner culture up to twenty times the
proliferation rate when cell-seeded microcarriers were kept under
static condition, or when maintained in monolayer culture. Colla-
gen type II expression was enhanced in chondrocytes maintained
in dynamic stirring condition Whereas collagen type I was undetec-
table. There was also increased de novosynthesis of high molecu-
lar weight proteoglycans associated with higher levels of aggrecan
transcripts. The chondocyte-seeded microcarriers form "hyaline
cartilage-like tissue" within one month of culture.
Conclusion: Our studies demonstrate that propagating chondro-
cytes in a dynamic microcarrier spinner culture system enhanced
the proliferative capacity and production of cartilage-specific ECM
components. Our in vitro conditions appear to offer a suitable
biomechanical environment that facilitates cell proliferation and
phenotype expression. This approach offers an attractive tech-
nique for cell based tissue engineering application in the repair of
cartilage defects.
PS51
RESPONSE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN
GENE TO BMP-2 AND MAP KINASE SIGNALING IN
CHONDROGENIC CULTURES OF C3H10T1/2 CELLS
J Roman-Bias, R Modarresi, G Bonavita, C Williams,
SA Jimenez, MR Seghatoleslami
Divisionof Rheumatology,Departmentof Medicine,
Thom?S JeffersonUniversity,Philadelphia,PA 19107, USA
Aim: To study the response of cartilage oligomeric matrix protein
(COMP) gene to BMP-2, p38, and ERK mitogen activated protein
kinase in chondrogenic cultures of C3H10TI/2 cells.
Methods: Multipotential mouse C3HIOT1/2 cells were used either
as monolayer (nonchondrogenic) or high density micromass
(1x10S cells/10~1; chondrogenic) cultures. Cells were cultured for.
2.5 days. Total RNA was isolated using TRizol reagent. Relative
mRNA levels were determined using reverse transcription, low
cycle PCR (15-20 cycles), and SYBR green staining. For quanti-
tative analysis of mRNA levels the intensity of each band was
normalized to the intensity of B-actin PCR bands. Micromass
cultures were treated with 100 ng/ml BMP-2 and/or 5J1M-20 ~M
PD98059, an inhibitor of MEKIERK, and/or 5~M SB202190, an
inhibitor of p38 kinases.
Results: Expression of aggrecan and type II collagen genes were
used as early markers of chondrogenesis. The expression of type
II B collagen, a spliced form of type II collagen mRNA associated
with differentiating chondrocytes, is upregulated in chondrogenic
cultures, whereas aggrecan gene is neither expressed in monol-
ayer nor in high density cultures of C3HIOTI/2 cells. COMP as type
liB collagen gene is expressed at very low levels in nonchondro-
genic cultures but highly induced once cells are cultured at high
density. BMP-2treatment of C3H10TI/2 micromass cultures results
in <50% induction of type II B collagen and COMP mRNA, but high
induction of aggrecan gene. ERK or p38 inhibition of the BMP-2
treated micromass cultures results in reduced expression of aggre-
can as well as type liB collagen mRNAs. ERK inhibition slightly
increases while p38 inhibition slightly reduces the expression of
COMP gene in BMP-2 treated micromass cultures.
Conclusions: High expression of COMP is dependent on the
signaling activity established by cell condensation, an event
induced by high density cell seeding and necessary for initiation of
chondrogenesis in C3H10TI/2 cells. BMP-2 treatment of micro-
mass cultures has greater effect on type JIB collagen and aggre-
can gene expression than on expression of the COMP gene. In
chondrogenic cultures of C3HIOT1/2 cells the cross talk between
BMP-2 and MAP kinase signaling has a different effect on COMP
than type liB collagen or aggrecan genes.
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PS52
HYPOXIA INDUCIBLE FACTOR-1-ALPHA EXPRESSION IN
NORMAL AND OA HUMAN CHONDROCYTES
IB Coimbra', SA Jimenez, DG Stokes
Divisionof Rheumatology,DepartmentofMedicine, Thomas
JeffersonUniversity,JeffersonMedicalCollege, Philadelphia,PA,
USA 'RheumatologyDivision,State Universityof Campinas,
Brazil.
AIM: The aim of this study was to investigate the expression profile
of hypoxia inducible factor-I-alpha (HIF-1 a.) in normal and osteoar-
thritic human chondrocytes under normoxic and hypoxic condi-
tions, and in response to the pro-inflammatory cytokine TNFa..
METHODS: Articular chondrocytes were isolated by enzymatic
digestion of human normal and osteoarthritic knee cartilage and
cultured in suspension on poly-HEMA coated dishes. Nuclear
extracts and total RNA were prepared and HIF-Ia. protein and
mRNA levels were assayed by immunoblotting and Northern
hybridization. Localization of HIF-1 a. by immunofluorescence was
performed on frozen sections of cartilage tissue by confocal
microscopy.
RESULTS: Human OA and normal chondrocytes expressed HIF-Ia
-2 a. and -lmRNA. HIF-1 a. protein expression was detectable in
human OA and normal chondrocytes by both immunoblotting and
immunofluorescence under normoxic conditions. Culture of OA or
normal chondrocytes under hypoxic conditions (1 % 02 for 4 hours)
did not result in increased expression of HIF-Ia whereas the same
conditions significantly induced HIF-Ia in Hep-3B cells. TNFa.
treatment of both normal and OA human chondrocytes resulted in
a dramatic down-regulation of HIF-I a. protein levels by immuno-
blotting.
CONCLUSIONS: We observed expression of HIF-Ia., a protein that
is normally induced by low 02 tension, in human articular chondro-
cytes under normoxic conditions. We also demonstrated a
dramatic decrease in HIF-1a. levels in response to TNFa
The constitutive expression of HIF-Ia. by chondrocytes may be
an important adaptation to survival in the avascular-hypoxic
environment of cartilage.
PS53
VERSICAN/PG-M REGULATES CHONDROCYTE
DIFFERENTIATION
Nobuhiro Kamiya, Hideto Watanabe, Hidekazu Takagi, Tamayuki.
Shinomura, Akitoshi Jikko, Caroline Damsky, Katsuji Shimizu and
Koji Kimata
Institutefor MolecularScienceofMedicine, AichiMedical
University,Aichi, Japan
Aim: The objective of this study was to analyze versican/PG-M
function during chondrogenesis using new chondrocytic cell line,
N1511, derived from p53-null mice.
Methods: We used a chondrocytic cell line, N1511, obtained from
rib cartilage of p53-null mice. Expression of aggrecan and
versican/PG-M was measured by Northern blot, real time quanti-
tative RT-PCR, and immunostaining. To examine effects of
versican/PG-M on differentiation, stable antisense mutant clones
of versican/PG-M were established.
Results: Characterization of N1511 cells demonstrated that these
cells undergo multiple steps of chondrogenesis toward hypertro-
phy, when induced by a combined treatment of either BMP-21
insulin or PTH/dexamethasone. In the PTH/dexamethasone-
treated cells, expression of versican/PG-M and aggrecan was
upregulated to 21-fold at day 2 and 12-fold at day 13, respectively.
Stable antisense mutant clones of versican/PG-M showed various
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extents of its delayed deposition, and following aggrecan expres-
sion was correlated with the delay. Out of four spliced forms of
versican/PG-M, VO and V1 variants were mainly expressed in the
early phase of differentiation, suggesting that these variants may
regulate chondrocyte differentiation.
Conclusions/Future directions: Versican/PG-M plays a major
role during chondrogenesis as an extracellular matrix molecule.
Studies of the function of versican/PG-M may contribute to the
tissue engineering of articular cartilage repair in osteoarthritis.
PS54
EXPRESSION OF THIOREDOXIN GENE IN RAT KNEE
ARTICULAR CARTILAGE
Hiroyuki Kakimaru1, Hiroko Kataoka1, Nobuyuki Kumahashi1,
Yuji Uchi01, Junji Yodoi2, and Mitsuo Ochi3
1Departmentof Orthopaedics,Shimane MedicalUniversity,
Izumo, 2Departmentof BiologicalResponses, Institutefor Virus
Research, Kyoto University,Kyoto, and 3Departmentof
OrthopaedicSurgery, HiroshimaUniversitySchoolof Medicine,
Hiroshima,Japan.
Aim of study: Thioredoxin (TRX), a small antioxidative and
antiapoptotic protein involved in the control of the cellular
oxidation-reduction state, is expressed in a wide variety of
prokaryotic and eukaryotic cells. To study the function of TRX in the
articular cartilage, we examined trx mRNA expression patterns in
rat intact and injured knees.
Methods: We created a full-thickness cartilage injury in the distal
femoral condyle of 5-week-old male Wistar rats, and obtained knee
joints from the rats 1, 3, 7, 14, and 28 days postoperatively. Four
percent paraformaldehyde-fixed, paraffin-embedded tissue sec-
tions were analyzed by in situ hybridization using the mouse trx
cONA sequence as probes. Total RNA was extracted from the
distal femoral articular cartilage, and the expression of TRX was
assayed using semiquantitative reverse transcriptase chain reac-
tion (RT-PCR).
Results: trx mRNA expression was observed in almost all
chondrocytes in the intact knee articular cartilage using in situ
hybridization. In the injured cartilage, stronger expression occurred
in a small number of chondrocytes surrounding the injured region
than the outside from 1 day after the operation and it continued
until the 28th day. No significant differences were detected using
RT-PCR, probably because the total RNA of the whole cartilage
chondrocytes was pooled.
Conclusions: We showed that rat knee articular chondrocytes
constitutively expressed TRX, and that when cartilage was injured,
the expression level of trx mRNA was up-regulated in chondro-
cytes surrounding the damage. These findings indicated the pres-
ence of a defense system against various stresses in the articular
cartilage, in which TRX plays a role.
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CROSS-LINKING OF COLLAGENS II, IX AND XI IN
CHONDROCYTE CULTURES AS A MONITOR OF NORMAL
MATRIX ASSEMBLY
RJ Fernandes and DR Eyre
Departmentof Orthopaedicsand SportsMedicine, Universityof
Washington,Seattle, WA, USA.
Aim: This study investigated the ability of cultured chondrocytes to
assemble collagen types II, IX and XI into the co-polymeric
cross-linked network that typifies cartilage matrix in vivo.
Methods: Monoclonal antibody (mAb) 10F2 was raised against a
synthetic peptide that corresponds to a sequence from the
C-telopeptide cross-linking domain of type II collagen. Human
chondrocytes (fetal and adult) and the rat chondrosarcoma cell
line, RCS-LTC, were each maintained as pellet, high density
micromass or monolayer cultures for 2-4 weeks in the presence
of serum and ascorbate. Cell layer collagen was solubilized
by pepsin digestion. The collagen chains were resolved by
SOS-PAGE, transferred to PVOF membrane and probed with
the mAb.
Results: The collagen network laid down by the cultured cells was
depolymerized by pepsin. Pepsin cleaves the telopeptides from
type II collagen and the non-collagenous domains of the minor
collagens, type XI and IX, but leaves the triple helix intact. The
cleaved telopeptides remain cross-linked to the triple-helical sites
to which they were attached in the matrix. The mAb 10F2 detects
the C-telopeptides cross-linked to collagen chains. Western blot
analysis showed an intense reaction for 71 (II) in all cultures as
expected for the cross-linked type II collagen polymer. The 71 (XI)
collagen chain was also immunoreactive, showing that this chain
was cross-linked to the C-telopeptide of 71 (II) or 73(XI) (or both
since they are the product of the same gene, COL2A1). In rat
chondrocyte cultures mAb 10F2 also reacted with a third band,
which had properties consistent with the COL2 domain of type IX
collagen, a known cross-linking partner for the type II C-telopeptide
on fibril surfaces.
Conclusion: Under appropriate culture conditions chondrocytes
deposit a matrix of the collagen II, IX, XI heteropolymer character-
istic of hyaline cartilage matrix. Since the minor collagens regulate
the organization of this network (e.g. fibril diameter modulated by
type XI), a profile of inter-type cross-linking can screen for normal
assembly. This could be useful in assessing the quality of cartilage
in disease and that induced by tissue engineering methods for a
normal polymeric phenotype.
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THE EFFECT OF OPIOIDS AND CANNABINOIDS ON
CHONDROCYTES
KO Rainsford, J Parker, R Seabrook, N Scheinkonig, RAO
Bunning
BiomedicalResearch Centre, SheffieldHallam University,
Sheffield, UK
The aim of this study was to determine whether opioids and
cannabinoids, which are used to control pain and inflammation,
have direct effects on chondrocytes to reduce cartilage
breakdown.
Methods: The effects of opioids met and leu enkephalin and
morphine sulphate and cannabinoids anandamide and R-(+)-win
55, 212-2 (win-55) were studied on chondrocyte nitric oxide (NO)
production and cartilage proteoglycan breakdown. Bovine articular
chondrocytes were used to study NO production. These were
prepared by sequential enzymic digestion and plated directly into
24-well plates at high density (2 x lOs/cm2 ). After 5 days they were
incubated with the opioids (0.1 - 100 IJM), win-55 (0.01 - 10 IJM) or
anandamide (1-100 IJM) in the presence or absence of interleukin
1a (IL-1a) (100Ulml) for 48h. NO production was determined in
culture media using the Greiss reaction. Cartilage proteoglycan
breakdown was determined using cultured bovine nasal cartilage
explants, unstimulated or stimulated to resorb with IL-1 a (500U/ml)
in the presence or absence of opioids (1-100 IJM) or win-55
(10-100 IJM).
Results: Studies of the effects of opioids indicated variable effects
on IL-1 stimulated NO production in bovine articular chondrocytes,
either no effect, inhibition or a slight stimulation. The effects of
opioids on IL-1 stimulated cartilage proteoglycan breakdown gen-
erally showed little significant effect. However the cannabinoids,
an~mdamide and win-55 inhibited IL-1 stimulated NO production,
win-55 being the more potent, producing inhibition at 1-1 0 ~M
compared with 50-100 ~M for anandamide. Win-55, at 10 and
100 ~M, also inhibited IL-1 stimulated cartilage proteoglycan
breakdown.
Conclusions: Opioids had no consistent effects on the chondro-
cyte systems used, however our studies indicate that cannabinoids
may be chondroprotective, possibly in part by inhibition of NO
production.
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EXPRESSION OF BMP-2 IN OSTEOARTHRITIC CARTILAGE
AND CHONDROCYTES
N Fukui, Y Zhu, and L Sandell
DepartmentofOrthopaedicSurgery, WashingtonUniversityat
Barnes-JewishHospital, St. Louis, MO 63110, USA
AIM OF THE STUDY: The aim of this study was to investigate the
expression of BMP-2 in OA chondrocytes together with mediators
of BMP activity, including extracellular binding proteins, cell
receptors, and cytokine regulation.
METHODS: Articular cartilage was obtained from 28 osteoarthritic
knee joints at the time of joint replacement surgery. Control
cartilage was obtained from 8 age-matched donors who did not
have any history or evidence of joint disease. Presence of BMP-2
in cartilage was detected by immunohistochemistry. Expression of
mRNA was evaluated quantitatively by real-time RT-PCR analysis,
and proteoglycan synthesis was measured by incorporation of
35S-sulfate. Western blot analysis was performed to detect BMP-2
in culture media.
RESULTS: The result of immunohistochemistry showed that
BMP-2 is expressed in both control and OA cartilage chondro-
cytes. While positive cells were observed mostly in the middle
layer in control cartilage, they were more extensively seen in OA
cartilage from superficial to deep layers, showing stronger staining.
Consistent with this, higher levels of BMP-2 mRNA were detected
in cultured chondrocytes obtained from OA cartilage. When added
to the media, recombinant human BMP-2 increased mRNA expres-
sion for type II procollagen and aggrecan significantly in cultured
chondrocytes. An increase of proteoglycan synthesis was also
observed, demonstrating anabolic actions of this factor. The results
of growth factor and cytokine treatment revealed that pro-
inflammatory cytokines IL-1P and TNF-a enhanced BMP-2 mRNA
expression more than 10-fold, while neither of TGF-p and IGF-1
significantly altered the expression level. Under the conditions we
used, TNF-a stimulated BMP-2 expression stronger than IL-1 p.
and the induction of BMP-2 was most obvious in the chondrocytes
from macroscopically preserved cartilage in OAjoints. Subsequent
studies revealed that up-regulation of BMP-2 mRNA resulted from
increase in mRNA stability by the mechanism(s) involving the
NF-lCB pathway. Cycloheximide completely abolished the
cytokines' effect. The expression of BMP receptors, BMPR-IA and
BMPR-II, and chordin, a major BMP antagonist expressed in
articular cartilage was' not altered significantly by either of the
cytokines, suggesting that chondrocyte anabolism is actually
promoted by induced BMP-2.
CONCLUSIONS: The present study has shown the possibility that
pro-inflammatory cytokines IL-1 p and TNF-a paradoxically stimu-
late anabolic actions in articular chondrocytes through the induc-
tion of BMP-2. This phenomenon may contribute to the retardation
of cartilage loss or formation of osteophytes in osteoarthritic joints.
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THE DIFFERENT RESPONSE OF CHONDROCYTES AND
ENDOTHELIAL CELLS TO PHOTODYNAMIC THERAPY (PDT)
G Fleischer-Kurtz, S Kimel and A Menhem Nahir
The H. SchussheimRheumatologyResearch Unit, Bruce
RappaportFacultyofMedicine, Technion- Israel Instituteof
Technology,Haifa, Israel.
When cartilage and synovial tissue grafted on the chick chorioal-
lantoic membrane (CAM), were exposed to PDT, damage occurred
only to the vascularized synovium grafts. It was not clear whether
chondrocytes per se are PDT-resistant or whether their resistance
is due to the avascularity of the cartilage. To investigate this point
we compared PDT damage in two types of cells: cultured bovine
brain capillary endothelial (BBCE) cells, and cultured chrondro-
cytes isolated from calf knee-joint cartilage. PDT was applied using
two synthetic phthalocyanine photosensitizers: a hydrophilic one -
CAPcS4 (chloro-aluminum-phthalocyanine-tetrasulfonate), and
a hydro one - CAPcS1 (chloro-aluminum-phthalocyanine-
monosulfonate). The photodynamic damage was measured by
vital staining with methylene blue. BBCE cells showed enhance-
ment of the photodynamic damage with increasing concentrations
of both photosensitizers at constant light dose, approximating total
destruction at high doses of the sensitizers. On the other hand,
chondrocytes remained almost unaffected by PDT, even at high
doses of the sensitizers. Exposure to both cell types to carious
biological agents like IL-1 beta & TNF alpha did not change the
different response to PDT.
These results suggest that chondrocytes per se are much less
susceptible to PDT damage than endothelial cells. The relative
insensitivity of chondrocytes to PDT in addition to their location in
avascular tissue makes PDT a safe procedure in treating arthritis.
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HUMAN CHONDROCYTES AND REACTIVES OXYGEN
SPECIES PRODUCTION: NOX IN THE SPOTLIGHT
L Grangeab, MJ Stasiaa. Vergnauda, JS Lua ; C Trocmea ,
P Gaudinab. F Morela
BGREPI EA 2938 UJF, EnzymologyLaboratoryand
bRheumatologyDepartment, CHU 38043 GrenobleCedex 9
France.
Joint destruction is a key point in many inflammatory and degen-
erative diseases. This is mainly mediated by inflammation cells
such as neutrophils and macrophages and resident cells such as
synoviocytes and chondrocytes. Matrix metalloproteinases and
reactive oxygen species are widely involved.
In the present work, we show that three different human
immortalized-chondrocyte (HIC) cell lines (gift from M. Goldring)
and native chondrocytes can generate superoxide anions (02)
constitutively and after PMA or ionomycin activation. The 02
produced by chondrocytes NAPH oxidase is about 0.1 % of the
respiratory burst measured in phagocytic cells such as neutrophils
and is the same in adherent cells or in cells suspension. All the
components of NADPH oxidase were detected by Western Blot
analysis: the cytosolic factors p47phox,p67phoxand p40phoxand
the two subunits of the cytochrome b558, gp9Iphox(Nox2) and
p22phox. The presence of cytochrome b558 was also demon-
strated by reduced minus oxidized differential spectra in 1% Triton
X100 soluble extract from the three HIC cell lines. The cytochrome
b558 content in chondrocytes was about 10 pmol/mg of proteins:
this amount is lower than in neutrophils (200 pmol/mg of proteins)
and probably overestimated by the presence of contaminant
mitochondria. The presence of Nox1 and Nox2 mRNA in the three
HIC cell lines was demonstrated by RT-PCR and Northern Blot
analysis. The sequence of Hie Nox2 cDNA was 100% analogue
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to that of neutropbils or Epstein-Barr-Virus immortalized B-
lymphocytes. The sequence of Nox1 cDNA is under investigation.
In conclusion, the three HIC cell lines and native chondrocytes
contain phagocyte NADPH oxidase components, and
Nox2(gp9lphox) analogs as Nox1. The presence of Nox5 is
suggested due to the 02 ionomycin specific activation. The low
level of superoxide anions 02 produced by chondrocytes com-
pared to neutrophils may be involved in signal transduction, and
implicated in the structural and functional alterations of cartilage
matrix observed during arthritis and osteoarthritis.
M-H, Paclet, AW Coleman, S Vergnaud, F Morel. Biochemistry
(2000). 39(31): 9302-9310.
C. Trocme, P. Gaudin, S. Berthier, C. Barro, P. Zaoui, F. Morel.
J. Bioi. Chem. (1998).273 (32) : 20677-20684.
PS60
EXPRESSION OF TRANSDUCED HSP70 GENE PROTECTS
CHONDROCYTES FROM APOPTOSIS
*R Terauchi, K Takahashi, Y Arai, T Ikeda, S Ohashi, *0 Mazda,
*J Imanishi, T Kubo
Depts. of OrthopaedicSurgeryand *Microbiology,Kyoto
PrefecturalUniversityofMedicine, Kyoto, Japan
Aim of the study was to investigate the efficacy of the heat shock
protein70 (HSP70) gene transfer to chondrocytes apoptosis.
Methods: We used two adenovirus vectors, one was AxSHEwt
that included wild-type HSP70 gene, another was Ax1w that
included no expression gene unit. Chondrocytes were obtained
from articular cartilage of Japanese white rabbits. Apoptosis was
induced by 0.5mM sodium nitroprusside dihydrate (SNP) which
produced nitric oxide (NO). The effect of adenovirus vector medi-
ated - HSP70 gene transfer on the apoptosis was investigated
using the lactate dehydrogenase (LDH) activity assay, the
Hoechst33342 staining, and Terminal transferase dUTP Nick-End
Labeling (TUNEL) staining. The expression of HSP70 gene was
confirmed by western blotting.
Results: In the LDH activity assay, OD at 570 nm- OD at 690 nm
were 423.3±30.5 (control), 465.0±15.9 (Ax1w), and -26.3±2.3
(AxSHEwt) (n = 5). In the Hoechst33342 staining assay, the
percentages of positive cells were 12.3±3.8% (control), 11.9±2.4%
(Ax1w), and 0.8±0.4% (AxSHEwt) (n=5). In the TUNEL-staining
assay, the percentages of positive cells were 29.3±13.9% (control),
23.3±9.2% (Ax1w), and 0.4±0.6%(AxSHEwt) (n=10). Western blot-
ting analysis confirmed the expression of transduced HSP70 gene
expression only in the AxSHEwt transduced cells.
Conclusions: HSP70 has been known to protect cells from
various stresses. Recent studies demonstrated that the apoptosis
of articular chondrocytes plays an important role in the pathogen-
esis of osteoarthritis (OA) and that NO could stimulate this pro-
cess. This study showed that the HSP70 gene transfer protected
chondrocytes from the apoptosis induced by NO. This suggests
that the HSP70 gene transfer to chondrocytes could be useful for
the treatment for OA.
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DIFFERENTIAL EXPRESSION OF HIGH MOBILITY GROUP
PROTEIN IN HUMAN NORMAL AND ARTHRITIC CARTILAGE:
A FUNCTIONAL GENOMIC ANALYSIS
Attur, M~, Dave, M~, Akamatsu, MO , Nakagawa, N°, Miki, P,
Yang, Hi, Katoh, MO , Wisniewski, J*, Tracey, Ki and Amin, A~
11 Hospitalfor JointDiseases, Departmentof Rheumatologyand
Medicine, New York, NY 10003, USA, °Yamanouchi
PharmaceuticalCo., Ltd., Tsukuba, Ibaraki305-8582, Japan,
iNorth Shore UniversityHospital,Manhasset, NY 11030, USA,
*MDS ProteomicsAlS, Denmark
Aim of study: To identify the role of differentially expressed DNA
binding architectural protein (High Mobility Group) family in
osteoarthritis-affected cartilage.
Methods: Differential expression of HMG group of proteins was
performed using Affymetrix Gene Chip analysis and confirmed by
Real Time PCR (RT-PCR). The HMG proteins were immunos-
tained in cartilage. The biologically active recombinant proteins
and domain-specific deletion mutants were cloned, expressed, and
purified to study their function in human OA-cartilage organ
cultures/chondrocytes.
Results: Gene chip and Real Time PCR analysis showed a
marginal increase in HMGB1 and a significant difference with
HMGA1 mRNA in human OA-affected cartilage as compared to
normal cartilage. The expression of these proteins could be
identified by immunostaining and Western blot analysis. Functional
genomic analysis of various recombinant HMGB1 and their deleted
mutant proteins in human OA-affected cartilage explant assays
showed (a) that addition of 1-5 19 of recombinant HMGB1 up
regulated NO, PGE2, IL-6 and IL-8 in a dose dependent manner
and (b) that the B box (but not the A box) significantly regulated
inflammatory mediators and demonstrated a complex intra-
molecular regulation of HMGB1 in inflammation. Comparison of
HMGB1/IL-1 using Affymetrix chips showed modulation of 506-
HMGB1-specific transcripts and 321 commonly modulated
(HMGB1 and IL-1) pro-inflammatory transcripts in human chondro-
cytes, covering various cartilage homeostatic pathways.
Conclusion: In summary, HMGB1 (like IL-1) plays a broad role in
cartilage homeostasis by acting as a unique proinflammatory
growth factor/cytokine. The B box of HMGB1 harbored the proin-
flammatory activity whereas the A box is reported to be involved in
DNA binding and facilitating gene transcription. This report for the
first time demonstrates the role of non-histone DNA binding
proteins (e.g. HMGB1) in cartilage homeostasis and arthritis.
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TRANSCRIPTOME AND PROTEOME ANALYSIS OF HUMAN
CHONDROCYTES STIMULATED WITH IL-1
Yokota, HO , Attur MG~, Dave MN~, Hiramoto MO, Akamatsu MO ,
Katoh MO , Amin AR~
11 NYU Schoolof Medicine/Hospitalfor JointDiseases,
DepartmentofPathologyand Medicine, New York, NY, USA, °
Institutefor Drug DiscoveryResearch, Yamanouchi
PharmaceuticalCo., Ltd., Tsukuba, Ibaraki, Japan
Aim of study: In view of the detrimental effects of IL-1 on cartilage
homeostasis, we analyzed the global expression of mRNA and
proteins modulated by IL-1 in vitro in human chondrocytes.
Methods: Primary human OA-affected chondrocytes were grown
for 2 days and induced with 10 ng/ml IL-1 B for 24 hr. The mRNA
was analyzed using a U95AAffymetrix gene chip. The total protein
extracted was analyzed by 2-D gel (2D-DIGE/MS). The proteins
were identified and analyzed by mass spectral analysis. Bioinfor-
matic and annotation of data was performed using Gene Spring
and DeCyder 2D-DIGE gel image analysis software for cDNA and
proteins respectively.
Results: OA chondrocytes showed that 41-43% of genes (out of
12,000 cDNAs) were transcriptionally active as compared to
28-30% in human macrophages, T cells or neutrophils. IL-1 B
modulated (by 2 fold) -900 mRNA transcripts representing -8% of
the transcriptionally active genes in chondrocy1es. These included
growth factors, structural proteins, matrix proteins, MMPs, disin-
tegrins, signaling molecules including kinases and phosphatases,
oncogenes and metabolic enzymes. Among these, 455 were up
regulated and 430 were down regulated.
Proteomic analysis (2D-DIGElMS) of OA chondrocy1es ± IL-1
identified differentially expressed proteins. Among these, 12 were
identified by MS, 6 were reported to be involved in arthritis and
cartilage homeostasis and the others were novel. Approximately
25% of the differentially expressed proteins were found to overlap
both in the gene chip and proteomic screen.
Conclusion: Microarray based global gene expression analysis
was observed to be a sensitive and reliable technique. OA
chondrocytes showed "hypertropic gene signatures" as compared
to other inflammatory cells. These genes are involved in various
cellular functions. Novel genes involved in cartilage homeostasis
were identified. The data suggest that the comprehensive
approach of both microarray and proteomic analyses may be
required to analyze complex interactions to dissect the pathophysi-
ology of osteoarthritis.
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COUNTERACTION OF IL-1-REGULATED GENES BY TGF
IN A MURINE CHONDROCYTE CELL LINE
Nozomi Takahashi, Peter van der Kraan# Klaus Rieneck*,
Henk van Beuningen, Klaus Bendtzen*, Wim van den Berg
DepartmentofExperimentalRheumatology,Nijmegen Center for
MolecularLife Sciences, Nijmegen, The Netherlands. *Institute
for InflammationResearch, NationalUniversityHospital,
Copenhagen, Denmark(' correspondingauthor)
The aim was to investigate the counteracting effects of TGF ~ on
IL-1-induced changes in gene expression in chondrocytes.
Methods: A murine articular cartilage chondrocyte cell line was
selected based on similar responses to IL-1 and TGF ~ as intact
murine articular cartilage in vivo. This cell line was incubated for
9 hours with IL-1a, TGF ~1 or a combination of both factors
(10 ng/ml). After incubation RNA was isolated and gene expression
was analyzed using the murine genome array of Affymetrix which
represents -6,000 functionally characterized murine genes and
[]6,OOO EST clusters.
Results: Interleukin-1-induced significant upregulation of 199
genes and downregulated 144 genes, with a maximum of 30 fold
upregulation and 8 fold downregulation. Of the upregulated genes
40 percent were ESTs while only 14% of the downregulated genes
were uncharacterized. TGF ~ counteracted approximately 40% of
both the IL-1 upregulated and downregulated genes. The counter-
action of TGF ~-induced changes in gene expression by IL-1 was
less pronounced, only the expression of 15% of TGF ~ regulated
genes was significantly affected by IL:1.
Interleukin-1 enhanced, amongst others, the expression of genes
involved in matrix catabolism, stress reponse and apoptosis. Gene
expression of IL-1 a, 11-6, NOS2, COX2, MMP-13 and TDAG51 was
significantly increased by IL-1 incubation. Interleukin-1 also
induced a number of chemokines, such as RANTES. TGF ~
opposed the stimulating effects of IL1 on the gene expression of all
these genes in this murine cell line. Aggrecan expression was
enhanced by TGF ~ and subsequently down-regulated by IL-1.
Conclusions: Counterregulation of IL-Hnduced gene expression
by TGF ~ is more pronounced than vise versa. A large number of
expected, new and uncharacterized genes are regulated by IL-1
and subsequently counteracted by TGF ~ in this murine articular
cartilage chondrocyte cell line.
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A NOVEL GENE PRODUCT DERIVED FROM DEER ANTLER
CHONDROCYTES STIMULATES MITOGENESIS WHEN
TRANSFECTED INTO RABBIT CHONDROCYTES
R Roubin, M Messina*, P Ghosh, SM Smith, B Robinson*,
R Goomert, D Amielt
Instituteof Bone and JointResearch and *KollingInstitute,
RNS Hospital, Sydney, Australia;tDepartmentof Orthopaedics,
UCSD-SchoolofMedicine, La Jolla, California, USA
Aims of this study. Deer antler consists of rapidly growing
cartilage that regenerates annually. Deer are the only adult mam-
mals that exhibit the capacity to completely regenerate a cartilagi-
nous tissue which is eventually converted to bone. As part of a
program aimed at identifying the mechanisms responsible for the
remarkable regenerative process, we have isolated a novel gene
product from deer antler cartilage (DAC) which we are investigat-
ing as a potential promoter of chondrogenesis.
Methods. In the present study we constructed a cDNA library from
DAC. A human riboprobe was used to screen the DAC cDNA
library for abundantly expressed genes. A novel gene product
(DACC-?) was isolated and sequenced using standard techniques.
DACC-? was then subcloned using a mammalian expression
vector for non-viral transfection into rabbit chondrocytes in vitro.
Mitogenic activity in transfected rabbit chondrocy1es was examined
by tritiated thymidine incorporation into DNA. Expression of
DACC-? in human foetal cartilage was also examined by in situ
hybridisation with a DACC-? riboprobe.
Results. DACC-? mRNA was found to consist of 1.5 kb, encoding
a predicted protein of 30kDa. BLAST searches of GenBank
databases failed to detect similar known functional proteins. The
DACC-? transfected rabbit chondrocytes grown in pellet culture
showed enhanced proliferation, as determined by the higher
tritiated thymidine incorporation into DNA, as compared to mock
transfected rabbit chondrocy1es. The chondrocy1e phenotype was
maintained by pellet culture. DACC-? was expressed in early
stages of chondrogenesis in human foetal tissues by chondrocytes
in the knee and finger joints and notochordal cells in the nucleus
pulposus of the foetal intervertebral disc. DACC-? was also
detected in human adult osteoarthritic cartilage in regions where
repair and attempted restoration of the extracellular matrix was
apparent histologically.
Conclusions. This study has demonstrated that DACC-? stimu-
lated lapine chondrocyte cell proliferation. As damaged adult
articular cartilage is incapable of spontaneously undergoing repair,
this can lead to joint failure. We propose that transfection of human
chondrocytes with DACC-? and implantation of the transfected
cells within cartilage defects may promote growth and restoration
of the extracellular matrix, thereby restoring joint function and
possibly slowing degenerative changes in joint tissues associated
with the development of osteoarthritis.
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ASSOCIATION OF AN INSULlN·LlKE-GROWTH FACTOR I
(IGF-I) GENE PROMOTER POLYMORPHISM AND ITS
INTERACTION WITH THE COLLAGEN TYPE II ALFA 1
(C0L2A1) GENE ON THE OCCURRENCE OF
RADIOGRAPHIC OSTEOARTHRITIS (ROA): THE
ROTIERDAM STUDY
G Zhail, F Rivadeneira1 , JJ Houwing-Duistermaatl,
I Meulenbelt3 ,4, C Bijkerk3 , PE Slagboom3 ,4, HAP Pols1.2,
CM van Duijn 1
1 DepartmentofEpidemiology& Biostatistics,2 Departmentof
InternalMedicine, ErasmusMedicalCentre, The Netherlands,3
Departmentof Rheumatology,Leiden UniversityMedicalCentre,
The Netherlands,4 TNO Preventionand Health, Gaubius
Laboratory,Leiden, The Netherlands.
The relationship between the IGF-I and osteoarthritis is yet
unclear. Previously, we found the presence of the 192-bp (wild
842
type) allele of a microsatellite IGF-I gene promoter polymorphism
associated with increased IGF-I serum levels, and a COL2A1 gene
VNTR polymorphism associated with ROA. In this study, we
examined the role of the 192-bp allele of this IGF-I gene polymor-
phism with ROA, and studied the gene interaction with the
COL2A1 gene, within the same population based cohort, the
Rotterdam Study. A random sample (n= 3908) of the study was
genotyped for the IGF-I (n=1546) and the COL2A1 (n=808) gene
polymorphisms. Presence of ROA at baseline was defined as a
Kellgren score of two or higher in at least one of four joint sites
(knee, hip, hand and spine). Trend analysis and estimation of
genotype related odds ratios, and interactions, all adjusted for age,
gender, body mass index (BMI) and bone mineral density (BMD),
were modelled using logistic regression. All genotype frequencies
in cases and controls were in Hardy-Weinberg equilibrium. Overall,
no association was found between the IGF-I polymorphism and
ROA. In subjects younger than 65 years old (n = 971), we found an
association using a multiplicative model (p for trend = 0.03). As
compared to homozygotes for the 192-bp allele, the risk of ROA for
heterozygotes and non-carriers of the allele was 1.4 (95% CI 1.0 -
1.8) and 1.9 (95% CI 1.1 - 3.3) respectively. No such effect was
observed in subjects older than 65 years (p for trend = 0.34). We
found also, some evidence of interaction of the IGF-I gene and the
COL2A1 gene, being the odds ratio significantly increased only in
those with the risk genotype of both genes (odds ratio = 3.4, 95%
C11.1 -10.7). Our findings suggest that the absence of the 192-bp
allele increases the risk for early onset ROA, independently of
BMD, most likely in interaction with COL2A1.
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EVALUATION OF HYALURONAN SYNTHESIS AND
EXPRESSION OF CD44 BY GENE TRANSFER OF
HYALURONAN SYNTHASE 2
K Tsuchiya, Y Wada, K Takase, K Nakagawa, T Yamashita,
A Watanabe, H Moriya
Departmentof OrthopaedicSurgerySchoolofMedicine,Chiba
University,Japan
The aim of this study was to evaluate hyaluronan synthesis by
gene transfer of hyaluronan synthase 2(HAS2)with retrovirus and
the relationship between the production of hyaluronan(HA)and the
expression of cell surface CD44.
Methods: In this study, Plasmids containing HAS2 under the
PMX-IRES-GFP retrovirus vector were transfected into undifferen-
tiated ATDC5 cells. As a control, cells transfected with the empty
vector were used. ATDC5 differentiated in the presence of insulin
and we evaluated visualization of pericellular coats which was
composed of newly synthesized HA using by immunofluorescent
staining and analyzed HA concentration in culture medium by high
performance liquid chromatography .The amounts of CD44 on
HAS2 ATDC5 transfectants and control cells were measured by
flow cytometory.
Results: The signal of the cells transfected with HAS2 was visually
much stronger than that of control cells. The HA concentration of
the cells transfected with HAS2 in culture medium was much
higher than that of control throughout 21 days.The amount of CD44
on HAS2 ATDC5 transfectants was smaller than that of control
cells.
Conclusions: By transfection of HAS2 with retrovirus, we are able
to expect the continuous synthesis of HA. The inverse relationship
between the production of HA and the expression of CD44 may be
important for the regulation of cell-extracellular matrix interaction.
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CARTILAGE COLLAGEN GENES AND PRIMARY
OSTEOARTHRITIS
E Jakkula1, M Melkoniemi 1 , J Lohiniva1, S Raina1, M Perala1,
M L Warman2 , K Ahonen4 , I Kiviranta3 , H Kroger4, H HH Goring5
and L Ala-Kokko 1. 6
CollagenResearch Unit, BiocenterOulu and Departmentof
MedicalBiochemistryand MolecularBiology,Universityof Oulu,
Oulu, Finland;controls<'Departmentof Genetics, Case Western
Reserve SchoolofMedicine, Cleveland, OH, USA; 3 Department
of Surgery, JyvaskylaCentral Hospital,Jyvaskyla,Finland;4
Departmentof Surgery, KuopioUniversityHospital, Kuopio,
Finland;5 Departmentof Genetics, SouthwestFoundationfor
BiomedicalResearch, San Antonio,TX, USA; 6 Center for Gene
Therapyand DepartmentofMedicine, Tulane UniversityHealth
SciencesCenter, New Orleans, LA, USA
Mutations in genes for cartilage collagens II, IX, and XI have been
shown to cause various chondrodysplasias that overlap with
osteoarthritis (OA). OA can be the main clinical finding in some of
these dysplasias. Initially, a North American family with early onset
primary OA was referred to us for mutation analysis, and we
identified a splicing mutation in C0L11A2 in this family. This
mutation resulted in skipping of exon 43 and thus an in-frame
deletion of 36 amino acids in the triple-helical region of the (f,2
chain of collagen XI. For these reasons, we performed a systemic
analysis of 73 OA patients for mutations in cartilage collagen
genes (COL2A1, COL9A1, COL9A2, COL9A3, COL11 A1 and
COL11 A2) using conformation-sensitive gel electrophoresis
(CSGE). All patients included in the study were of Finnish origin.
They were examined clinically and radiologically, and selected
using the following criteria: (a) age of onset less than 50 y, (b)
primary hip and/or knee OA, (c) at least two joint disease or one
joint disease and positive family history or age of onset <40 y, (d)
BMI <30. 103 unrelated controls (>45 y) were also from Finland.
They were not examined but they had no history of OA. Mutation
analysis identified six unique changes in OA patients: P693P in
COL2A1; E341Q; D1472E; IVS8+87T>C and P974Q in C0L11A1
and R539W in COL11 A2. The last nucleotide of exon 38 in
COL2A1 was changed from G to A (P693). Even though it did not
change the amino acid, it could result in splicing defect. RT-PCR
analysis showed that only the wild type allele was present.
Because CSGE is not likely to have a sensitivity of 100% and it
does not detect changes in the promoter region or putative intronic
regulatory regions, allele frequencies of 5 to 8 SNPs per gene were
determined and are currently being statistically compared between
73 patients and 103
In conclusion, results from this mutation analysis suggest that
sequence variations in collagen XI genes play a role in the
pathogenesis of primary OA.
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ULTRASTRUCTURAL CHANGES IN RELATION TO
COLLAGEN DEGRADATION IN ARTICULAR CARTILAGE OF
MICE PREDISPOSED TO OSTEOARTHRITIS
RE Seegmiller1, W Babcock1, R Rodriguez1 , R Poole2 and
L Bridgewater3
Departmentsof 1Physiologyand DevelopmentalBiologyand
3Microbiologyand MolecularBiology,BrighamYoung University,
Provo, UT, USA; 2ShrinersHospital, Montreal, Quebec, Canada
In the present study we examined knee-joint articular cartilage of
heterozygous chondrodysplasia (cho/+) mice which carry a reces-
sive mutation in the Coillal gene for type XI collagen. The aim
was to determine the existence of a temporal relationship between
ultrastructural changes in the cartilage matrix and the occurrence
of enzymatic degradation of matrix collagen. Such analysis is
important in light of the role played by type XI collagen in limiting
the diameter of type II collagen matrix fibrils, and in view of our
understanding that enzymatic degradation of type II collagen is a
key step in osteoarthritis (OA).
Methods: With wild-type (+/+) mice of the C57BL strain serving as
controls, knee joints from 6, 9, 12, and 15 month old heterozygotes
(cho/+) were examined ultrastructurally to compare mean fibril
diameter, and immunohistochemically to analyze the extent of
degraded type II collagen as detected by the coI2-3/4m antibody.
Results: Relative to control, significantly larger diameter collagen
fibrils were observed in the experimental group at six months of
age. The change in fibril diameter was observed in the superficial
zone. Degraded collagen was detected in the superficial and
transitional zones of both mutant and control articular cartilage.
Here the difference between mutant and control mice was not
statistically significant until 12 months of age, i.e., six months after
the occurrence of the increase in fibril diameter. The area of
immunofluorescence in the mutant was greater than twice that of
control.
Conclusions: These results suggest that the cho/+ haploinsuffi-
ciency effect predisposes articular cartilage to early onset OA by
compromising the integrity of the matrix structure, subjecting the
cartilage to a cascade of degenerative events that lead to OA. This
study adds to the mounting evidence that the chomutant can serve
as an animal model for the study of early-onset OA in human
chondrodysplasia, e.g., Stickler syndrome.
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EXPRESSION OF THE GENE FOR PROGRESSIVE
ANKYLOSIS (ANKH) DURING INSULIN-INDUCED
CHONDROGENESIS IN ATDCS CELLS
R Zaka, G Bonavita, S Piera-Velazquez, CJ Williams
Thomas JeffersonUniversity,Philadelphia,PA 19107, USA.
Aim: To study the expression of ANKH mRNA during induced
chondrogenesis in the ATDC5 in vitrochondrogenic model system.
Methods: ATDC5 is a clonal murine cell line established from a
differentiated culture of embryonic cell-derived AT805 cells. When
cultured in the presence of insulin, the cells under a program of
chondrogenesis that includes the induction of chondrocyte-specific
gene expression. Cells were plated at low density and grown as
monolayers with and without the addition of insulin for a period of
28 days. Media were changed every other day and cells were
harvested on days 1, 3, 7, 14, 21, and 28 for histochemical
analyses and RNA isolation. For histochemistry, cells grown in
glass culture slides were stained with Alcian blue to microscopi-
cally assess proteoglycan synthesis. For RNA analyses, transcript
levels of various cartilage-expressed genes were determined by
relative quantitative RT-PCR.
Results: Consistent with previous reports of the induction of
chondrogenesis in this cell line, we observed weak Alcian blue
staining of isolated clusters of cells by day 7 of culture of cells
treated with insulin. By day 14, the Alcian blue staining was strong
in areas of densely-packed multicellular nodules. Again as pre-
viously described, analyses of transcripts for cartilage-expressed
genes was also consistent with the induction of chondrogenesis.
ANKH transcript was present in cells from Day 1 of culture in both
media. The levels of transcript, however, increased with time and
reached a plateau at about Day 14 of culture. Relative levels of
ANKH were similar in cells with and without insulin, suggesting that
jnduction of chondrogenesis by insulin had no significant effect on
the levels of ANKH expression in ATDC5 cells.
Conclusions: Our current studies show that ANKH is abundantly
expressed in ATDC5 cells during the induction of chondrogenesis.
ANKH codes for a transmembrane protein that appears to regulate
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intra- and extracellular levels of inorganic pyrophosphate. Mis-
sense mutations in ANKH have been reported by us and others in
autosomal dominant calcium pyrophosphate dihydrate deposition
disease. The experiments presented here were undertaken to
establish baseline information for future studies that will examine
the expression of normal and mutant ANKH in the ATDC5 cell line.
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QUANTITATIVE TRAIT LINKAGE ANALYSIS OF FIVE LOCI
TO DETERMINE CONTRIBUTION TO OSTEOARTHRITIS OF
THE HAND IN A TASMANIAN POPULATION
A Reilly, J Stankovich, MM Sale, H Cooley, G Jones
Menzies Research Institute,Universityof Tasmania, Hobart,
Australia
To identify susceptibility genes involved in osteoarthritis of the
hand in the Tasmanian population, we have examined 5 previously
reported suggestive linkage regions by quantitative trait linkage
analysis.
Our study population consisted of 74 families with at least 2
members affected with hand OA. Phenotypic traits assessed
included joint space narrowing and osteophyte formation at the
distal interphalangeal (DIP) and the first carpometacarpal (CMC)
joints, and Heberden's nodes (HN) at each DIP joint. All 452
phenotyped subjects and an additional 55 spouses were geno-
typed at 9 markers from 5 regions: 2q12-13, 4q12-21.2, 7p15-21,
8q21-24 and 9q33-34. Data were analysed using quantitative trait
linkage analysis with the program SOLAR. Heritability was esti-
mated for each of the above traits after adjusting for the covariates:
age and sex and an age-sex interaction. Two-point analysis was
used to test for linkage at each of the markers in the 5 regions.
Age and sex covariate effects accounted for between 36% and
46% of variance in the different trait scores. Heritability estimates
ranged in magnitude from 24% for Heberden's Nodes to 33% for
DIP joint space narrowing. All heritabilities differed significantly
from zero (p-values <0.0001 - 0.0006). The highest LOD score of
1.21 (single-test p=0.0091) was derived at a marker on chromo-
some 9 when analysed for linkage to the DIP joint space narrowing
trait. Further evidence of possible linkage was provided by non-
parametric dichotomous trait analysis of this marker (nonparamet-
ric linkage score of 1.084; p=0.13).
Each of the X-ray phenotype and HN traits is heritable within our
population. There is some evidence, though not significant, that a
OTL contributing to DIP joint space narrowing, a common trait of
hand osteoarthritis, may exist on chromosome 9. Inclusion of
additional markers in this region for multipoint linkage analysis
might strengthen evidence of a linkage at this locus.
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DNA FINGERPRINTING OF FRESH VIABLE MENISCAL
ALLOGRAFTS TRANSPLANTATED IN THE HUMAN KNEE
P Verdonk, KF Almqvist, T Lootens, D Van Hoofstatt ,
E Van Den Eeckhoutt , G Verbruggen, R Verdonk
Dept. of PhysicalMedicineand OrthopaedicSurgery, Ghent
UniversityHospital, and fLab. of PharmaceuticalBiotechnology,
Ghent University,Ghent, Belgium.
Purpose of the study: The capability of recipient fibrochondro-
cytes to integrate into human viable meniscal allografts was
investigated in vivo.
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Materials and Methods: 26 of 104 patients who had received an
allogenic viable meniscal transplant, underwent a control arthros-
copy. A biopsy specimen was harvested from the implanted
menisci during this second operation. DNA was extracted and
amplified by PCR. Subsequently, the DNA-profile was compared to
the DNA-profile of the host to evaluate possible ingrowth of the
meniscal allograft by acceptor fibrochondrocytes.
Results: The compared DNA profiles (12 STR loci) of the retrieved
maniscal fragment showed a complete matching to the host in 13
cases, incomplete matching or partial DNA profile (cell population
of the recipient and the donor) in 4 cases, and a different DNA
pattern in 3 cases. The remaining 8 cases could not be analyzed
due to culture failure. Two patients underwent a second control
arthroscopy. The initial DNA determination was mixed or non-
matching, and at the second arthroscopy this became matching or
mixed DNA profile, respectively.
Conclusion: These findings suggest partial or complete ingrowth
of the transplanted meniscus by acceptor fibrochondrocytes as
soon as 3 months postoperatively. However, a different DNA profile
does not imply graft failure as evidenced by a simultaneous clinical
examination using the Hospital for Special Surgery score, and by
the macroscopic aspect during control arthroscopy.
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AGGRECANASE·1 OF HUMAN SYNOVIOCYTES IS ONLY
UP-REGULATED WITH CO-CULTURED CHONDROCYTES;
H Nishina, S Fujita, E Hoshino, S Matsubara
ProductResearch Laboratory,Chugai PharmaceuticalCo., Ltd.,
Tokyo
Aim: The synovial fluids from OA patients contain aggrecan
fragements with aggrecanase. However, it is unclear which of
aggrecanase-1 or -2 degradates the aggrecan, and which is
derived from synovium or cartilage. The aim of this study was to
investigate this problem, using a co-culture system with human
synoviocytes and chondrocytes.
Methods: In the present study, we cultured human syoviocytes as
a monolayer, and human chondrocytes in alginate to maintain the
phenotype. When both cells were co-cultured or single-cultured,
the aggrecanase-1,2 mRNA expression of human synoviocytes
were examined by RT-PCR. Aggrecan fragments with aggreca-
nase in the cultured medium were also examined by Western Blot
analysis, using the antibody to recognize the aggrecan 1718 N
terminal peptide containing GLGSVEL.
Results: The aggrecanase-2 mRNA of synoviocytes was con-
stantly expressed in the absence and presence of chondrocytes.
However, aggrecanase-1 was only expressed with co-cultured
chondrocytes in the presence of cytokines such as IL-Ia or
TNFa. Furthermore, the medium, but not alginate beads con-
taining chondrocytes, showed bands of aggrecan fragments with
aggrecanase when synoviocytes were co-cultured with chondro-
cytes, and the intensity of the bands increased by addition of
cytokines.
Conclusion: The above results showed that aggrecanase-1 of
synoviocytes was only up-regulated by cyokines co-cultured with
chondrocytes, resulting in degradation of the aggrecan in the
medium. This observation suggests that some part of aggrecan
fragments in OA synovial fluids are formed by aggrecanase-1 from
the stimulated synovium.
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CONTROL OF HUMAN SYNO VIAL FIBROBLAST
COLLAGENASE-L (MMP-L) GENE EXPRESSION BY
CYTOKINES AND PROSTAGLANDINS; A CLASSIC
YING-YANG PARADIGM OF GENE REGULATION
OW He, W Faour, JA Di Battista
DivisionofRheumatologyand ClinicalImmunology,Royal
VictoriaHospital,McGillUniversityHealth Center, Montreal(OC),
Canada.
Our previous studies demonstrated that basal and cytokine-
induced production of MMP-1 by human OA-affected synovial
membranes or by human OA synovial cells in culture, depend
entirely on the status of eicosanoid prOduction, particularly PGE2.
Using an ectopic over-expression strategy with active MAP kinase
constructs transfected into human synovial fibroblasts (HSF), we
demonstrated that MMP-I mRNA expression (Northern analysis)
and protein synthesis (ELISA) respond exclusively to the activated
TRAF6/MKK1/MKK4/7/JNK cascade; co-expression of dominant-
negative mutants of TRAF6 or INK completely inhibited IL-IB or
MEKK1 induced MMP-I expression, respectively. Adding increas-
ing concentrations of exogenous PGE2 also abrogated the induc-
tive response, a process associated with the stimulation of the
MEK-3/p38a MAP kinase pathway. The PGE2-dependant acti-
vation of the MEK-3/p38o. MAP kinase pathway inhibits JNK
phosphorylation (activation) as judged by Western analysis using
specific anti-phospho JNK antibodies.
In the absence of any demonstrable regulation of MMP-1 mRNA
expression by post-translational/translational mechanisms, we
turned our attention to human MMP-I promoter (4.1 kb) analysis
(transcription). Using wild-type and mutant promoter constructs
fused to a luciferase reporter, we observed that while the TRAF6/
MEKK1/MKK4/7/JNK cascade induction of promoter activity in
HSF is dependent, in part, on the proximal (-66 bp) AP-1 activation
as judged by transient transfection analysis, PGE2 is actually more
potent in this regard. Interestingly however, overexpression of a
Wild-type p53 construct potently induced MMP-I expression, an
effect abrogated by dominant negative mutants of p53 and PGE2.
We conclude that the role of AP-1 in the induction of MMP-1 gene
expression in HSF requires further analysis. This study describes a
novel negative feed-back signaling paradigm in which membrane
phosphofipid-derived eicosanoids control cytokine target genes by
mitigating cytokine stimulated signaling cascades.
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CHEMOKINES INDUCE HUMAN CARTILAGE DEGRADATION
RM Borzi'*, I Mazzetti*, G Magagnoli*, S Paoletti°,
M Uguccionio, Cattini* A Facchini*
*Lab. Immunologiae Genetica, IstitutiOrtopediciRizzoli,
Bologna, Italy;
°lnstitutefor Research in Biomedicine,Bellinzona,Switzerland;
[JDip.MedicinaInterna e Gastroenterologia,UniversitAdi
Bologna, Italy
Aim of the study: Human chondrocytes cultured in vitroproduce
CC and CXC chemokines and express chemokine receptors.
Activation of this autocrine loop induces the production and
release of matrix degrading enzymes (matrix metalloprotease-3
and N-acetyl-B-D-glucosaminidase). In this study we investigated
on chondrocytes cultured within an intact extracellular matrix
(ECM) whether chemokines playa significant modulating role in
activities involved in cartilage damage in osteoarthritis (OA) and
whether the effect of chemokines is differentially distributed across
the various cartilage layers.
Methods: Full thickness pieces of cartilage obtained from OA
patients undergoing arthroscopy were incubated in vitro with
chemokines (GROa MCP-I, RANTES) or control stimuli. The
conditioned media were used for assessment of the concentration
of sulfated glycosaminoglycans and for detection of several enzy-
matic activities (MMP-I, MMP-3, cathepsin Sand N-acetyl-B-D-
glucosaminidase). Complementary evaluations of ECM
degradation were also performed by Safranin-O staining. Apopto-
sis was investigated by means of TUNEL and in situ immuno-
detection of activation of caspase 3.
Results: We found that cartilage stimulation with chemokines
increased the release of glycosaminoglycans and strongly reduced
the intensity of Safranin-O staining, and this effect was similar to
that obtained with IL--IB. Matrix turnover was mainly accounted for
by MMP-3 and cathepsin S. Chemokine effects appeared to be
selectively restricted to cells of the deeper layers of cartilage.
Notably, GROa stimulation of cartilage explants with reduced
extracellular matrix induced chondrocyte apoptosis in the deeper
of the tissue as indicated by TUNEL staining and colocalization of
activated caspase 3.
Conclusions: Our findings further support the existence in human
chondrocytes of a novel catabolic pathway leading to the break-
down of cartilage matrix components, which is primed by chemo-
kines and their receptors, setting up an autocrine loop. The
differential effects across the different layers of the tissue suggest
the existence of several levels of controls of chemokine action
in vivo.
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PRO·MATRIXMETALLOPROTEINASE-3 LEVELS IN
SYNOVIAL FLUID AND SERUM AFTER KNEE INJURY
Sobacz K", Maier R#, Gruber W, Fialka C$, Ekhart H",
Woloszczuk W§, Geyer G§, Erlacher L", Smolen J",
Graninger WS"
"Clinicof InternalMedicine III, Departmentof Rheumatology,
Universityof Vienna, Austria
#Departmentof Traumatology,HospitalBaden, Austria
+ Schoolof Dentistry,Departmentof Oral Surgery, Universityof
Vienna
$Departmentof Traumatology,Universityof Vienna, Austria
§LudwigBoltzmannInstitutefor ExperimentalEndocrinology,
Vienna
Aim of study: To correlate the extent of arthroscopically deter-
mined cartilage damage with synovial fluid (SF) lavage and serum
concentrations of pro-matrixmetalloproteinase-3 (proMMP-3),
matrixmetalloproteinase-3 (MMP-3) and cartilage oligomeric
protein (COMP).
Methods: SF lavage and serum samples were collected from 259
patients of our trauma clinic at the time of arthroscopy. The extent
of cartilage damage was assessed according to the Outerbridge
score. ProMMP-3 levels in SF and serum were determined by
enzyme-linked immunosorbent assay (ELISA) using a monoclonal
antibody. Additionally we determined SF and serum levels of total
MMP-3 and COMP levels in 40 randomly selected patients by
ELISA.
Results: Serum proMMP-3 levels of the total cohort were mark-
edly increased compared to reference ranges (p< 0.0001). Serum
and SF lavage proMMP-3 concentration correlated significantly
(rs= 0.41, p< 0.0001). The grade of cartilage damage did not
correlate with enzyme concentration in patients' serum or SF
samples. Furthermore, the detection of total MMP-3 and COMP
levels showed no statistically significant correlation (rs=0.2,
p=0.08 and rs= 0.3, p=0.09) between serum and SF.
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Conclusions: The detection of proMMP-3 levels in serum or SF
did not reflect the grade of cartilage damage. However, the
elevated serum proMMP-3 concentrations and the positive corre-
lation between serum and SF lavage in 259 patients after knee
injury might propose a role as a clinical marker for metabolic
alterations after joint damage.
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SHORT·TERM EXPOSURE OF EXPLANT CULTURES OF
ARTICULAR CARTILAGE TO PENTOSAN POLYSULFATE
RESULTS IN LONG-TERM PROTECTION TO AGGRECAN
LOSS
S. Munteanu, M.Z. lIic and C.J. Handley
Schoolof Human Biosciences,La Trobe University,Melbourne,
Australia
The aim of this work was to establish the effects of short-term
exposure of articular cartilage to calcium pentosan polysulfate
(CaPPS) on the long-term ability of the tissue to resist induced
aggrecan loss.
Methods: Explant cultures of articular cartilage were maintained in
culture for 5 days and incubated with sulfate for 6h. The tissue was
then maintained in medium containing 10IJg CaPPS/ml for 5 days
and then in medium alone or medium containing either 10-6M
retinoic acid or 40ng interleukin-1 alml for up to a further 20 days.
Loss of radiolabeled and chemical levels of aggrecan from the
tissue were determined by the appearance of radiolabeled macro-
molecules in the medium on each day and by the hexuronate
content of the tissue. The effects of CaPPS on cartilage metab-
olism were monitored by lactate production and protein synthesis.
Results: Exposure of articular cartilage to CaPPS for 5 days
resulted in the suppression of loss of both radiolabeled and
chemical levels of aggrecan by explant cultures of articular carti-
lage for periods of up to 20 days. When challenged with either
retinoic acid or interleukin-1 there was a continued suppression of
aggrecan loss from the tissue. It was also evident that CaPPS
specifically suppressed the basal rate of aggrecan catabolism in
the tissue. The inclusion of CaPPS in the cultures did not affect
lactate production or protein synthesis by the tissue.
Conclusions: Short-term exposure of articular cartilage to CaPPS
results in a long-term protection of the tissue to induced aggrecan
loss. This work suggested that CaPPS has the ability to specifically
suppress aggrecanase activity (ADAMTS-4 and ADAMTS-5) over
a long period. This could result from the down regulation of the
expression of aggrecanase proteinases or systems that are
involved in the activation of these enzymes.
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CLONING AND CHARACTERIZATION OF BOVINE
AGGRECANASE-1
M Arai, D Anderson, S Annis, L Collins-Racie, C Corcoran,
E DiSlasio-Smith, E Morris, and E LaVallie
Wyeth Research, Cambridge, MA.
Aggrecanases are thought to be the major proteinases responsible
for proteoglycan (PG) breakdown that occurs in progressive oste-
oarthritis. Investigators have commonly used bovine in vitroand ex
vivosystems to study inflammatory cytokine-induced extracellular
matrix breakdown; however, a full-length bovine aggrecanase
cDNA has not yet been cloned and tested. We have used a PCR
strategy to obtain a cDNA for full-length bovine aggrecanase-1 and
have characterized its expression pattern in various tissues and its
activity in in vitrocartilage culture systems.
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Conclusions: Fibrinogen aggregates crosslinked by oxidative
stress under specific conditions may be relatively resistant to
enzymatic degradation by trypsin, MMP-2 and MMP-9. This sup-
ports our hypothesis that free radicals may contribute to adhesion
formation via this mechanism in osteoarthritis of the temporoman-
dibular joint.
LC Dijkgraaf, G Zardeneta, FW Cordewener, RSB Liem,
LGM de Bont, SB Milam
GroningenUniversityHospital, Groningen,The Netherlands,and
Universityof Texas Health Science Centerat San Antonio,USA
Aim: To evaluate the resistance of oxidized proteins to protease
degradation, in order to test our hypothesis that oxidative modifi-
cation of proteins by free radicals underlies the formation of
adhesions in osteoarthritis of the temporomandibular joint. Oxidat-
ive stress induces the formation of intra- and intermolecular
crosslinks that may stabilize protein aggregates to resist degrada-
tion by specific proteases.
Methods: Crosslinked fibrinogen aggregates were formed in vitro
via oxidative stress using the Fenton reagents Fe(II)S04 (1-250
mM) and H202 (8.8 mM), either or not in the presence of ascorbic
acid. Both native protein solutions and the protein aggregates were
subsequently subjected to proteolytic degradation by trypsin (10-
400 :g/ml), MMP-2 (1-300 :g/ml) or MMP-9 (1-20 :g/ml). The
reactions were carried out at the pH optimum for each of these
proteases. and the time necessary for optimum digestion at 37 0
was empirically determined. Protein samples were analyzed by
SDS-PAGE. and quantified by densitometric analysis of protein
bands from scanned stained gels.
Results: Crosslinked fibrinogen aggregates induced by limited
oxidation showed an enhanced susceptibility to proteolytic degra-
dation relative to the native fibrinogen. However, crosslinked
fibrinogen aggregates induced by extensive oxidation showed
increasing resistance to degradation by trypsin, MMP-2 and
MMP-9.
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RESISTANCE OF OXIDIZED PROTEINS TO PROTEASE
DEGRADATION MAY RESULT IN ADHESION FORMATION IN
OSTEOARTHRITIS OF THE TEMPOROMANDIBULAR JOINT
(N=4); no effect was seen at 2 mg/ml.Adding HA 15 minutes after
IL-1 B did not alter its effectiveness in decreasing MMP activity.
Conclusions: High molecular weight HA at physiologic concen-
trations mitigates the activity of IL-1 B-induced MMPs. HA is
effective in attenuating MMP activity when added either concomi-
tantly with IL-1 B or after IL-1 B has initiated the degradative
process.
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EXTRACELLULAR SUPEROXIDE DISMUTASE AND THE
ROLE OF OXIDANT STRESS IN OSTEOARTHRITIS
EA Regan, RP Bowler, JJ Enghild, JD Crapo
NationalJewishResearch and MedicalCenter, Denver Co.USA
.AarhusUniversity,Aarhus. Denmark
Oxidant stress has been postulated to be a factor in the etiology of
osteoartbritis (OA). The aim of this study was to measure the levels
of extracellular superoxide dismutase (EC-SOD), the most import-
ant antioxidant of the extracellular space, in human cartilage
samples and to compare the relative amounts of EC-SOD in
osteoarthritic and aged normal tissue. Evidence of corresponding
oxidant damage to collagen was also sought.
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Bovine aggrecanase-1 (bAgg-1) encodes an 839 amino acid
protein that is highly homologous (92% identical) to human
aggrecanase-1 (hAgg-1). As in the case of other homologous
species, the catalytic domain is the region of greatest similarity to
hAgg-1 (95 %). All of the sequences proposed for functional
importance (cysteine switch, furin cleavage site, C-terminal auto-
catalytic sites) are conserved between hAgg-1 and bAgg-1 except
for one amino acid difference in the putative zinc-binding motif.
Induction of bAgg-1 mRNA by IL10., IL-1~ and TNF was tested in
cartilage explant culture using Northern blot hybridization. In this
system. IL-10. was the most potent inducer of bAgg-1 mRNA
followed by TNF and IL-1~. Up-regulation of bAgg-1 mRNA corre-
lated well with increased proteoglycan breakdown measured by
3sS-labelled PG release into culture media (50%, 40% and 19%
respectively). The magnitude of bAgg-1 mRNA increase by IL-10.
was higher in nasal cartilage compared to articular cartilage
explants. Unlike hAgg-1, bAgg-1 expression was very low or
absent in other tissues tested (cerebellum, liver, lung, kidney
skeletal muscle, heart, spleen, intestine, testis).
To directly assess the role of bAgg-1 on proteoglycan breakdown,
full-length bAgg-1 eDNA was cloned into an adenoviral expression
vector and adrenovirus containing the bAgg-1 eDNA were gener-
ated. Chondrocytes were isolated from bovine metacarpophalan-
geal joint cartilage and infected with adenovirus expressing bAgg-1
or control virus. The expression of bAgg-1 in the infected chondro-
cytes was confirmed by Western blot using human Agg-1 antibody.
Chondrocytes expressing bAgg-1 show increased breakdown of
newly synthesized PG compared to controls in monolayer. pellet
and alginate culture as measured by dimethylmethyJene blue
(DMMB) assays and Safranin-O staining.
In summary, we have cloned the full-length bovine Agg-1 and
successfully demonstrated its potential for proteoglycan degrada-
tion in explant organ culture and in primary chondrocyte cell culture
systems.
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EFFECT OF CONCENTRATION AND MOLECULAR WEIGHT
OF HYALURONAN ON INTERLEUKIN-1-INDUCED MATRIX
METALLOPROTEASE ACTIVITY
S Dunn, 0 Kolomytkin, D Waddell, A Marino
LSU Health SciencesCenter, Shreveport,Louisiana,USA
Aim of Study: To determine the influences of the molecular weight
and concentration of hyaluronan (HA) on interleukin-1 B (IL-1 B)-
induced matrix metalloprotease (MMP) activity in vitro.
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Methods: Confluent layers of rabbit synovial fibroblasts (HIG-82)
were incubated for 48 hours in defined medium containing IL-1 B
(100 pg/ml) with and without HA. Supernatant for each condition
was assayed spectrophoto-metrically for MMP activity. To assess
whether access of IL-1 Bto its receptor was diffusion-limited, some
studies were done in which HA was added 15 minutes after IL-1 B.
Results: At 5 mg/ml, addition of HA antagonized IL-1 B-induced
MMP activity by a process that depended on HA molecular weight
Methods: Articular cartilage was obtained from the femoral heads
of patients undergoing total hip replacement for OA and patients
with hip fractures undergoing hemiarthroplasty. The tissue was
assayed for EC-SOD by Western blot. (OA n:15 and controls
n:15) Samples were taken from grossly normal areas of the
arthritic joints, and Safranin 0 staining was used to confirm
preservation of the proteoglycans in the matrix of the samples and
essentially normal histology. (Mankin grades 0/1) The tissue
samples were also analyzed for the formation of 2-pyrrolidine in
the collagen, which is associated with hydroxyl radical cleavage of
the collagen molecule and oxidative stress.
Results: EC-SOD protein was found to be present in relative
abundance when compared to other tissues (lung, liver, kidney and
brain). The cartilage taken from normal appearing areas of oste-
oarthritic femoral heads showed a three to five fold decrease in the
expression of the EC-SOD protein when compared to similar
tissue from age equivalent controls with fractures. 2-Pyrrolidine
cleavage sites were demonstrated in the OA samples but were not
found in the control cartilage.
Conclusions: A decrease in EC-SOD combined with evidence of
hydroxyl radical damage to collagen in osteoarthritic cartilage
suggests a potential role for oxidant stress in the pathogenesis of
osteoarthritis. The presence of BC-SOD in high concentrations
within the cartilage matrix makes it likely that potent free radicals
are commonly produced in the tissue thus requiring a capacity to
protect the joint from the damaging effects of free radical species
on structural proteins, enzymes and DNA. Defining alterations in
antioxidant capacity related to osteoarthritis could clarify the impor-
tance of oxidative stress in the disease and open up opportunities
to explore mechanisms of action and treatments.
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INFLUENCE OF CIPROFLOXACIN ON MMP AND COLLAGEN
EXPRESSION BY HUMAN TENDON FIBROBLASTS
GP Riley, AN Corps, RA Harrall, V Curry and BL Hazleman
RheumatologyResearch Unit, Box194, Addenbrooke'sHospital
NHS Trust, CambridgeCB2 2QQ.
Introduction: There have been several reports associating pain or
rupture of tendons with the use of fluoroquinolone antibiotics, but
no causal mechanism has been established. We and others have
shown that there is a high rate of matrix turnover in certain
tendons, and altered matrix gene expression in tendinopathy . In
this study, we are investigating whether the fluoroquinolone cipro-
floxacin (CIP) influences the expression of MMPs or collagens by
human Achilles tendon-derived cells in culture.
Materials and Methods: Tendon cell cultures were treated for two
periods of 48h with CIP (50 ~g/ml) and IL1 (1 ng/ml), alone and in
combination. Samples of medium were assayed by Western
blotting for MMP-1, MMP-2 and MMP-3. mRNA encoding for
MMPs and collagens I and III was assayed by one-step RT-PCR,
with normalisation for GAPDH.
Results: The expression of MMP-1 and MMP-3 by tendon cells
was not detectable in control cells, and was greatly increased by
IL1. Pre-incubation of the cells with CIP increased the stimulation
of MMP-3 expression by IL1 but decreased (or had no significant
effect) on that of MMP-1. CIP had no effect on the basal expression
of MMP-2, but inhibited the small stimulation of MMP-2 expression
by IL1. Tendon cells expressed mRNA for both collagens I and III,
and the ratio of Colla1 to Colllla1 mRNA was decreased after
treatment with IL1. In contrast, CIP increased the ratio of Colla1 to
Colllla1 mRNA.
Discussion: CIP influences the balance of MMP expression and
the relative expression of major matrix components in tendon-
derived cells. Such changes might proVide a basis for altered
matrix structure, which could lead to the observed tendency
towards tendon problems in fluoroquinolone-treated patients.
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ENDOGENOUS CYTOKINE ANTAGONISTS REGULATE
NITRIC OXIDE PRODUCTION IN OSTEOARTHRITIC
CARTILAGE
K Vuolteenaho, T Moilanen, E Moilanen
The ImmunopharmacologicalResearch Group, MedicalSchool,
Universityof Tampere and Tampere UniversityHospital,
Tampere, Finland
Interleukin-1 B (IL-1 B) and tumour necrosis factor (TNFa) playa
central role in the pathogenesis of osteoarthritis (OA). The destruc-
tive effects of these cytokines are partly mediated by inducible
nitric oxide (NO) production by chondrocytes.
The aim of the present study was to investigate the role
endogenous IL-1 Band TNFantagonists on NO production in OA
cartilage.
Methods: Cartilage specimen were collected from OA patients
undergoing knee replacement surgery. NO production (nitrite accu-
mulation) and iNOS expression (Western blot) were studied in
organ culture to allow intact chondrocyte - matrix interactions.
ELISA was used to measure cytokines and cytokine antagonists in
the culture medium.
Results: OA cartilage produced low concentrations of NO in the
absence of exogenous cytokines. NO production was linear up to
72h follow-up and it was inhibitable both with non-selective NO
synthase (NOS) inhibitors and a highly selective iNOS inhibitor
1400W. Proinflammatory cytokines IL-1 Band TNF and bacterial
lipopolysaccharide (LPS) enhanced NO synthesis and inducible
NO synthase (iNOS) expression in OA cartilage in a dose- and
time-dependent manner.
OA cartilage produced spontaneously low concentrations of IL-1
receptor antagonist (IL-1 ra). IL-1 B stimulated IL-1 ra production in
OA cartilage and this was further enhanced by 1400W, a highly
selective inhibitor of iNOS, suggesting a positive feedback loop
between these two destructive pathways in OA cartilage. NO
production induced by TNFa ?was inhibitable with TNFa antagon-
ists infliximab and etanercept in a concentration-dependent man-
ner. In contrast, IL-1 Band LPS-stimulated NO production was not
altered by infliximab and etanercept suggesting that TNF is not an
autacoid mediator in these processes. NeutraliZing antibody
against soluble TNFa receptor I (sTNFRI) enhanced spontaneous
NO production suggesting that endogenous cartilage-derived
TNFa -antagonists modulate NO production in OA cartilage.
In conclusion, the biological activity of destructive cytokines
IL-1 Band TNFis regulated by cytokine antagonists IL-1 ra and
sTNFRI produced by OA cartilage. The ability of iNOS inhibitor
1400W to enhance the production of IL-1ra suggests another
anti-inflammatory mechanism for selective iNOS-inhibitors in the
treatment of OA.
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QUANTIFICATION OF COLLAGEN TYPE II DEGRADATION IN
VITRO USING A NOVEL IMMUNOASSAY
S Christgau1, D Bang Henriksen1, C Christiansen2 , J A Mo1 .
1NordicBioscienceAlS, Herlev, Denmark;2Center for Clinical
and BasicResearch, Ballerup, Denmark.
Cartilage explants are routinely used to study cartilage metab-
olism. This in vitro system provides an opportunity to assess the
effects of hormones, growth factors and therapeutic compounds on
chondrocyte metabolism and cartilage turnover. Because chondro-
cytes are the only cell-type present in cartilage explants,
direct effects on chondrocytes and cartilage metabolism can be
investigated.
Our aim was to assess the applicability of an immunoassay
specific for collagen type II C-telopeptide fragments (CTx-ll) for
assessment of collagen type II degradation and thus cartilage
catabolism in cartilage explant cultures.
Method: Bovine articular cartilage was cultured in vitro in conven-
tional serum-free medium. Bone and synovial tissue was included
as control tissues. IL-1 a and Oncostatin M was added to the
explants cultures to induce aggrecan but not collagen type II
degradation. Addition of plasminogen or other MMP activators was
necessary to induce collagen type II degradation. Degradation of
aggrecan was measured as release of glycosaminoglycan (GAG)
and degradation of type II collagen was measured as release of
hydroxyproline as well as by the CTx-11 assay. The supernatants
analysed in the assays demonstrated 100 - 1000 fold elevation in
CTx-1i as well as hydroxyproline after 2 weeks of culture in the
presence of IL-1?a and plasminogen. Elevated GAG release was
apparent after only 2 - 3 days of culture. Culture medium from
synovial tissue or bone cultures showed no significant production
of CTx-1i antigens. When collagen type I fragments was measured
using an immunoassay for collagen type I C-telopeptide fragments
(CrossLaps for Culture), no reactivity was found in the superna-
tants from cartilage, very low levels in synovial tissue and high
levels in bone samples in accordance with the tissue distribution of
collagen type I. CartiLaps and hydroxyproline measurements were
well correlated in the supernatants from the cartilage explants.
In conclusion these experiments demonstrate the ability of the
CTx-1i assay to reflect ongoing cartilage degradation manifested
as collagen type II degradation in the extracellular cartilage matrix.
The assay may provide a valuable tool for assessment of cartilage
turnover in vitro and assessment of potential drug-induced
chondro-protective effects.
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EARLY OSTEOARTHRITIS SYNOVIAL TISSUE
DEMONSTRATES PROMINENT MANIFESTATIONS OF
INFLAMMATION
Maria J Benito, Douglas Veale, Oliver FitzGerald,
Wim van den Berg, Barry Bresnihan.
Nijmegen, The Netherlands,and Dublin, Ireland.
Background: Synovial tissue (8T) in established osteoarthritis
(OA) may demonstrate histologic features of inflammation. Few
studies have evaluated tissue samples from patients with very
early disease. The aim of this study was to compare the immuno-
histologic manifestations of inflammation in 8T samples from
patients with early and late OA.
Methods: 8T samples were obtained from 10 patients with knee
pain, normal radiographs, and manifestations of OA confirmed at
arthroscopy (early OA), and from 15 patients with OA undergoing
knee joint arthroplasty (late OA). Conventional immunohistochemi-
cal techniques were employed to quantify the microscopic mani-
festations of inflammation in 8T samples. In addition, synoviocyte
cultures were established from early and late OA tissues for the
measurement of constitutive and inducible PGE2 production.
Results: ST samples from early OA demonstrated significantly
greater CD4+ (p=0.017) and CD68+ (p<0.001) cell infiltration,
vascularity (p=0.01), VEGF (p=0.001) and ICAM-1 (p<0.001)
expression. The numbers of TNFa- and IL-1 ~-producing cells were
also significantly greater in early OA (p<0.001). The prominent
manifestations of ST inflammation in early OA were associated
with increased expression of both the NF-KB p50 (p<0.001) and
p65 (p=0.015) subunits, and with increased COX-2 expression
(p=0.04). Moreover, cultured synoviocytes from patients with early
OA demonstrated higher basal levels of PGE2 production.
Conclusion: This study demonstrated unexpectedly high levels
NF-KB activation, proinflammatory cytokine, COX-2 and PGE2
production, and mononuclear cell infiltration in ST from patients
with early OA. These observations may have important therapeutic
implications during the early evolution of OA.
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EARLY OSTEOARTHRITIS SYNOVIAL TISSUE IS
CHARACTERIZED BY INCREASED MONONUCLEAR CELL
INFILTRATION AND DYSREGULATION OF APOPTOSIS
Maria J Benito, Douglas Veale, Oliver FitzGerald,
Wim van den Berg, Barry Bresnihan.
Nijmegen, The Netherlands,and Dublin, Ireland.
Backround: Synovial tissue (ST) from patients with early osteoar-
thritis (OA) demonstrate significantly greater mononuclear cell
infiltration than ST from late OA. The aim of this study was to
compare factors regulating apoptosis in ST from patients with early
and late OA.
Methods: 8T samples were obtained from 10 patients with knee
pain, normal radiographs, and manifestations of OA confirmed at
arthroscopy (early OA), and from 15 patients with OA undergoing
knee joint arthroplasty (late OA). Conventional immunohistochemi-
cal techniques were employed to quantify ST inflammation and the
apoptosis-related proteins, Bcl-2, Bax and Bad. In addition, syn-
oviocyte cultures were established from early and late OA tissues.
Results: Bax and Bad expression were significantly reduced in
early OA (p=0.01 and 0.04, respectively); there was no significant
difference in Bcl-2 expression. However, there was a strong
positive correlation between Bcl-2 and Bax in early OA (r=0.92)
compared to late OA (r=0.52), suggesting greater Bax/Bcl-2 bind-
ing, thus producing greater inhibition of apoptosis in early OA.
Moreover, cultured synoviocytes from early OA tissues
co-expressed Bax and Bcl-2. In contrast, there was a strong
correlation between Bad and BcI-2 in late OA (r=0.76), increasing
the amount of free Bax and enhancing pro-apoptotic pathways.
Conclusion: This study suggests that the increased mononuclear
cell infiltration observed in early OA may be in part related to a
dysregulation of apoptotic pathways.
PS86
PRESENCE OF PANNUS-LIKE SOFT TISSUE ON THE
SURFACE OF OSTEOARTHRITIC CARTILAGE AND ITS
FUNCTION
A Shibakawa, H Nakamura, K Nishioka
InstituteofMedicalScience, Sf. Marianna University,Kawasaki,
Japan
The aim of this study was to clarify frequency, localization,
characteristics and function of pannus-like soft tissue in osteoar-
thritis cartilage.
Methods: Twenty joints (15 knee and 5 femoral heads) from 17
osteoarthritis patients were examined histochemically and immu-
nohistochemically.
Result: Total 18 joints (90%) showed pannus-like soft tissue. It
preferentially located in the marginal area and the area where
cartilage was relatively presented. Histologically, the tissue was
divided into two types, granular type and fibrous type. The extra-
cellular matrix showed safranin-O (-), type I collagen (+) and type
II collagen (-). Some of granular type showed CD68 (+) cell
infiltration. Many specimens showed IL-1 B(+) cell and MMP3(+)
cell.
Conclusion: Pannus-like tissue exists on osteoarthritis cartilage.
Expression of IL-1 Band MMP3 suggest that pannus-like soft
tissue is one of the sources of those proinflammatory cytokine and
protease in osteoarthritis joint.
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PREVALENCE OF CHRONIC INFLAMMATORY INFILTRATES
IN EARLY AND END STAGE OSTEOARTHRITIS OF THE
KNEE AND HIP
A 0 Pearle, C R Scanzello, E F DiCarlo, M K Crow, T P Sculco
Hospit'!lfor SpecialSurgeryNew York, New York USA
AIM: The purpose of this study was to determine the prevalence of
synovial inflammation in a retrospective series of cases of osteoar-
thritis (OA).
METHOD: Microscopic findings were reviewed in specimens
received from total arthroplasty of the hip and knee and arthro-
scopic procedures of the knee in patients who had a clinical and
pathologic diagnosis of OA. Arthroplasty cases were regarded as
end-stage disease; arthroscopy cases were defined as early
disease. Based on reports from a single pathologist, synovial
inflammation was graded as absent, low-grade (perivascular lym-
phocytic infiltrates only), or high grade (perivascular and diffuse
lymphocytic or Iymphoplasmacytic infiltrates). In total knee arthro-
plasty cases, predominant compartment of disease (medial,
lateral, patellofemoral) was recorded.
RESULTS: 297 total hips, 317 total knees, and 141 arthroscopies
were identified. The average age of the hip arthroplasty, knee
arthroplasty, and knee arthroscopy patients was 64.2, 67.8, and
55.5, respectively. For the total joints, inflammation was absent in
46.8% of hip and 54.5% of knee cases; low grade in 48.5% of hip
and 41.6% of knee cases; and high grade in 4.7% of hip and 3.8%
of knee cases. In arthroscopy cases, inflammation was absent in
57.4%, low grade in 41.1%, and high grade in 1.4%. Statistical
analysis revealed significantly lower rates of synovial inflammation
in patients with end stage knee OA who were younger than 55
years old (76% no inflammation, 24% low grade inflammation)
compared to those older than 55 (51.7% no inflammation, 43.9%
low grade, 4.3% high grade inflammation) (p=0.006); no significant
differences were noted in knee versus hip OA, early versus end
stage disease, or in knee OA classified by predominant compart-
ment of disease.
CONCLUSIONS: In this large retrospective review, low or high
grade synovial inflammation was present in almost half of OA
cases. Younger patients with end stage disease had a lower
prevalence of inflammation. In contrast to previous studies, chronic
synovial inflammation appeared to be nearly as prevalent in early
as in end stage disease. This suggests the synovial response
in the osteoarthritic process may reflect different subtypes of
OA rather than disease severity. Distinguishing these subsets
may allow for more appropriately targeted anti-inflammatory
intervention.
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THE PRESENCE OF CHRONIC INFLAMMATORY
INFILTRATES IN EARLY AND END STAGE OA IS
ASSOCIATED WITH ELEVATED PLASMA CRP LEVELS
A 0 Pearle, C R Scanzello, E F DiCarlo, M K Crow, T P Sculco
Hospitalfor SpecialSurgeryNew York, New York, USA
AIM: The purpose of this study was to determine the relationship
between synovial inflammation and C-reactive protein (CRP) lev-
els in a prospective series of hip and knee osteoarthritis (OA).
METHOD: Patients with idiopathic OA undergoing either total hip
or knee arthroplasty or knee arthroscopic debridement were ident-
ified by a single surgeon. Joints with Kellgren-Lawrence grade of
1-2 were regarded as early stage and 3-4, end stage. Control
samples were obtained from patients with chronic internal
derangement, no intra-articular evidence of OA, and a Kellgren-
Lawrence grade of O. Synovial samples were obtained from
standardized locations and were reviewed by a single pathologist.
Inflammation was graded as absent, low-grade (perivascular lym-
phocytic infiltrates only), or high grade (perivascular and diffuse
lymphocytic or Iymphoplasmacytic infiltrates). CRP levels in patient
plasma were measured using a high-sensitivity ELISA.
RESULTS: 12 patients with early OA, 35 patients with end stage
OA, and 4 controls were identified. In early OA patients, inflamma-
tion was absent in 33%, low grade in 58%, and high grade in 8%.
In end stage OA, inflammation was absent in 26%, low grade in
60%, and high grade in 14%. Inflammation was absent in all
controls. Mean CRP levels were higher in end stage (mean ± SEM
= 3.60 19lml ± 0.73) and early disease (2.73 19lml ± 0.91) than in
controls (0.17 19lml ± 0.17). OA patients with inflammatory infil-
trates had higher CRP levels (4.02 19lml ± 0.78) compared with OA
patients without inflammation (1.04 19lml ± 0.42) (p=0.02).
CONCLUSION: Elevated CRP levels in OA have been shown to
predict disease progression. We have demonstrated that higher
CRP levels are associated with histologic evidence of inflamma-
tion. This suggests that the presence of synovial inflammation may
have prognostic significance. In a related retrospective study, we
observed that the prevalence of synovial inflammation remains
relatively constant regardless of the severity of the disease,
suggesting the existence of distinct inflammatory subtypes of OA.
This prospective study further supports the concept that OA
subtypes may be defined by the presence or absence of a chronic
inflammatory infiltrate. The ability to distinguish these OA subtypes
may allow for more appropriately targeted anti-inflammatory
intervention.
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DOUBLE-NEGATIVE (CD4-CD8-) T-CELLS ARE ENRICHED IN
THE SYNOVIAL MEMBRANE (SM) OF PATIENTS WITH
OSTEOARTHRITIS
C R Scanzello, A 0 Pearle, K Kirou, and M K Crow
Hospitalfor SpecialSurgery, New York, NY USA
Many osteoarthritis (OA) patients develop synovitis with infiltrates
of macrophages and T-Iymphocytes. Synovial thickening, reflective
of these infiltrates, has been found to be a source of pain in OA
patients. The nature and function of these synovial T-cells are
unclear. To characterize expression of CD4 and CD8 on SM
infiltrating T-cells in OA, peripheral blood mononuclear cells
(PBMC) and mononuclear cells eluted from SM (SMMC) were
analyzed by flow cytometry using fluorescently-Iabeled anti-CD3,
anti-CD4 and anti-CD8 monoclonal antibodies. PBMCs and
SMMCs were obtained from 10 patients with OA and 3 patients
with Rheumatoid Arthritis (RA) undergoing arthroscopy or total joint
arthroplasty. One unmatched SM specimen was obtained from a
RA patient, and unmatched PBMCs were obtained from 12 OA
patients, 3 RA patients, and 7 normal controls. After gating on the
S50
C03+ population, a decrease was seen in the percentage (mean ±
SEM) of C03+C04+ cells from PB to SM in both OA (SM: 49.82±
3.13, PB: 66.00 ± 3.02, Mann-Whitney p=0.002) and RA patients
(SM: 52.32 ± 3.24, PB: 66.11± 4.93, ns). An increase in the
C03+C08+ population was seen in RA SM (36.87% ± 3.29 vs. PB:
26.56% ± 5.15, ns), but much less so in the OA SM (28.72% ± 3.26
vs. PB: 26.56% ± 2.50, ns). Instead, there was enrichment of
C04"C08" (SM: 15.95% ±1.80, PB: 5.35% ±0.62, p<0.0001), and
to a lesser extent C04+C08+ cells (SM: 3.80% ±1.13, PB: 1.89%
±0.46, p=0.049), in SM from OA patients. Smaller increases in the
double-negative and double-positive subsets were seen in RA SM.
Thus, in OA patients, the decrease seen in SM C04+ cells was
accompanied by an increase in C04"C08" cells, while in RA
patients it was primarily accompanied by an increase in C08+
cells. C04"C08" cells in the SM of patients with OA may represent
NKT-cells, premature C03+ cells generated through a process of
extra-thymic maturation, or previously activated single-positive
T-cells that have lost cell-surface expression of C04 or C08.
Further characterization of these SM infiltrating T-cells is very likely
to advance our understanding of OA pathogenesis and lead to new
therapeutic targets in this disease.
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MOLECULAR MECHANISM OF NOTCH1 ACTIVATION IN
SYNOVIOCYTES FROM OA AND RA PATIENTS
Trieu NV, Nakajima T and Nishioka K
St.Marianna University,InstituteofMedicalScience Kanagawa
Japan
Objective: The aim of this study was to detect the expression
and molecular mechanism of Notch1 activation in OA and RA
synoviocytes.
Methods: Two OA and two RA patients participated in this study.
The expression of Notch1 was detected by immunocytochemistry.
To analyze the role of TNF-a in Notch1 activation we used
immunocytochemistry with cells treated by TNF-a. To find out more
detail molecular mechanism of Notch1 activation via TNF-a, immu-
nocytochemistry with cells treated by both TNF-a and inhibitors
which block all the way of TNF-a signaling were used. We further
confirmed the results by transfection technique following by
immunocytochemistry.
Result: Notch1 protein were detected in all study subjects. Fur-
thermore TNF-a increased NICO translocation in to the nuclei of
both OA and RA synoviocytes in a dose dependent manner.
Moreover ERK was detected as an inducer of Notch1 activation in
both OA and RA synoviocytes.
Conclusion: TNF-a activates Notch1 in synoviocytes via ERK.
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CALCIUM PENTOSAN POLYSULFATE INCREASES BOTH
CONCENTRATION AND MOLECULAR WEIGHT OF
HYALURONAN SYNTHESISED BY HUMAN
OSTEOARTHRITIC SYNOVIAL FIBROBLASTS IN VITRO.
MM Smith, S Pradhananga, P Ghosh
Instituteof Bone & JointResearch, RNS Hospital,Sydney,
Australia
The present study was undertaken to determine the effects of the
potential structure-modifying osteoarthritis drug (SMOAO), calcium
pentosan polysulfate (CaPPS), on in vitrobiosynthesis of hyaluro-
nan (HA) by cultured human synovial fibroblasts (HSF).
Methods: Human synovial tissue obtained from patients with OA
undergoing knee or hip surgery was digested with trypsin and
collagenase. The released HSF were cultured and labelled with
3H-glucosamine at the 4th to 15th passage in the presence and
absence of various concentrations of CaPPS. 3H-labelled HA in
media was quantitated and sized by differential digestion with
Streptomyces hyaluronidase and by gel permeation chromatog-
raphy (Superose 6). High molecular weight HA (HMW-HA) eluted
in the void volume (6-8mL) and total HA was determined as
total non-digested radioactivity eluting in the included fractions
(6-15mL).
Results: CaPPS, when added to HSF in culture, significantly
increased the biosynthesis of total HA by up to 50% with a
bell-shaped concentration curve which peaked at 5microg/mL, with
decreased stimulation, or even inhibition, at 50 or 100microg/mL
CaPPS. Biosynthesis of HMW-HA was stimulated up to 200% by
the addition of 5microg/mL CaPPS to the media. In control cultures
containing no CaPPS, the proportion of HMW-HA was 44-66% of
the total HA detected. In the presence of 5microg/mL CaPPS,
HMW-HA increased to 66-83% of the total HA and with
50microg/mL CaPPS, HMW-HA was 82-94% of the total HA.
Therefore, even though the stimulation of total HA was reduced at
higher concentrations of CaPPS, the increase in HA molecular size
was maintained.
Conclusions: These results suggest that CaPPS may enhance the
synthesis of HA by HSF via at least two mechanisms. The finding
that the stimulation of total HA decreased at high CaPPS concen-
trations suggests that the mechanism involves stimulation of HA
synthase (either directly or by increased expression). Secondly, the
increased levels of HMW-HA, which was not reduced at high
CaPPS concentrations, implies saturated inhibition of a cleavage or
degradation mechanism, possibly a hyaluronidase, perhaps when
newly synthesised HA is released from the cell membrane. Further
experiments are in progress to elucidate these mechanisms.
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CHARACTERIZATION OF HUMAN MESENCHYMAL
PROGENITOR CELLS FROM SYNOVIAL MEMBRANE IN
OSTEOARTHRITIC JOINTS
S. Fickert, J. Fiedler, R. Brenner
Dept. for Orthopaedics,Divisionfor BiochemistryofJointand
ConnectiveTissue Diseases, Universityof Ulm, Germany
The aim of this study was to identify and quantify human mesen-
chymal progenitor cells (MPC) in synovial membrane (SM) of
osteoarthritic joints by their expression of specific cell surface
markers and the ability to differentiate to chondrogenic and osteo-
genic phenotype.
METHODS: Explants from human SM were taken during total
knee arthroplasty from different sites of the joint. In order to test,
whether MPC were detectable in SM, first gene expression was
analyzed by RT-PCR for CO 9, 44, 54, 90, 105, 166. Second
freshly isolated cells of SM were quantified for protein expression
by flow cytometric analysis (FACS) for CO 9, 44, 54, 90, 166 and
CO 34, 45. In parallel SM-derived cells were expanded in monol-
ayer with serial passages. At different passages cells were again
quantified for the expression of progenitor markers and subse-
quently used for differentiation into osteogenic and chondrogenic
lineages. To test, whether specific subpopulations have the capa-
bility to differentiate, triple CO 9/90/166 positive cells were sorted
by FACS, expanded in cell culture and also used for osteogenic
and chondrogenic differentiation. Phenotype of differentiated cell
cultures were analyzed by histo-/ immunohistochemistry and by
RT-PCR for expression of lineage-related marker-genes.
RESULTS: Gene expression of progenitor markers CO 9, 44, 54,
90, 105, 166 could be shown in the SM of all 8 patients. FACS
allowed quantifying 1-14% triple positive cells in various combina-
tions of CO 9, 54, 44, 90, 166 of total cells. As they were cultured,
enrichment of these triple positive cells was observed. The cul-
tured cells were negative for reactivity to CO 34, 45. When
incubated under proper stimuli, SM derived cells differentiate to
chondrogenic and osteogenic phenotype. During differentiation
positive counted cells for progenitor markers decreased by a factor
of 2-3. CD9/90/166 sorted triple positive cells also expressed
chondrogenic and osteogenic phenotype after expansion in
monolayer and differentiation.
CONCLUSION: Human progenitor cells could be isolated from the
SM of osteoarthritic joints. These cells are well characterized by
the expression of specific cell surface markers. CD9/90/166 sorted
triple positive and culture-expanded progenitor cells could be
differentiated to chondrogenic and osteogenic phenotype.
SM-derived mesenchymal progenitor cells may playa role in the
regenerative process during arthritic diseases and are promising
candidates for developing novel-cell based therapeutic
approaches for postnatal skeletal tissue repair.
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EFFECTS OF ORALLY ADMINISTERED VITAMIN D ON
CARTILAGE DEGENERATION IN STR/ORT MICE
Masashi Suzuki1 Harumoto Yameda1 , Yuki Washimi1 , Shinchi
Kato1 , Osuke Washimi\ Nobuki Terada1 , Yasuhiro Oue2 , Shigeo
Nakamura3 , Yasushi Yatabe3
1Dept 6f OrthopaedicSurgery, Fujita Health University,Second
Hospital
2Tejin Institutefor Bio-MedicalRes.
3AichiCancer Center
Purpose: Recently, there have been accumulating data showing
that vitamin D and its receptor on cell surface has significant
effects on the pathomechanism of osteoarthritis(OA). In this study,
we examined the effects of orally administered 1,25(OH)2D3 on
cartilage degeneration using STR/ort mice which develope OA
-like lesions spontaneously.
Materials and Methods: 1,25(OH)2D3 (0.05-0.2 ug/kg body
weight) was orally administered daily to STR/ort mice from 10
weeks after birth. At 24 and 37 weeks after birth, mice were
sacrificed and radiological images of the knee joints were taken
using a microfocused X-ray. Severity of cartilage degeneration was
estimated using Mankin's histological scoring. Immunohistological
examination was performed using monoclonal antibodies against
TGF-B, bFGF and 1GF-1. mRNA expression of TGF-B1, ,bFGF
and IGF-1 was also studied with in situhybridization
Results: In this study, STR/ort mice showed cartilage lesions like
OA in the knee joint at 37 weeks after birth. Kellgren score using
microfocused X-ray showed that OA-like lesions in the knee joint
were milder In mice group treated with 0.2 ug/kg of 1,25(OH)2D3.
Evaluation with Mankin scoring showed that cartilage degeneration
in mice group treated with 0.2 ug4cg of 1,25(OH)2D3 was signifi-
cantly decreased compared with vehicle group. Immunohistologi-
cal and in situ hybridization findings indicated that expression of
TGF-B in chondrocytes was enhanced in mice group treated with
0.2ug/kg of 1,25(OH)2D3. IGF-1 and bFGF was not same
enhanced in 1,25(OH)2D3-treated mice
Discussion: Above results suggest that prophylactic admin-
istration of 1,25(OH)2D3 decreased the cartilage degeneration in
STR/ort mice. It was not clear in this study whether the suppres-
sion of OA-Iike lesions was the secondary results due to the effects
of 1,25(OH)2D3 on the subchondral bony tissue. Enhancement of
the expression of TGF-B in chondrocyte suggest that 1,25(OH)2D3
may act on cartilage tissue directly and influence the cartilage
degeneration in this mice.
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CHONDROPROTECTIVE ACTION OF ANTHRAQUINONE - 2,6
- DISULFONIC ACID IN AN EXPERIMENTAL ANIMAL MODEL
M Mian, A Conte*, G Ronca**
Eneo Research, Miami, USA; *DepartmentofAgricultural
Science, UniversityofModena and Reggio Emilia, Italy;
**DepartmentofHuman and EnvironmentalSciences,
Universityof Pisa, Italy.
The aim of this study was to evaluate in vitro and in the
experimental animal the chondroprotective effect of the water
soluble anthraquinone - 2,6 - disulfonic acid (GR373).
Methods. Explants of cartilage from bovine ankles were cut into
small pieces and mantained in culture for 10 days. The release
of matrix glycosaminoglycans and proteins was evaluated by
immunochemical determinations. The release was stimulated with
10 ng/ml interleukyn-1 B (IL 1B) in the absence and presence of
several GR373 concentrations up 100 ~M. Thirty New Zealand
rabbits, 2 months old, were divided into 5 groups of 6 animals
each. The first group did not receive any treatment (NT); to a
second group the medial meniscus of knee joint was monolaterally
removed (MMR) to induce degenerative changes in cartilage; a
third group was SHAM operated (OND); a fourth group (GR373)
was meniscectomized and treated with GR373 (25mg/kg/os/d); a
fifth group was meniscectomized and treated with diacerein (DAR)
(25mg/kg/os/d). After 3 months the rabbits were sacrificed and the
tibial plateaus were removed and processed for histological and
biochemical examinations.
Results. In the presence of GR373 the cartilage breakdown
induced by IL-1 B is greatly decreased. After 10 days the percent
breakdown with 50 and 100 ~M GR373 is 60.4±7.1 and 34.3±4.6
respectively of that observed in the absence of anthraquinone - 2,6
- disulfonic. After 3 months in the cartilage of MMR rabbits the
score/slide was: clusters 36.3±5.4; cysts 6.9±1.2; fibrillations
7.2±1.1; chondrophytes 7.1±0.9. In GR373 treated rabbits the
score/slide was: clusters 16.0±3.5; cysts 2.0±0.4; fibrillations
3.7±0.7; chondrophytes 3.6±0.8. No cysts and chondrophytes
were observed in NT and in OND groups. The score/slide was:
clusters 3.6±0.5 and 4.2±0.6; fibrillations 2.5±0.6 and 2.0±0.8 in
NT and OND groups respectively. In DAR group the score/slide
was: clusters 37.8±6.0; cysts 7.6±1.1; fibrillations 3,5±0,6; chon-
drophytes 4.6±0.7. All reported values are means ±SD,
Conclusions. The anthraquinone - 2,6 - disulfonic acid was
proved effective in reducing the matrix metabolic breakdown
induced by IL-1 B in cartilage culture and in decreasing cartilage
degenerative changes in meniscectomized rabbits. In this exper-
imental model GR373 was more active than DAR in reducing the
number of clusters and cysts.
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CHANGES IN SERUM CHONDROITIN SULFATE EPITOPES IN
A RABBIT MODEL OF OSTEOARTHRITIS INDUCED BY
INTRA-ARTICULAR HYDROCORTISONE INJECTION
Ong-chai So, Pothacharoen po, Yingsung W* ,Sugahara K**,
Hardingham TE** and Kongtawelert E*
* DepartmentofBiochemistry,FacultyofMedicine, Chiang Mai
University,Chiang Mai, Thailand. 50200.
** DepartmentofBiochemistry,Kobe PharmaceuticalUniversity,
Higashinada-ku,Kobe, 658-8558, Japan.
*** SchoolofBiologicalSciences, UniversityofManchester,
ManchesterM13 9PT, UK.
Objective: To study changes of serum chondroitin sulfate epitopes
using novel monoclonal antibodies in a rabbit model of osteoarthri-
tis induced by intra-articular hydrocortisone injection.
Methods: Mature female rabbits (n=7) were given intra-articular
knee injection with hydrocortisone succinate (Solu-Cortef® 25 mg
Conclusions: Surgical models of OA in mice have rarely been
utilized due to the technical difficulty of performing surgery in such
small joints. These models would be extremely valuable to evalu-
ate knockout or transgenic mice, with altered expression of genes
believed to be important in osteoarthritis. ACLT in mice gave a
rapid progression to severe OA which did not resemble spon-
taneous models of OA and is most likely too severe for pharma-
cologic intervention. The DMM model caused moderate OA in
similar regions to spontaneous disease and could be a useful
model to study the etiology of OA and efficacy of potential
therapeutics.
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EFFECT OF HYALURONAN ON PGE2 IN EXPERIMENTAL
POST-TRAUMATIC ARTHRITIS OF RABBIT KNEE JOINTS
C Yamazaki, S Matsuzaka, M Isohata, Y Yoshida, J Hoshino,
H Masuda
CentralResearch Laboratories,SeikagakuCorporation,Tokyo,
Japan
Aim: The aim of this study was to investigate the effects of
hyaluronan (Na-HA, Supartz®) preparations on post-traumatic
arthritis of early stage after anterior cruciate ligament transection
(ACLT) of rabbit knee joints.
Methods: The whole procedure was carried out under anesthesia
(Isoflurane, Abbot Lab., IL, USA). Forty male Japanese white
rabbits, aged 5 to 6 months, weighing approximately 3.5 to 4.0 kg,
were subjected to unilateral ACLT. One week after surgery, the
operated groups received a single intra-articular injection (0.5 mg/
501l/kg) of Na-HA and sterile phosphate buffered saline (PBS) into
the left knee joints once a week for a total of 5 weeks. All animals
were sacrificed 6 weeks after surgery, and level of prostaglandin
E2 (PGE2), synovial fluid volume, protein and chondroitin sulfate
(CS) in synovial lavage fluid were measured. Moreover, the
thickness of the synovial lining layer was measured using an
image analysis system.
Results: All parameters were elevated in the operated groups as
compared with the non-operated group. Synovial fluid analysis;
Na-HA treatment significantly suppressed the increase in PGE2
level (p<0.05 versus PBS-treatment). Furthermore, Na-HA treat-
ment significantly suppressed the increase in synovial fluid volume
and protein content (p<0.05 versus PBS treatment). Na-HA treat-
ment suppressed the increase in CS contents. Thickness of
synovial lining cell layer; ACLT operation induced thickening,
synovial lining cell layer be consistent. Na-HA treatment signifi-
cantly suppressed thickening of the synovial lining cell layer
(p<0.05 versus PBS treatment). PGE2 level was correlated with
synovial fluid volume, protein content, CS and thickness of the
synovial lining layer.
Conclusion: Treatment with Na-HA significantly suppressed the
increase in PGE2 level in synovial fluid and thickening of the
synovial lining layers in the present ACLT model, indicating that
treatment with Na-HA could prevent synovitis in the early stage of
post-traumatic arthritis.
S52
in 0.2 ml NSS) once a week for 13 weeks under sterile condition.
The control group rabbits (n=5) were injected similarly with 0.2 ml
NSS into both knee joints. All rabbits were bled from the ear at
weekly intervals. One week after the 13th injection, all animals
were sacrificed and the treated joints were collected. Chondroitin
sulfate in all serum samples was quantified by ELISA technique
using monoclonal antibodies (mAbs), which recognize epitopes
(niAb 3B3) on newly synthesised chondroitin sulfate chains and
(mAb WF6) on mature chondroitin sulfate chains.
Results: The repeated injection of hydrocortisone succmate into
rabbit knee joints for 13 weeks induced a mild cartilage degenera-
tion. The ELISA assays for chondroitin sulfate epitopes in serum
showed that in the hydrocortisone treated group there was a
marked increase in the release of WF6 chondroitin sulfate epitope
into circulating blood one week after the first injection and this
persisted throughout the treatment. In contrast, 3B3 chondroitin
sulfate epitope in this group dramatically decreased during the
treatment period in comparison with the saline control group.
Conclusion: These results showed that the analysis of
CS-epitopes in serum detected the cartilage degeneration caused
by repeated intra--articular hydrocortisone injection. The results
suggested that there was a potentially harmful inhibition of chon-
droitin sulfate proteoglycan synthesis, combined with an increased
release of degradation products of chondroitin sulfate proteoglycan
from articular cartilage.
Acknowledgement: This study is supported by European
Commission and the Thailand Research Fund (TRF).
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CHARACTERIZATION OF SURGICAL MODELS OF MURINE
OSTEOARTHRITIS
SS Glasson, TJ Blanchet, JL Tavares, 0 Peluso, B Canto,
EA Morris.
Wyeth Research, Cambridge, U.S.A.
Aim: The purpose of this work was to characterize a rapid model
of surgically induced murine osteoarthritis (OA) that could be
applied to transgenic or knockout mice.
Methods: All procedures were approved by the Institutional Care
and Use Committee. General anesthesia was induced in forty
129/SvEv mice (Taconic, Inc. Germantown, NY). Each mouse
underwent one of two unilateral surgical procedures. In the first
procedure, a medial arthrotomy was performed and the anterior
cruciate ligament visualized and transected (ACLT). Transection
was confirmed by presence of the anterior drawer sign. The
second surgical procedure consisted of transection of the ligament
anchoring the anterior medial meniscus to the tibial plateau. This
procedure destabilized the medial meniscus (DMM) without induc-
tion of the variable regenerative meniscal response seen after
removal of the meniscus. The incision was closed in 2 layers, and
animals were weight bearing upon recovery from anesthesia. At 4
or 8 weeks post-operatively the animals were euthanized. Histo-
logical sections were taken at 50 1m intervals through the joint and
scored using a pUblished grading scale from 0 (normal) to 6
(severe OA).
Results: Histologic scores demonstrated no appreciable OA in the
control joints. Transection of the anterior cruciate ligament caused
severe OA at both 4 and 8 weeks with severe destruction of the
posterior tibial plateau down to the level of the growth plate. This
severe OA was associated with an exuberant fibrocartilaginous
response in the synovium. DMM at 4 and 8 weeks caused a
progression from mild to moderate OA and was largely localized to
the central area of the medial tibial plateau and medial condyles.
Time (wks)
Mean±SEM 0.1±0.1
4
4.9±0.8
8
45.5±0.4
4
1.6±0.6
8
2.8±O.5
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SERUM BIOMARKERS DISTINGUISH EXERCISE FROM
OSTEOARTHRITIC PATHOLOGY
DD Frisbie, F AI-Sobayil, RC Billinghurst, CW Mcllwraith
OrthopaedicResearch Center, ColoradoState University,
Fort Collins, USA
The aim of this study was to determine if changes in serum
biomarker levels could distinguish athletic exercise from osteoar-
thritic pathology.
Methods: This study was an experimentally controlled randomized
block design that utilized 16 horses in an established model of
osteoarthritis (OA). Serum samples were collected weekly
throughout the study period. All horses began a 21-day athletic
exercise regime after a 2-week acclimatization period. On day-22
of the study, arthroscopic surgery was performed on both mid-
carpal joints of all horses. In 8 horses, OA was induced in one of
the mid-carpal joints. Horses were rested for 14 days after surgery
followed by a return to the previous exercise regime for 56
additional days. Serum biomarkers were quantitated for aggrecan
synthesis (CS846), proteoglycan release (sGAG), type II collagen
synthesis (CPII) and degradation (COL2-3/4Cshort), as well as,
bone synthesis (osteocalcin) and degradation (CTX-I). Statistical
analysis utilized both a Mixed model analysis of variance and
discriminate analysis, with p values <0.05 considered significant.
Results: All biomarkers increased significantly with exercise,
although some did plateau during the study period. A significant
difference in biomarker concentrations (non-OA versus OA) was
observed for each biomarker at some time during the study.
Multivariate analysis indicated CS846 & CPII as the most valuable
predictive biomarkers of OA. Using discriminate analysis, horses
with OA were correctly classified 100% of the time based on serum
marker levels 14 days after induction of disease.
Conclusion: In human and equine OA studies, many environ-
mental and subject variables have been shown to affect serum
biomarker levels, including exercise. The usefulness of serum
biomarkers in differentiating exercise-induced changes from dis-
crete OA pathology, especially in cases of solitary joint lesions, has
been questioned. Because of this, and the availability of an
experimental model that mimics both equine and human OA, the
current study was conducted. We were able to conclude from the
results of this study that serum biomarkers are indeed useful in
differentiating exercise from pathology and further work to corre-
late biomarker levels to clinical parameters of pain and histologic
pathology is warranted.
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EVIDENCE FOR INCREASED ARTICULAR CARTILAGE
MATRIX METALLOPROTEINASE 131N EARLY MURINE
OSTEOARTHRITIS
J Flannelly, L Clout, MT Bayliss, RM Mason
ImperialCollegeand Royal VeterinaryCollege, London, UK
Aim: Previous evidence indicated increased type II collagen
cleavage in tibial cartilage matrix adjacent to focal osteoarthritic
lesions in STR/ort mice and increased MMP13 mRNA in tibial
chondrocytes. However, MMP13 protein was not detected in
hyaline cartilage by immunohistochemistry, leaving some doubt as
to the nature of the enzyme(s) causing the cleavage. Thus the aim
of the current study was to assess MMP13 protein in STR/ort
articular cartilage extracts using a fluorokine assay and gelatin
zymography.
Methods: Tibial plateau cartilage was dissected from 40 STR/ort
mice aged 7-35 weeks and from 25 CBA and DBA control mice
(12-36 weeks). The cartilage was extracted in PBS with a protease
inhibitor cocktail excluding EDTA. Extracts were activated with
APMA and assessed for MMP13 by Fluorokine Assay (R & D
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Systems, Minneapolis, USA) and gelatin zymography, with and
without heparin enhancement, a sensitive method for detecting
MMP13, which also detects other MMPs.
Results: MMP2 and MMP9, but not MMP13, were detected by
zymography in extracts from both STR/ort and control mice.
There was no obvious difference in the gelatinase levels between
STR/ort mice and control mice at any age. Young STR/ort mice
(9-19 weeks) had much higher levels of MMP13 than controls in
the fluorokine assay (ng total MMP13 per tibial cartilage; STR/ort
29.4±7.1 SEM; controls 5.4±1.1 SEM; p = < 0.001). MMP13
levels in older STR/ort mice (25-36 weeks) were similar to
those in controls (STR/ort 8.3±1.8 SEM; controls 7.8±1.1 SEM;
p = NS).
Conclusion: The study suggests an important role for MMP13
during the early stages of the murine STR/ort model of OA. Only
the fluorokine assay has sufficient sensitivity to detect MMP13 in
the cartilage
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A SLOW RELEASE FORMULATION OF INSULIN AS A
TREATMENT FOR OSTEOARTHRITIS
L Cai, FW Okumu, JL Cleland, M Beresini, D Hogue, Z Lin, and
EH Filvaroff
Genentech, South San Francisco,CA, USA
Aim: To examine the potential of insulin, in a sustained delivery
system, as a treatment for arthritis.
Methods: The effect of insulin on matrix synthesis, matrix break-
down, and nitric oxide production in primary cartilage explants was
examined. The activity of insulin on diseased cartilage from Dunkin
Hartley guinea pigs, diabetic mice, and osteoarthritic patients was
measured. The specificity of insulin stimulation was compared
to that of IGF-I using osteoblasts and fibroblasts. Finally, the
stability of insulin in a biologically relevant system was tested,
and a slow-release formulation of insulin was developed and
characterized.
Results: In articular cartilage explants, insulin stimulated prote-
oglycan (PG) synthesis, inhibited PG release and nitric oxide
production, and overcame the detrimental effects of interleukin 1
(IL-1). The mechanism whereby insulin decreased matrix break-
down was through inhibition of aggrecanase activity. Insulin was
active on cartilage at concentrations at which insulin does not
cross-react with insulin-like growth factor I (IGF-I) receptors nor
stimulate proliferation of other cells types. The response of carti-
lage to insulin did not diminish with age or disease. Insulin
stimulated matrix synthesis in osteoarthritic cartilage and local
treatment with insulin overcame endogenous suppression of
matrix synthesis in diabetic cartilage. Poly-Iactic-coglycolic acid
(PLGA) was found to be a effective carrier for delivery of insulin,
and PLGA-Insulin was active on articular cartilage in vitro and
in vivo.
Conclusions: As the incidence of arthritis increases with the aging
population, an effective therapy to induce repair of cartilage is
needed. Based on its biological activities, insulin appears to be
an attractive protein therapeutic candidate. Maximum insulin
effectiveness may require a sustained delivery system
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HUMAN AND MURINE CARTILAGE RESPOND DIFFERENTLY
TO LEUKAEMIA INHIBITORY FACTOR
CI Westacott, LAB Joosten', WB Van den Berg'
UniversityofBristol,UK and 'UniversityHospitalNijmegen,
Netherlands.
Introduction: Although leukaemia inhibitory factor (L1F) is readily
detectable in tissue and synovial fluids from patients with osteoar-
thritis (OA), its role in joint pathology is not well defined. The aims
554
of this study were to compare the effects of L1F on human cartilage
metabolism in vitro,with those observed on murine cartilage in an
established model of osteoarthritis.
Methods: Murine studies:To determine the effects of L1F on
cartilage in vivo, C57/B16 were injected intra-articularly with
murine L1F (10-1 OOng) and allowed free ambulation. At days 1 and
2, patellae were removed and cartilage proteoglycan (PG) syn-
thesis and degradation measured. The response of murine carti-
lage in vitrowas determined by incubating patellae (with synovium
attached) from untreated mice with mLiF (IO-IOOng/ml) for 3 days.
PG synthesis and PG loss were assessed. Human studies:Carti-
lage was obtained from OA and non-arthritic (NA) patients under-
going joint replacement surgery. Cartilage biopsies were incubated
for 14 days in either culture medium alone (control) or medium
supplemented with L1F (0.1-IOng/ml). To determine the effects of
synovium on L1F activity, some cartilage biopsies were incubated
with supermatant obtained from separate 24 hr culture of synovium
(SS), or SS and L1F combined. GAG release from biopsies into
culture medium was measured using the DMMB assay.
Results: Murine studies:No significant inhibition of chondrocycte
PG synthesis was observed following intra-articular injection of L1F
into murine joints, although mild PG loss from cartilage (10%) was
apparent. For in vitro cultures, PG loss increased (20%) when
patellae with synovium attached were incubated with L1F. Human
studies:SS, but not L1F, were able to stimulate significant GAG
release from OA, but not NA cartilage. The effects of combinations
of L1F and SS on GAG release from OA and NA cartilage were not
significantly different to those induced by SS alone.
Discussion: These results show L1F may induce mild degradation
of murine cartilage, which may be enhanced by soluble products
released from synovium. By contrast, L1F had no significant
stimulatory effect on GAG release from either NA or OA human
cartilage. In addition, supernatants from synovium had no effect on
L1F activity. These data suggest the response of human cartilage to
L1F is different to that of murine cartilage. Moreover, they imply that
interactions between L1F and other cytokines may differ between
murine and human joints.
Acknowledgements. This work was supported by the European
Union, contract QlRT 1999-02072
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EFFECTS OF INTERLEUKIN-1 ON RHEUMATOID ARTHRITIS
MODEL INDUCED BY TYPE COLLAGEN
Jiangning Wang
Dalian MunicipalCentralHospital
Objective: To observe the effect of interleukin-1(ll-1) on collagen
induced arthritis.
Methods: The multiple arthritis in DBN1 mice was induced with
native type (C); Il-1 was injected intradermally to observe its effect
on collagen induced arthritis (CIA). 18 days later. Serum antibody
to C was measured by ELISA. Disease incidence and severity
were assessed by clinical index and histological features.
Results: All of the mice immunized with Cdeveloped CIA, but no
one immunized with complete freund's adjuvant (CFA) HAD CIA.
The levels of anti-C antibody in serum of CIA mice were higher
than that in control. Incidence and severity of CIA in mice treated
with Il-1 are more significant than those without treatment.
Conclusion: Ccan induce CIA in DBN1 mice. The development of
CIA IN DBN1 mice was accelerated by Il-1.
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BIOMECHANICAL, BIOCHEMICAL AND ULTRASTRUCTURAL
CHANGES IN THE CRUCIATE LIGAMENTS OF
OSTEOARTHRITIC KNEES
Hl Quasnichka, JM Anderson-MacKenzie, MEJ Billingham and
AJ Bailey
Collagen Research Group, BristolUniversity,UK.
Aim of study: Evidence is mounting that demonstrates that joint
instability, induced by cruciate ligament alteration, leads to the
early onset of osteoarthritis (OA). Dunkin-Hartley (DH) guinea pigs
develop OA earlier than the control Bristol Strain 2 (BS2). The
biomechanical biochemical, and ultrastructural properties of the
anterior and posterior cruciate ligaments (ACl and PCl) of these
two stains of guinea pig were assessed.
Methods: The ACls of four male DH and four male BS2 guinea
pigs, aged 3, 6, 9, 12, 16, 20 and 24 weeks, were biomechanically
tested using an Instron mechanical testing rig. The extract of both
the ACl and PCl of an identical cohort of animals was assessed
for gelatinase (MMP-2) and tissue inhibitor of MMP-2 (TIMP-2)
activity using gelatin and reverse zymography. The level of colla-
gen synthesis in the ligaments was determined by quantification of
the procollagen type I C-terminal propeptide (PICP) and the
crosslink marker of newly synthesised collagen, dihydroxylysinon-
orleucine (DHlNl), using a competition ELISA and cellulose/ HPl
chromatography respectively. Transverse sections of both cruciate
ligaments at 6, 12 and 20-week animals were analysed using
transmission electron microscopy (TEM).
Results: The toe region energy of the load-deformation curve,
which is associated with ligament laxity, was greater in the ACl of
DH animals aged 12, 16, 20 and 24 weeks compared to aged
matched BS2. The ACls of the DH failed at a higher ultimate load
and had a higher linear stiffness at 20 and 24 weeks of age,
compared to age matched BS2. This corresponded with a broader
distribution of fibrils with more large diameter fibrils at 20 weeks in
the DH. MMP-2 was elevated in both the ACl and PCl of the DH
compared to BS2 at all ages, whereas its inhibitor, TIMP-2, was
not. There was significantly more PICP and DHlNl in both
cruciate ligaments of the DH animals at most ages, compared to
age-matched BS2.
Discussion: Increased laxity of the DH ligaments may predispose
this strain to early onset of OA. Increased ligament remodelling,
illustrated by elevated MMP-2 and collagen type I expression in the
DH animals, may cause this increased laxity. The elevated ultimate
failure and linear stiffness of the DH ACl in the older animals may
be due to an increase in fibril size, perhaps in response to a laxer
joint.
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FUNDAMENTAL BONE REMODELLING IN GUINEA PIG
OSTEOARTHRITIS DEVELOPMENT
JM Anderson-MacKenzie, Hl Quasnichka, R Starr, EJ lewis,
MEJ Billingham, AJ Bailey
CollagenResearch Group, Universityof Bristol,Bristol
The aim of this study was to define a control strain for the guinea
pig model of OA and use it to investigate the role of bone change
in OA development.
Methods: Four male Dunkin-Hartley (DH) and four Bristol Strain 2
(BS2) guinea pigs were studied at 3, 6, 9, 12, 16, 20, 24 and 36
weeks of age. Posterior-anterior (PA) and lateral view microfocal
X-ray images were obtained from each leg. Bone density was
measured from the growth plate to the articular cartilage for the
tibia and femur, and for a 1600 wide and 450?m deep immediate
subchondral area of the lateral and medial tibial plateau. MMP-2,
9, TIMP and collagenase activity were assayed from 450um deep
immediate subchondral bone samples from the medial tibial pla-
teau. At 16, 20, 24 and 36 weeks film images of the X-rays were
scored blindly for radiological features of OA and toludine blue
sections of the medial tibial plateau were scored for OA using
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adapted Mankin criteria, and subchondral bone/cartilage depth
ratios obtained.
Results: At later time points the radiological (24 and 36 weeks)
and histological (24 weeks) OA scores are significantly lower in the
BS2 than the DH. There is significantly larger subchondral bone/
cartilage depth ratio in the DH at 20 and 24 weeks. At 24 and 36
weeks bone density is higher in the DH than BS2 in the lateral view
of the femur and tibia and immediately subchondral. At 16 weeks
there was significantly increased MMP-2 and collagenase activity
in the DH bone than in the BS2. At 20 weeks there was also
significantly more MMP-2 activity. There were no significant differ-
ences in TIMP activity.
Conclusions: Since OA does not progress in BS2 guinea pigs up
to 36 weeks, while DH develop radiological and histological signs
of OA, BS2 are a control strain for guinea pig OA. Subchondral
bone is being remodelled in DH at 16 and 20 weeks, by 24 weeks
the bone density is higher, at 24 and 36 weeks the DH have higher
OA scores. These data show that metabolic bone remodelling is
fundamental during the very earliest development of OA and
occurs prior to detectable cartilage pathology or bone density
change.
The procedure was performed with a stab incision in the right knee
of 13 2,5-months-old standard NMRllaboratory mice, and their left
knee served as a control. The progression of osteoarthritic
changes was followed by serial radiological examinations in 3 - to
4- week intervals up to 16.5 months of age when the animals were
sacrificed and the knee joints were dissected for histology. A knee
score (0-8) evaluating medial-lateral radiographs was developed
featuring the appearance of osteophytes, subchondral sclerosis
and joint space narrowing in these affected joints.
The joint destruction was apparent and statistically significantly
greater than in the control knees by 2 months from the operation
and thereafter remained fairly constant as compared to the control
joints. The osteophytic changes in posterior part of knee joint were
the first signs of joint destruction, followed by calcification of soft
tissues. The progression of radiological joint destruction score is
presented graphically below.
In conclusion, cruciate ligament disruption initiates rapid and
marked osteoarthritis?like changes in mouse knee, and the pro-
cess can be monitored using serial radiography. This model
enables the use of mice as experimental animals in further
pharmaceutical and other studies on osteoarthritis.
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THE EFFECTS OF INTRAARTICULAR HYALURONAN ON
SYNOVIAL PATHOLOGY, NITRIC OXIDE SYNTHASE
EXPRESSION AND HYALURONAN PRODUCTION IN AN
OVINE MODEL OF OSTEOARTHRITIS
MM Smith, D Burkhardt, SM Smith, M Cake', R Read', P Ghosh
InstituteofBone & JointResearch, RNS Hospital, Sydney,
Australia
'Veterinary& BiomedicalSciences, MurdochUniversity,Perth,
Australia
The present study was undertaken to determine the effects of
intraarticular (ia) administration of two hyaluronan (HA) prepara-
tions, Hyalgan (HG; 0.5-0.73 x 106 Da) and Hylartil (HT; 3.0-6.9 x
106 Da), on the synovial pathology and expression of iNOS by
synoviocytes from osteoarthritic (OA) ovine joints. Ex vivobiosyn-
thesis of HA by synoviocytes was also studied.
Methods: Eighteen of 24 aged ewes were subjected to meniscec-
tomy to induce OA. After 4 months, 6 each of the OA ewes were
administered either placebo, HG or HT ia weekly for 5 weeks. After
a further 5 weeks, all 18 OA and 6 non-operated controls (NOC)
were killed. Supra-patellar synovia were removed to neutral-
buffered formalin for histology and the remaining synovium
digested with trypsin and collagenase. The released ovine synovial
fibroblasts (OSF) were cultured and labelled with 3H-acetate for
24h when 70% confluent. 3H-labelled HA was quantitated by
differential digestion with Streptomyces hyaluronidase and by gel
permeation chromatography. Histological sections were stained
with H&E and scored by a blinded observer for intimal hyperplasia,
cellular infiltrate, subintimal fibrosis and vascularity. Inducible nitric
Age
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FEMORAL INTERCONDYLAR NOTCH SHAPE CHANGES IN
GUINEA PIG OSTEOARTHRITIS DEVELOPMENT
JM Anderson-MacKenzie, HL Quasnichka, R Starr, EJ Lewis,
MEJ ~illingham, AJ Bailey
CollagenResearch Group, UniversityofBristol,Bristol
The aim of this study was to ascertain if the OA associated change
in notch shape occurs during OA development or is a developmen-
tal featu re.
Methods: Four OA prone male Dunkin-Hartley (DH), and four non
PA developing Bristol Strain 2 (BS2) guinea pigs were studied at 3,
6, 9, 12, 16, 20, 24 and 36 weeks of age. Posterior-anterior (PA)
view microfocal X-ray images were obtained from each leg. The
shape of the femoral intercondylar notch was determined from the
X-ray images and by direct measurement with callipers. The notch
width index was calculated (notch width at 2/3rd height/femur
width. This cohort of animals were separately studied for OA
development and at 24 and 36 weeks the DH had significant early
radiological and histopathological signs of OA and the BS2 did not.
Results: Radiological NWI was larger in the DH than the BS2 at 24
weeks and then, significantly decreased in the DH between 24
weeks and 36 weeks. Morphological measurements of the NWI
show that the DH is significantly lower than that for the BS2 at 24
and 36 weeks of age
Conclusions: The notch has undergone significantly different
remodelling, resulting in a narrowing of the notch width in mature
DH animals compared to BS2. The NWI is not different between
the strains during and immediately after development, instead
narrowing is occurring concurrently with other mineralised tissue
changes associated with disease development, prior to any gross
cartilage change. This strongly suggests that the NWI is an early
indication of disease and an early consequence but not a causal
event.
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A NEW MODEL OF EXPERIMENTAL OSTEOARTHRITIS BY
CRUCIATE LIGAMENT TRANSSECTION IN MOUSE KNEE
T Moilanen, H Sirkkola, K Vuolteenaho, E Moilanen
ImmunopharmacologicalResearch Group, MedicalSchool,
Universityof Tampere and Tampere UniversityHospital, Finland
To enable the use of mice as experimental animals in trials of basic
mechanisms and drug treatment of osteoarthritis, we developed a
model by transsecting the cruciate Jigament(s) of mouse knee.
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oxide synthase (iNOS) was immunolocalised using pUblished
methods.
Results: OSF from OA sheep produced significantly less HA per
cell than OSF from NOe sheep (p < 0.05). OSF from OA and
HG-treated sheep produced significantly more HA per cell than
OSF from placebo-treated OA sheep (p < 0.05). HA produced by
OSF from HT-treated sheep was not significantly different from
either OSF from NOe or placebo-treated sheep. In iNOS-stained
synovial sections, the number of iNOS cells per mm synovial lining
measured in the placebo- and HT-injected OA sheep were signifi-
cantly higher than the number of cells in synovia from NOe sheep.
However, no significant difference was observed in the number of
iNOS-positive cells in synovia from the HG-treated group and the
NOe group. Histological scores for all parameters were signifi-
cantly different between NOe and OA groups (p < 0.05) but not
between ia treatments.
Conclusions: HG enhanced the ex vivo biosynthesis of HA in
OSF from OA sheep and did not increase the iNOS in OA synovia.
Based on these results, it would appear that Hyalgan was a more
effective ia treatment than Hylartil in this model of OA.
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THE QUANTITY AND QUALITY OF HYALURONAN IN
SYNOVIAL FLUIDS FROM OSTEOARTHRITIC SHEEP ARE
IMPROVED BY INTRA-ARTICULAR HYALGAN TREATMENT
MM Smith, P Ghosh, B Kipic, D Burkhardt, M Swain*, M eake~,
R Read~
InstituteofBone & JointResearch, RNS Hospital,Sydney.
Australia.
*MechanicalEngineering,UniversityofSydney. Sydney, Australia
'Veterinary& BiomedicalSciences, MurdochUniversity.Perth,
Australia
Intra-articular (ia) hyaluronans (HAs) of different molecular weights
(MW) are widely used to treat osteoarthritis (OA) but the impor-
tance of MW on their ability to protect joints by improving synovial
fluid (SF) rheology and HA content has not been investigated. The
aim of this study was to examine this question.
Methods: Eighteen aged ewes were subjected to meniscectomy
to induce OA. After 4 months, 6 each of the OA ewes were given
either placebo, Hyalgan (HG; 0.5-0.73 x 106 Da) or Hylartil (HT;
3.0-6.9 x 106 Da) ia weekly for 5 weeks. After a further 5 weeks, all
18 OA sheep were killed. SF was aspirated from knee joints
immediately before the first ia injection (week 16); at the time of the
fifth injection (week 21) and 5 weeks after the last injection (week
26). SF was centrifuged to remove cells and debris and its HA
content, storage moduli (SM), viscosity (V) and loss moduli (LM)
were determined using published methods.
Results: Mean SF-HA levels in animals treated with HG showed
an increase from baseline of 24+/-14% on week 21 whereas the
placebo and HT group values decreased by -23+/-16% and
-33+/-18% respectively. The differences between the HG-treated
group and the other groups were significant (p < 0.05). However,S
weeks post-treatment no differences between groups were
observed. Rheological analysis of SF from placebo animals
showed a progressive decline in V and SM over the experimental
period of 26 weeks; in contrast SF from the HG-treated but not
HT-treated animals increased in V and SM relative to pre-
treatment values (week 16). The % changes from pre-treatment
values of the SF from HG-treated sheep were significantly different
to the corresponding placebo group values at week 21 (p < 0.005)
and week 26 (p < 0.005).
Conclusions: These results showed that ia treatment with Hyal-
gan but not with Hylartil, improved the HA concentration, elasticity
(SM) and viscosity of SF in OA joints. These SF changes would be
expected to improve joint lubrication and reduce cartilage damage.
These findings were consistent with a parallel study which demon-
strated synovial fibroblasts cultured from joints of HG-treated
animals synthesised more HA than cells derived from placebo-
injected joints.
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EPIPHYCAN/BIGLYCAN DOUBLE KNOCKOUT MICE HAVE
AN OSTEOARTHRITIC PHENOTYPE
Satoshi Nuka" Wei Zhou 1, Stephen Henry1 , Kazuo Ito"
Marian F. Young2 , Tamayuki Shinomura3, Magnus Hook1
1Texas A & M University.DepartmentofBiochemistryand
Biophysics,AlbertB. Alkek Instituteof Biosciencesand
Technology.Center for ExtracellularMatrix Biology.Houston,
Texas
2MolecularBiologyof Bones and Teeth Unit, CSDB,
DIR NIH/NiDCR
3Departmentof Hard Tissue EngineeringDivisionof Bio-Matrix,
Tokyo Medicaland Dental University.Tokyo, Japan
Epiphycan is a member of the small leucine-rich repeat proteogly-
can gene family (SLRPs). During mouse embryonic development,
we have shown that the mRNA expression of epiphycan is prefer-
entially in the chondrocytes of the growth plate cartilage, and the
epiphycan protein is localized to the extracellular matrix surround-
ing the chondrocytes of the resting, proliferating, and hypertrophic
zones of the growth plate. Biglycan is also a member of the SLRP
gene family, and is widely distributed in the extracellular matrices
of bone, cartilage, and nonskeletal connective tissues. We have
generated epiphycan deficient mice. Although the newborn mutant
mice do not display any overt abnormalities, the adult epiphycan-
null mice have a reduced bone length. Histological analysis of the
mutant mice indicates that the hypertrophic zone of the growth
plate in the mutant mice is wider than the hypertrophic zone in the
wild-type littermates. We have bred the epiphycan-null mice to the
biglycan-null mice to obtain double knockout epiphycan/biglycan
mutant mice. The double knockout mice display an osteoarthritic
phenotype marked by a deterioration of the articular cartilage in the
joints that is supported by X-ray and histological evidence. In the
single epiphycan-null mice as well as the single biglycan null-mice,
a slight fibrillation of the articular cartilage was observed in
9-month-old single knockout mice. However, the 9-month-old dou-
ble knockout mice develop degenerative joint disease that
resembles human osteoarthritis characterized by a progressive
loss of the articular cartilage. These studies demonstrate that the
single epiphycan and biglycan-null mice display only minor hall-
marks of osteoarthritis. On the other hand, the double epiphycan/
biglycan knockout mice have a greatly exacerbated osteoarthritic
phenotype supporting the hypothesis that a functional redundancy
may exist between the two SLRP family members. The double
knockout mice may serve as an animal model of osteoarthritis.
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MRI-BASED ANALYSIS OF KNEE AND ANKLE CARTILAGE
IN MONOZYGOTIC TWINS SUGGESTS THAT ITS
MORPHOLOGY IS STRONGLY DETERMINED BY GENETICS
V Siedek, e Glaser, K-H Englmeier, M Reiser, R Putz, F
Eckstein
InstitutesofAnatomyand ofDiagnosticRadiology.LMU
MOnchen, GSF NationalResearch CenterNeuherberg,
OberschleiBheim,Germany
Aim of study: It is known that about 50-70% of human skeletal
peak bone mass is determined by genetics, and only a relatively
small proportion by environmental factors. Because of the lack of
non-invasive imaging modalities, this relationship has so far,
however, not been established for articular cartilage morphology.
In this pilot study we use a validated MRI-based method of in vivo
cartilage morphometry, to assess cartilage morphology in the knee
and ankle in monocygotic twins. We tested the hypothesis that
inter-subject differences in cartilage volume and thickness are
strongly determined by genetics, that is that differences between
monocygotic twins are considerably smaller than the normal inter-
subject variability (differences between pairs of twins)
Methods: We investigated 11 pairs of monocygotic twins, aged 20
to 60 years (5 female, 6 male). Cartilage volume, thickness, and
surface areas, were quantified with MR imaging (high resolution
FLASH water excitation sequence) and dedicated software. Values
were obtained for the knee (Eckstein et al. 2001 Anat Embryol
203:147) and ankle (AI-Ali et al. 2002 JOR 20: 249). Differences
between twins were quantified by calculating the coefficient of
variation (CV%) for each twin pair, and their mean (11 cases). The
inter-subject variability was assessed by calculating the CV% of
the mean values of the 11 twin pairs.
Results: In the knee, the average difference between twins was
3.6% for mean cartilage thickness, 3.7% for volume, and 1.8% for
joint surface area. The inter-subject variability was 8.8% (ratio
2.5:1) for thickness, 16.6% (ratio 4.5:1) for volume, and 14.7%
(ratio 8.0:1) for surface area. Values for the ankle were 3.0% vs.
13.0% (ratio 4.4:1) for thickness, 2.9% vs. 23.3% (ratio 8.0:1) for
volume, and 2.5% vs. 16.6% (ratio 6.8:1) for surface area. The
correlation between the knee and ankle was 0.50 (n.s.) for thick-
ness, 0.62 (p < 0.05) for volume, and 0.82 (p < 0.01) for area.
Conclusion: These data show that differences of cartilage mor-
phology between monocygotic twins are considerably smaller than
the f}ormal inter-subject variability, suggesting that cartilage mor-
phology is strongly determined by genetic factors. However, there
only exists a moderate (non-significant) association between the
knee and ankle, indicating that cartilage morphology in these joints
is not determined by identical genes.
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KNEE CARTILAGE VOLUME ASSESSED BY MRI HAS
HIGHER HERITABILITY THAN RADIOGRAPHIC SCORES
1J Stankowich, 2F Cicuttini, 1C Ding, 1F Scott, 2M Glisson,
1G Jones
1Menzies Research Institute,Universityof Tasmania, Hobart, 2
Monash UniversityMedicalSchool, Victoria,Australia
Previous studies have indicated that osteoarthritis has a significant
genetic component. However, these studies have generally used a
semi-quantitative measure of disease which may limit power for
genetic studies. In this study, we report on the feasibility of using
MRI assessment of knee cartilage volume as a quantitative trait for
osteoarthritis genetic studies.
We studied 128 male and female offspring of 51 people who had
undergone knee replacements for primary osteoarthritis (2-6 off-
spring per family). The mean age of the offspring was 45 years
(range 26-58). Articular cartilage volume was determined at the
patella, medial and lateral tibial compartments by MRI utilizing a
fUlly quantitative technique. Radiographic osteoarthritis (ROA) was
also assessed using standard AP views. The genetic analysis
program SOLAR was used to estimate the heritability of cartilage
volume at the different sites and ROA both before and after
adjustment for sex, age, height and weight.
Cartilage volume was normally distributed in this sample. The table
below gives adjusted heritability estimates for cartilage volume.
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Cartilage volume Heritability Standard p-value
Error
lateral tibial 0.74 0.20 <0.001
medial tibial 0.61 0.22 <0.001
patellar 0.85 0.20 <0.001
total 0.84 0.20 <0.001
In contrast, the heritability estimates for ROA in this early cohort
were less robust (any ROA 0.50, p=0.24, total ROA score 0.57,
p=0.02).
In conclusion, in this sample with a high risk of knee osteoarthritis,
the heritability of the knee cartilage volume varied between 61 and
85%. This compares very favorably to published estimates for
ROA of the knee which are generally less than 40% (although
somewhat higher in this sample) suggesting that knee cartilage
volume may be superior to X-ray as a phenotypic assessment for
linkage studies of osteoarthritis of the knee.
PS112
A CROSS-SECTIONAL STUDY OF THE DETERMINANTS OF
KNEE CARTILAGE VOLUME
1CH Ding. 2F Cicuttini, 1F Scott, 2M Glisson, 1G Jones
1Menzies Research Institute,Universityof Tasmania, Hobart,
2DepartmentofEpidemiologyand PreventiveMedicine, Monash
UniversityMedical School, Victoria,Australia)
OBJECTIVE: To describe the associations between gender, life-
style factors, occupation and radiographic osteoarthritis (ROA)
status and knee cartilage volume in healthy adults.
METHODS: We studied 372 male and female adults aged
between 26 and 61 (58% female, mean age 45.1 yrs). Of these,
50% had a parent who has severe knee OA and 50% were
randomly selected controls. Articular cartilage volume was deter-
mined at the patella, medial and lateral tibial compartments by
MRI. Anthropometric factors were measured while knee injury
history, knee pain and occupation involving significant bending
were assessed by questionnaire. Endurance fitness was
measured by bicycle ergometric testing and ROA was assessed
using standard X-ray.
RESULTS: Males had more knee cartilage volume than females at
all three sites (all P<0.0001). Height was also a significant deter-
minant of knee cartilage volume at all sites, with taller subjects
having more knee cartilage volume (all P <0.0001). Smokers had
significantly higher lateral tibial cartilage volume (p=0.001) and
trends to higher medial tibial (p=0.055) and patellar cartilage (p=
0.088). There was a significant 9-12% reduction in knee cartilage
volume in all three sites in subjects with ROA which was mainly
OARSI grade 1 (all P5, 0.001). Those whose occupation involved
significant bending had more medial tibial cartilage (P=0.018), but
not lateral tibial and patellar cartilage volume, than those not
involving bending. There was a continuous positive association
between endurance fitness and medial tibial cartilage (P=0.032)
which persisted after adjustment for body size. All the factors
combined explained a high proportion of the variation in cartilage
volume at all sites (R242-53%). There was no association between
age, body weight, knee pain and/or knee injury history and knee
cartilage volume at any site (all P>0.05).
CONCLUSION: There is convincing evidence relating gender,
height and smoking to knee cartilage volume in this young cohort.
Early ROA (but not knee pain) is associated with substantial
decreases in knee cartilage volume. Lastly, physical activity during
the middle years appears beneficial for knee cartilage volume
suggesting a possible preventive role for knee OA.
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THE ANABOLIC EFFECT OF PULSED LOW-INTENSITY
ULTRASOUND ON HYALINE CARTILAGE
Z-J Zhang#, J Huckle%, and RGS Spencer#
#NationalInstituteon Aging, BaltimoreUSA; %Smithand
Nephew Group Research Centre, York, UK
AIM OF STUDY: To elucidate some of the underlying molecular
mechanisms of the anabolic effects of pulsed low-intensity ultra-
sound (PLlUS) on cartilage repair.
METHODS: The distal third of the sternum of 16-day-old chick
embryos was used for explant culture. PLiUS at 1.5 MHz was
applied with a spatial-temporal average intensity of 30 mWecm-2,
with pulse burst frequency 1 kHz. The treatment was applied once,
for 20 minutes on day O. Samples were collected at days 1, 3, 5
and 7 for histology and immunohistochemistry. Primary antibodies
included mouse against avian type II collagen, proteoglycan, and
type X collagen.
RESULTS: At day 1, type II collagen was seen in the intracellular,
pericellular, and interterritorial matrix regions in both groups.
Staining for aggrecan was stronger and more uniform in the PLiUS
group. At day 3, as compared with day 1, type II collagen staining
increased in both groups, while aggrecan staining increased in the
PLiUS group. At day 5, type II collagen staining was much stronger
and more uniform in the PLiUS group than in the controls. At day
7, the extracellular matrix stained evenly with type II collagen and
aggrecan. Quantification of the optical density of the immunos-
tained sections confirmed these qualitative results. Peripheral and
central regions of the explants were analyzed separately. At day 1,
the PLiUS and control groups had a similar density of type II
collagen in both areas. Starting at day 3, type II collagen staining in
the PLiUS group was approximately 10% greater than in the
control group in both areas. This difference persisted throughout
the entire study (p<0.001). Aggrecan staining was seen to be
increased by approximately the same amount even by day 1 in the
PLiUS group (p<0.001). The magnitude of the difference between
the groups decreased gradually, but remained statistically signifi-
cant throughout the study (p<0.05). Staining for type X collagen
was negative at all time points in both groups.
CONCLUSIONS: Our previous work on the application of PLiUS to
chick sternal chondrocytes demonstrated an increase in mRNA
expression for type II collagen and aggrecan. The present study
confirmed that these increases in mRNA expression result in
functional protein production. The fact that PLiUS did not induce
expression of type X collagen, which is a marker for the hyper-
trophic phenotype and may represent a response to injury, indi-
cates that PLiUS is consistent with normal chondrocyte
metabolism. The results of this study support the further evaluation
of PLiUS to the treatment of cartilage degeneration and damage.
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CHANGE IN TIBIAL CARTILAGE VOLUME IS ASSOCIATED
WITH CHANGE IN SYMPTOMS IN SUBJECTS WITH KNEE
OSTEOARTHRITIS
AE Wluka1, R Wolfe1, S Stuckey2, FM Cicuttini1
1DepartmentofEpidemiologyand PreventiveMedicine, Monash
University,and 2MRI Unit, AlfredHospital, Melbourne,Australia.
Background: The relationship of pain and structural damage in
osteoarthritis (OA) is poorly understood. No consistent relationship
between change in radiological OA and change in symptoms of
knee OA has been demonstrated.
Aim: To determine the relationship between change in symptoms
of knee OA and tibial cartilage volume over a 2 year period.
Method: Prospective cohort study examining subjects with symp-
tomatic early (mild to moderate) knee OA, recruited by advertising
from the community, general practitioners, rheumatologists and
orthopedic surgeons. At baseline and 2 years later, participants
had MRI scans of their knee and completed questionnaires to
quantify symptoms of knee OA (WOMAC: pain, stiffness, function)
and general health status (SF-36). Tibial cartilage volume was
determined using sagittal T1-weighted fat suppressed images.
Results: 126 subjects entered the study. Complete data was
available for 117 subjects (93%). Over 2 years, reduction in tibial
cartilage volume was associated with an increase in pain scores
(r=-0.27, p=0.003), and to a lesser extent with worsening of
stiffness (r=-0.17, p=0.07), deterioration in function (r=-0.19,
p=0.19), worsening general physical health functioning (r=0.11,
p=0.26) and improved mental health (r = -0.08, P = 0.39).
Conclusion: Increased loss of tibial cartilage in knee OA is
associated with worsening of symptoms in knee OA. This suggests
that the structural change of loss of tibial cartilage contributes to
symptoms in knee OA and provides support for a role for strategies
to prevent knee cartilage loss in the management of OA.
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QUANTITATIVE EVALUATION OF ARTICULAR CARTILAGE
IN SITU WITH ULTRASOUND INDENTATION
Laasanen MS, Saarakkala S, T6yras J, Hirvonen J, Rieppo J,
Korhonen RK, Helminen HJ and Jurvelin JS
Department of Anatomy, University of Kuopio, Kuopio and
Department of Medical Biochemistry and Molecular Biology,
Universityof Turku, Turku, Finland
Aim of the study: Even the best clinical methods, such as
magnetic resonance imaging, do not provide direct information
about cartilage functional properties. We have developed a novel
handheld ultrasound indentation instrument for diagnosing carti-
lage mechanical and acoustic properties (Laasanen MS et ai,
PhysiolMeas, in press 2002). This study investigates the feasibility
and reproducibility of the instrument to evaluate cartilage proper-
ties in situ.
Methods: Osteochondral blocks (n=6 per site) were prepared from
the medial femoral condyle (FMC), the lateral facet of the patello-
femoral groove (LPG) and medial tibial plateau (MTP) of bovine
knee. The ultrasound indentation instrument consisted of an ultra-
sound transducer (Panametrics XMS-310) installed to the tip of a
commercial Artscan 200 instrument. During the measurement of
cartilage dynamic modulus (Hayes et ai, J Biomech 5, 541-51
1972) tissue thickness and deformation (4%) were calculated from
the ultrasound signal and the induced stress was detected with
strain gauges inside the instrument. High-resolution material tester
was used for reference mechanical measurements in unconfined
compression (stress-relaxation: 10% prestrain, 10% step 2 mm/s,
2400 s relaxation, sample dia=4 mm). Cartilage glycosaminogly-
can (GAG) content was determined from the safranin O-stained
samples using digital densitometry (Panula HE et ai, Ann Rheum
Dis 57 237-451998).
Results: Cartilage dynamic modulus, as obtained with the ultra-
sound indentation instrument, correlated highly linearly (r = 0.913,
p<0.01) with the reference values. Dynamic modulus was signifi-
cantly (p<0.05, Tukey One-Way Post Hoc test) higher at LPG
(10.14±3.11 MPa) than at other sites (FMC: 4.63±1.32 MPa, MTP:
2.92±1.38 MPa). Ultrasound reflection coefficient from the articular
surface was significantly (p<0.05) smaller at MTP (2.04±0.73%)
than at other sites (FMC: 4.22±0.88%, LPG: 4.43±0.83%). Repro-
ducibility (standardized coefficient of variation) of ultrasound inden-
tation was 3.0%, 5.2% and 1.7% for thickness, dynamic modulus
and ultrasound reflection coefficient, respectively. Cartilage
GAG content (optical density) correlated positively with dynamic
modulus (r = 0.678, p<0.01) and especially with the equilibrium
Young's modulus (reference device, r = 0.874, p<0.01), but it
was not related with the ultrasound reflection coefficient (r= 0.294,
p = 0.24).
Conclusions: Manual measurements were reproducible and the
instrument can be used in situto detect topographical variation of
cartilage mechano- acoustic properties. This study establishes a
step towards clinical use.
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COMPARISON OF CARTILAGE VOLUME AND
RADIOLOGICAL ASSESSMENT OF THE TIBIOFEMORAL
JOINT
F Cicuttini, A Wluka, R Wolfe, A Forbes
Departmentof Epidemiologyand PreventiveMedicine, Monash
UniversityMedicalSchool, Victoria,Australia
OBJECTIVE: To compare knee cartilage volume as measured by
magnetic resonance imaging with radiological assessment of the
tibiofemoral joint.
METHODS: The MRI determined cartilage volume was compared
to the radiological grade of individual features of osteoarthritis
(osteophytes and joint space narrowing) in 252 subjects with
tibiofemoral knee osteoarthritis (mean age 60.2 +/- 10 years,
females 62%) who were participating in studies of osteoarthritis.
RESULTS: Joint space narrowing (JSN) in both the medial and
lateral tibiofemoral radiographs was inversely associated with the
respective tibial cartilage volume. This inverse relationship was
strengthened following adjusting for age, gender, body mass index
and bone size. After adjusting for these confounders, for every
increase in JSN grade (0 to 3), the medial tibial cartilage volume
was reduced by 257 (193, 312) mm,3 the lateral tibial cartilage
volume by 396 (283, 509) mm3. A similar relationship existed
between tibial cartilage volume and grade of osteophytes. After
adjusting for the above confounders, for every increase in osteo-
phyte grade (0 to 3), the medial tibial cartilage volume was reduced
by 77 (-3, 156) mm3 and the lateral tibial cartilage volume by 255
(173,336) mm3.
CONCLUSION: We have shown a strong negative association
between medial and lateral tibial cartilage volume and radiological
grade of individual features of OA. Longitudinal studies will be
needed to determine the role of tibial cartilage volume in measur-
ing progression of tibiofemoral osteoarthritis.
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FACTORS AFFECTING KNEE CARTILAGE VOLUME IN
HEALTHY MEN
F Cicuttini" A Wluka', M Bailey,' R O'Sullivan2 , C Poon3,
S Yeung,3 P Ebeling3
1DepartmentofEpidemiologyand PreventiveMedicine, Monash
UniversityMedicalSchool, Prahran, Vic; 2MRI Unit, Mayne
Health DiagnosticImagingGroup, EpworthHospital, Richmond,
Vic; 3Dept ofDiabetes & Endocrinology,Royal Melbourne
Hospital, Parkville, Vic.
OBJECTIVE: To determine factors influencing knee cartilage
volume in healthy men.
METHODS: 45 healthy males aged (mean +/- SO) 52.5+/-13.2
years were recruited through advertising in newspapers and sport-
ing clubs. Articular cartilage volume were determined at the
patella, medial and lateral tibial compartments by MRI. Anthropo-
metric factors were measured while knee injury history and knee
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pain were assessed by questionnaire. Early morning blood
samples were taken from all subjects and assayed for testoster-
one, sex hormone binding globulin, dehydroepianosterone sul-
phate, oestradiol and luteinising hormone. Total body bone mineral
content was measured by dual energy x-ray absorptiometry.
RESULTS: Total and medial tibial volumes were inversely associ-
ated with age, BMI and amount of physical activity and positively
associated with total bone content. BMI explained the largest
amount of the variation in tibial cartilage volume (18.7%). There
were similar findings at the lateral tibial cartilage, but for age and
total bone content this did not reach statistical significance. There
was a positive association with serum testosterone at all tibial
cartilage sites but this only reached statistical significant for medial
tibial cartilage, where serum testosterone explained up to 8% of
the variation in cartilage volume.
CONCLUSION: Modifiable risk factors of osteoarthritis appear to
also be significant determinants of tibial cartilage volume. Serum
testosterone may provide one possible explanation for gender
differences in tibial cartilage volume and prevalence of tibiofemoral
osteoarthritis. The proposed link between osteoarthritis and knee
cartilage volume and the effect of testosterone will need to be
confirmed in longitudinal studies.
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THE DETERMINANTS OF CHANGE IN PATELLA CARTILAGE
VOLUME IN OSTEOARTHRITIC KNEES
F Cicuttini, A Wluka, W Yuanyuan
Departmentof Epidemiologyand PreventiveMedicine, Monash
UniversityMedicalSchool, Victoria,Australia
Objective: The rate of change in patella articular cartilage and
factors influencing it, in subjects with osteoarthritis (OA), is
unknown. We performed a cohort study to determine this.
Methods: One hundred and ten subjects with OA, had baseline
skyline and lateral radiographs and MRI on their knee. They were
followed 2 years later with a repeat MRI of the same knee. Patella
cartilage volume was measured at baseline and follow up. Risk
factors assessed at baseline were tested for their association with
change in patella cartilage volume over time.
Results: The annual percentage loss of patella cartilage was 4.5
+/- 4.3%. Gender, BMI and pain score at baseline were associated
with an increase in cartilage loss. The rate of patella cartilage loss
was greater in women than men, 5.3% versus 3.5%, P<0.03,
independent of age, BMI and pain score.
Conclusion: In OA, patella cartilage volume is lost at 4.5 +/- 4.3%
per year. The main factors affecting cartilage loss are gender, 8MI
and baseline pain score. Further work will be required to determine
whether the rate of patella cartilage loss in OA is steady or phasic,
and to determine which factors can be modified to reduce cartilage
loss.
PS119
COMPARISON BETWEEN PATELLA CARTILAGE VOLUME
AND RADIOLOGICAL ASSESSMENT OF PATELLOFEMORAL
JOINT
F. Cicuttini, A. Wluka, W Yuanyuan, A Forbes, M Glisson
DepartmentofEpidemiologyand PreventiveMedicine, Monash
UniversityMedicalSchool, Victoria,Australia
OBJECTIVE: Radiological definition has been used for epidemio-
logical studies of osteoarthritis (OA). Whether a relationship exists
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between radiological patellofemoral OA and patellar cartilage vol-
ume, is unknown. In this study, we compared patella cartilage
volume as measured by magnetic resonance imaging (MRI) with
radiological assessment of the patellofemoral joint.
METHODS: 157 subjects with patellofemoral osteoarthritis, with
specific features (osteophytes and joint space narrowing) ranging
from grade 0-3 were examined (age 62+/-10 years, 62% female).
Each subject had skyline and lateral patellofemoral radiographs
performed. Patella cartilage volume was determined by processing
images acquired in the sagittal plane using n-weighted fat satu-
rated MRI on an independent work station.
RESULTS: Grade of joint space narrowing (JSN) as measured on
skyline and lateral patellofemoral radiographs was inversely
associated with patella cartilage volume. After adjusting for age,
gender and body mass index, for every increase in grade of skyline
JSN (0-3), the patella cartilage volume was reduced by 411 (391,
503) mm3. For every increase in lateral patellofemoral JSN grade
(0-3), the adjusted patella cartilage volume was reduced by 145
(28, 262) mm3. The relationship was stronger for patella cartilage
volume and skyline JSN (r= -0.54, p<0.001) than for lateral
patellofemoral JSN (= -0.16, p=0.015). There was no significant
association between patella cartilage volume and osteophytes
measured on skyline or lateral radiographs.
CONCLUSION: There is a significant negative association
between patella cartilage volume and JSN, but not osteophytes.
This association was strongest for the skyline rather than lateral
radiographs. Longitudinal studies will be needed to determine the
role of patella cartilage measurement in assessing progression of
patellofemoral osteoarthritis.
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THE VALUE OF FAT SATURED MRI SEQUENCES IN
CLINICAL ASSESSEMENT OF PAINFUL KNEE
OSTEOARTHRITIS
CF Tan MemorialHospital, Taiwan
Aim of study: A simple tailored magnetic resonance imaging (MRI)
with fat saturated sequences is used for clinical assessment of
various patterns in painful knee osteoarthritis (OA-knee).
Methods: Fifty seven consecutive patients with atraumatic painful
OA-knees were assessed with both T1-weighted sagittal and
T2-weighted coronal fat saturated sequences in addition to con-
ventional MRI. Patterns of painful OA-knee were grouped into:
cartilaginousform for the presence of cartilaginous lesion or
erosion; osteocartilaginousform for the presence of subchondral
osteosclerosis and or marrow edema; and arthropathicformfor the
presence of arthritis.
Results: The study group included twenty nine males and twenty
eight females with age ranged from thirty to seven-eight of years
(mean 55.4). Forty two patients (74%) had cartilaginous form of
knee pain from osteoarthritis shared common internal derange-
ments of degenerated anterior cruciate ligament or menisci.
Cartilaginous lesions in OA-knee ranged from blister formation,
cartilage plate thinning to subchondral bone denudation. Seven
patients (12%) had osteocartilaginous form of painful OA-knee
characterized by subchondral sclerosis with or without bone
edema resulting from reactive subchondral bone edema or
spontaneous osteonecrosis. Eight patients (14%) had joint dis-
ease in knee osleoarthrosis with joint effusion, synovitis or
hemarthrosis.
Conclusions: Conventional MRI provides general information of
OA-knee such as osteophyte formations, degeneration or tear-
ing of ligaments and menisci. However, a correlation of such
findings to knee pain in OA-knee is not clear. Supporting
evidence demonstrated pain resulted from OA-knee originates
from cartilage degradation, bone marrow edema and knee
arthritis. T1-weighted fat-saturated sequence allows accurate
cartilage imaging by a high signal to noise ratio and a less
chemical shift artifact of cartilage plates to neighboring joint
structures. Marrow edema can be assessed on T2-weighted
fat-saturated images. In this study, the cartilaginous form in
painful OA-knee is more commonly occurred than the osteocar-
tilaginous form and the arthropathic form although the latter
forms may also caused painful OA-knees. Subchondral sclerosis
(reactive bone fibrosis and pain cause) may be obscured by fat
suppression technique that is remediable by comparing findings
on conventional MRI.
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IMAGE REGISTRATION OF 3D·SPGR AND MULTI-ECHO
MRI FOR THE REMOVAL OF PARTIAL VOLUME ERRORS
IN T2 MEASUREMENTS OF ARTICULAR CARTILAGE IN
THE KNEE
JA Lynch, J Zhao, A Guermazi, B Taouli, CG Peterfy,
HK Genant
Osteoporosis& ArthritisResearch Group, Departmentof
Radiology, Universityof California,San Francisco,CA, USA.
Aims of Study: The aim of the study was to determine whether
it is feasible to use multi-echo (MEMP) MRI images to provide
accurate, and reliable estimates of T2 within articular cartilage in
both cross sectional and serial studies of cartilage in the osteoar-
thritic knee, by automated image registration of 3D-SPGR
images and automatically outlined 3D boundaries of articular
cartilage of the knee.Methods: Early osteoarthritic alterations
in cartilage matrix often cause high signal intensity in articular
cartilage on T2 weighted MRI images, before lesions are visible
morphologically. Typically, fat suppressed, three dimensional (3D)
spoiled gradient echo (SPGR), are used to examine cartilage
morphology. T2 measurements are taken from multi-echo
(MEMP) sequences. 3D-SPGR sequences show anatomy with
high resolution, but MEMP sequences suffer from poor visualiza-
tion of anatomy, low resolution and large slice thickness. This
leads to the occurrence of partial volume artifacts within MEMP
images, which cause large errors in measurements of T2 in
articular cartilage where the neigbhouring tissues can have very
high T2 (synovial fluid), or low T2 (subchondral cortical bone).
Five patients who developed osteoarthritic changes following
meniscal surgery were examined using 3D-SPGR and MEMP
sequences in a GE Signa scanner at 1.5T. Following segmenta-
tion of articular cartilage from the 3D-SPGR data, and image
registration to the MEMP images, the proportion of the femoral,
tibial, and patellar cartilage which is likely to have errors in T2
due to partial voluming was estimated.
Results: The patella showed the smallest degree of partial volume
error, with 71% of cartilage voxels in the MEMP scan having low
partial voluming. For the tibia, 66% of cartilage voxels had low
partial volume error, with partial voluming occurring mainly where
the cartilage sloped up against the tibial spines. In the femoral
cartilage, 57% of the cartilage voxels had low partial volume error,
with errors occurring all over the curved surfaces, but most severe
where the medial and lateral condyles curved into the trochlear
groove. The main sites of cartilage with very low partial volume
errors were the femoral cartilage within the trochlear groove where
it articulates with the patella, the central part of the patella
cartilage, and tibial cartilage on the flattest portions of the tibial
plateau.
Conclusions: T2 measurements in cartilage from MEMP scans
need to be taken carefully. Image registration and cartilage seg-
mentation may help to improve localisation of sites where low
partial volume errors will occur.
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PREDICTIVE MARKERS OF CARTILAGE INJURY
PROGRESSION: AN IN VIVO MRI FOLLOW UP STUDY
DD D'lima 1,2, M Lotz 1, C Chung 2, P Pulido 2, H Hoenecke 2, J
Fronek 2, CW Colwell, Jr 2
1 DivisionofArthritisResearch, The ScrippsResearch Institute,
La Jolla, CA, USA
2 ScrippsClinic, La Jolla CA, USA
Introduction: Cartilage injury often leads to secondary osteo-
arthritis, The arthroscopic, histologic, and magnetic resonance
imaging (MRI) findings after acute joint trauma were
documented,
Methods & Materials: 20 patients were recruited into the study at
a mean 3 months after acute knee injury, Each patient underwent
cartilage specific magnetic resonance imaging (MRI) sequences of
the affected knee after injury, and at 6 months, 1 year, and. 2 years
after arthroscopy, Cartilage lesions were graded on MRI and
arthroscopy, Synovial fluid was sampled, and a 1,8 mm biopsy was
obtained from the edge of cartilage lesion. Control biopsies were
obtained from fresh cadaver donors, Cells undergoing DNA frag-
mentation in biopsies were counted,
Results: All cases of partial or full thickness cartilage loss were
detected by MRI. Biopsies from cartilage lesions had significantly
more cells undergoing DNA fragmentation (41%) than control
biopsies (12%), On MRI fqllow up, cartilage lesion grade improved
in 5 patients, worsened in 2, and did not change in 13 patients, The
percentage of cells undergoing DNA fragmentation correlated with
keratan sulfate levels in synovial fluid (R = 0,68), Keratan sulfate
levels were highest in knees with progressive lesions (72 vs, 31
microgm/ml),
Discussion: The longitudinal progression of cartilage lesions is
not fully documented, These results show that cartilage cell
viability directly impacts the potential for repair, The development
of accurate markers that may predict the eventual fate of the lesion
is of tremendous clinical value, Elevated levels of matrix degrada-
tion products such as keratan sulfate can be predictive of a poorer
prognosis,
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ELECTRON MICROSCOPICAL STEREOLOGY CONFIRMS
THE IMPORTANCE OF COLLAGEN FOR MRI AND
ULTRASOUND CHARACTERISTICS OF ARTICULAR
CARTILAGE
TK Umgsj61, MT Nieminen1 , J T6yras2 , J Rieppo1,
HJ Helminen1, JS Jurvelin2
DepartmentsofAnatomy1 andAppliedPhysicsZ, Universityof
Kuopio, Kuopio,Finland
Aim of the study: To evaluate the interrelationship of stereologi-
cally estimated collagen amount and the superficial zone T2
relaxation time of magnetic resonance imaging (MRI) and the
surface ultrasound (US) reflection,
Methods: Bovine osteochondral samples were treated with
30U/ml collagenase or 0,1U/ml chondroitinase ABC for 44h; con-
trol samples were obtained at Oh and 44h (5-6 samples per group),
With articular surface perpendicular to the static magnetic field, T2
relaxation time in the most superficial tissue (0-78 ~m) was
determined from high resolution spin echo experiments at 9,4
Tesla, Also, the saline-cartilage interface reflection coefficient (%)
was determined from high frequency broadband pulse-echo US
measurements (mean frequency 22MHz, range 3-35MHz, -3dB),
For electron microscopy, zonal isotropic, uniform, random (IUR)
sampling of the specimens was performed for the most superficial
80 ~m, and interterritorial collagen volume (VV) and surface (SV)
density was indirectly estimated using average collagen fibril
diameter (d) and length density (LV), according to formulae:
VV=1t/4*E(d2 )*LV*100% and
SV=1t*E(d)*LV,
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Results: Average diameter of collagen fibrils decreased from 36 to
14 nm after collagenase digestion, VV decreased from 20 to 2%
and SV decreased from 0,019 to 0,005 nm2/nm3 (p<0,01, Mann-
Whitney U-test), LV of the collagen fibrils remained unchanged,
ranging from 0,000118 to 0,000174 nm/nm3 , After collagenase
digestion, superficial T2 relaxation time increased from 45 to 347
ms and US surface reflection decreased from 2,594 to 0,094%
(p<0,01), Stereological parameters, T2 relaxation time and US
surface reflection remained unchanged after chondroitinase ABC
digestion,
Conclusions: Collagenase caused significant fibril thinning and a
decrease in collagen volume without remarkable decrease in
observed fibril length, This change was effectively observed with
MRI and US techniques, The results confirm that both T2 and US
surface reflection in articular cartilage are strongly determined by
the integrity of the collagen network, Thereby, high resolution MRI
and US may provide sensitive probes for in vivo diagnostics of
cartilage quality,
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FTIR IMAGING SPECTROSCOPY OF REGENERATIVE
CARTILAGE
N Camacho, E DiCarlo, E Jones, N Atwan, R Warren, S Rodeo,
The HSS CartilageStudyGroup, Hospitalfor SpecialSurgery,
New York, USA
Aim: FT-IR Imaging Spectroscopy (FT-IRIS), a technique utilized
to evaluate the molecular components of tissues, was applied to
the study of compositional changes in native and regenerative
human articular cartilage,
Methods: FT-IRIS analysis was performed on paraffin-embedded
biopsies from patients with either a medial femoral condyle (MFC)
defect (n = 2) or a trochlear defect (n = 1), The MFC biopsies were
obtained at the point of autologous chondrocyte implantation
(ACI), The trochlear biopsy was obtained 20 months after ACI.
Biopsies were sectioned for FT-IRIS analysis and data acquired
from a 400 X 400 micron region at 7 ~m spatial resolution, Infrared
images were created based on integrated areas of collagen and
proteoglycan (PG) absorbances,
Results: In all biopsy samples, FT-IR imaging of the collagen
distribution enabled differention of native and regenerative carti-
lage, and chondrocytes (Figure 1A, B), The regenerative tissue
typically had a lower collagen content compared to native carti-
lage, and a distinct interface was present between the regenera-
tive and native tissue, The proteoglycan content of the
regenerative tissue was also lower than that of the native articular
cartilage (Fig. 1C), and the orientation of the collagen was
more random compared to the collagen in the native cartilage
(Fig.1D),
Figure 1. A) Light microscope image of unstained section of native
cartilage and regenerative tissue. Chondrocytes (ch) are also
visible. B) FT-IR image calculated from collagen amide I peak area
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shows distribution of collagen. C) PG distribution based on FT-IR
image calculated from PG peak. D) FT-IR image from polarized
data; A higher ratio indicates greater collagen fibril orientation
vertically.
Conclusions: These data demonstrate the utility of FT-IRIS in the
evaluation of cartilage repair tissue. The ability to simultaneously
obtain information on collagen and PG content, distribution, and
orientation, particularly in conjunction with standard histological
and molecular techniques, will enhance our understanding of
cartilage repair and aid the design of new methodologies for tissue
engineering.
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THE FEASIBILITY OF USING YOGA FOR TREATING
SYMPTOMS OF OSTEOARTHRITIS OF THE KNEES
W Matz, A Gilden Tsai, M Garfinkel, HR Schumacher, and
SL Kolasinski
Universityof PennsylvaniaSchoolofMedicine, Philadelphia,PA,
USA
The aim of this pilot study was to assess the feasibility of using
yoga as an intervention to treat the symptoms of osteoarthritis of
the knees.
Methods: Subjects were recruited from outpatient medical and
subspecialty practices at an urban tertiary care university medical
center. They fulfilled the Criteria for Idiopathic Osteoarthritis (OA)
of the Knee of the American College of Rheumatology (ACR).
Participants completed a medical history and physical examina-
tion, Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC), Arthritis Impact Measurement Scales 2 (AIMS2)
social, psychological and physical subsets, Patient Global Assess-
ment (PGA) by Visual Analog Scale (VAS), Physician Global
Assessment by VAS and 50' Walk Time prior to and following an 8
week program of yoga instruction. The course included weekly
90-minute group sessions with an instructor with over 25 years of
experience with Iyengar yoga.
Results: Eleven subjects enrolled and 9 attended at least one
session. Seven had data pre- and post-course available for analy-
sis; 1subject dropped the class due to an unrelated illness (pneu-
monia) and the other was unable to accommodate the class in her
work schedule. Participants had not previously practiced yoga and
served as their own controls. The 7 women who completed the trial
had a mean age of 58.6 (range:50-68) and a mean body mass
index of 35.6 (28.7-39.1). Statistically significant reductions in
WOMAC Pain (46.7%reduction;p=0.039), WOMAC Disability
(39.1%reduction;p=0.039) and AIM2 Affect (23.2%improve-
ment;p=0.002) were observed when participants were compared
to their pre-course status. Trends in improvement of symptoms
were measured in WOMAC Stiffness (39.0%reduction;p=0.06),
AIM2 Symptoms (36.5% improvement; p=0.1), PGA (29.5%
improvement; p=0.18) and Patient Global Assessment (24.1 %
improvement; p=0.22), but did not reach statistical significance.
The 50' Walk Time was unchanged. No participant experienced an
adverse event.
Conclusions: ACR management guidelines emphasize the impor-
tance of nonpharmalogic therapy for OA and recent evidence
supports exercise as a beneficial intervention. This pilot study
suggests that yoga provides an exercise option for previously
yoga-naIve, obese patients over age 50 and offers potential
reduction in pain and disability due to OA of the knee.
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SELF-MANAGEMENT METHODS AND THEIR EFFICIENCY
USED BY PATIENTS WITH OSTEOARTHRITIS AND
RHEUMATOID ARTHRITIS
o Veitiene, M Tamulaitiene
Instituteof Clinicaland ExperimentalMedicine, Vilnius, Lithuania
Aim of study: To investigate and compare the efficiency of
self-management methods used by patients with osteoarthritis
(OA) and rheumatoid arthritis (RA).
Methods: Patients with OA and RA were asked about self-
management methods which they have used regularly for the last
month, asked to choose the most effective ones (1-3) and evaluate
their efficiency by percentages. Age, length of time since OA and
RA was diagnosed, the active range of motion, manual muscle
testing (0-5 points), Barthel index were recorded.
Results: 50 women participated in the research: 25 with OA and
25 with RA. The age of the patients was 56-80. The average of
disease duration was 10.9 ( SO 6.2) years with OA and 13.9 (SD
9.1) with RA.
The research indicated that 28 patients: 10 with OA and 18 with RA
(p=0.02) used heat. The assisting devices and joint protection
were used by 24 patients: accordingly 16 with OA and 8 with RA
(p=0.028), and 11 with OA and 13 with RA. Only 22 subjects
regularly made exercises: 12 with OA and 10 with RA. The other
measures such as ice, relax exercises, splints were used only by a
few patients.
24 patients: 13 with OA and 11 with RA indicated that the most
effective self-management methods were exercises, heat was on
the second place, pointed by 13 patients (7 with OA and 6 with
RA), the assisting devices were pointed by 7 subjects (6 with OA
and 1 with RA). The other measures were indicated as less
effective.
18 patients: 11 with OA and 7 with RA evaluated the efficiency of
their used self-management measures 50 and more percentages.
Conclusions: There were not large difference between self-
management methods used by patients with OA and RA. More
subjects with OA then RA preferred assisting devices and less
ones used heat (p<0.05).
Exercises, heat and assisting devices were indicated as the most
effective self- management methods in both groups. The similar
amount of subjects evaluated the efficiency of methods as
effective.
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EXAMINATION IN OSTEOARTHRITIS RELIABILITY AND
STANDARDIZATION OF THE KNEE
J Cibere1•2 , N Bellamy3, A Thorne2, SM Esdaile,,2, K McGorm',
A Chalmers2, S Huang2, P Pelos04 , J Singer2, K Shojania,,2,
J Kopec"2.
'ArthritisResearch Centre of Canada, Vancouver,2University
ofBritishColumbia, Vancouver;3Universityof Queensland,
Brisbane,4Universityof Iowa, Iowa City.
Aim of study: To evaluate the benefit of standardization on the
reliability of the physical examination of the knee by rheumatolo-
gists.
Methods: Six subjects with mild to severe knee osteoarthritis (OA)
were examined by 6 rheumatologists experienced in the assess-
ment of knee OA using a 6x6 Latin square design. Subjects were
examined, followed by a standardization meeting (chaired by NB)
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Conclusions: Although moderate to very good agreement was
present prior to standardization, standardization further improved
knee assessment. This will be important for improved outcome
studies of early knee OA.
Gait (normal/abnormal) 0.76 0.89
Effusion-bulge sign (present/ 0.69 0.79
absent)
Medial tibiolemoral crepitus (0-2) 0.51 0.71
Patellolemoral tenderness 0.66 0.83
(present/absent)
End-ol-motion stress pain 0.40 0.80
(present/absent)
Alignment (degrees) 0.84 0.99
Hyperextension (present/absent) 0.49 0.94
Quadriceps strength (0-2) 0.94 1.00
Bony swelling (0-3) 0.44 0.67
and, a day later, by post-standardization examinations. The physi-
cal examination consisted of 41 knee examination maneuvers
including warmth, effusion, tenderness, crepitus, and range of
motion. The order of examinations was randomized for each
rheumatologist. For each physical examination item, data were
analyzed for agreement among all 6 rheumatologists. For dichoto-
mous and ordinal variables, raw agreement was calculated as the
proportion of perfect agreements between all possible pairs of
rheumatologists for all six subjects (denominator=90). Continuous
variables were analyzed by ANOVA, using the proportion of
variance due to rheumatologists to calculate the reliability
coefficient.
Results: Subjects' mean age was 62 years (range 44-74). Mean
WOMAC pain on walking was 10mm (range 0-25). Pre-
standardization agreement ranged from 0.40 to 0.94, while post
agreement ranged from 0.46 to 1.0. Post-standardization, agree-
ment improved by ::>0.05 in 63%, remained the same in .20% and
worsened by ::> 0.05 in 17% of items. One new item resulted from
the standardization meeting. Pre and post agreement for a select
number of physical examination findings are summarized:
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AN EVALUATION OF THE SAFETY AND EFFECTIVENESS OF
REPEAT COURSES OF HYLAN G-F 20 FOR TREATING
PATIENTS WITH KNEE OSTEOARTHRITIS
JP Raynauld1 , N Bellamy2, CH Goldsmith3 , P Tugwell4 ,
GW Torrance3 .5 , D Pericak5 , P Band6 , R Polisson?, D Belovich5
1UniversityofMontreal, Canada, 2Universityof Queensland,
Brisbane,Australia,3McMasterUniversity,Hamilton, Canada,
4UniversityofOttawa, Canada, 51nnovusResearch Inc.,
Burlington,Canada, 6New York University,New York, USA,
7Genzyme Corporation,Cambridge, USA.
A prospective, one-year, pragmatic, randomized controlled trial
was conducted to investigate the effectiveness and safety of
appropriate care with hylan G-F 20 compared to appropriate care
without hylan G-F 20 (AC) in patients with knee osteoarthritis (OA).
One course of hylan G-F 20 consisted of three intra-articular knee
injections one week apart and could be repeated during the
12-month study.
In a subgroup analysis, patients with one course of hylan G-F 20
and those with two courses or more (in the study knee) were
evaluated for effectiveness and safety. It was hypothesized that the
1-course and 2-course groups would both be superior to AC and
no different from each other.
The primary effectiveness measure was change in WOMAC pain
score at month 12 as a percent of baseline. The 1-course and the
2-course subgroups were similar to each other (41% and 35%
improved, difference not statistically significant with 70% power to
detect at least a 20% difference) and better than the AC group
(14% improved, p<0.05). Findings from the secondary effective-
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A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL
EVALUATING THE EFFECTIVENESS AND SAFETY OF
HYLAN G-F 20 IN PATIENTS WITH KNEE OSTEOARTHRITIS:
SIX MONTH CLINICAL RESULTS OF A SINGLE COURSE OF
TREATMENT
GW Torrance1 .2 , N Bellamy3, JP Raynauld4 , CH Goldsmith 1 ,
R Polisson5 , D Belovich2 , D Pericak2 , J Gough2
1McMasterUniversity,Hamilton, Canada, 21nnovusResearch
Inc., Burlington,Canada, 3Universityof Queensland, Brisbane,
Australia,4UniversityofMontreal, Canada, 5Genzyme
Corporation,Cambridge, USA.
A one-year, open-label, randomized, controlled trial was conducted
to evaluate the use of hylan G-F 20 in the treatment of knee
osteoarthritis (OA).
255 patients were randomized to "Appropriate care with hylan G-F
20" (AC+H) or "Appropriate care without hylan G-F 20" (AC).
Appropriate care was defined according to published guidelines.
All patients had clinically and radiologically-confirmed OA of the
knee, and had failed prior therapy with either non-steroidal anti-
inflammatory drugs or acetaminophen. An analysis of effective-
ness and safety of a single course of hylan G-F 20 was conducted
at six months, corresponding to the duration on the current product
label.
The primary effectiveness measure was the mean change in
WOMAC pain score in the study knee from baseline to month 6.
Both groups improved over time, however the AC+H group
improved by 24% more (p<0.0001). The AC+H group also had
superior outcomes in the two secondary effectiveness measures
(at least 20% improvement in pain, and at least 20% improvement
in pain and either stiffness or function, p<0.0001). All effectiveness
results were statistically significant and exceeded the pre-defined
clinically important differences. There were 68 local adverse
events (in 31 AC+H patients) that occurred within 48 hours of
an injection. The event rate related to hylan G-F 20 was 1.9% in
any knee.
Results support the use of hylan G-F 20 within current treatment
paradigms. Hylan G-F 20, used in conjunction with "appropriate
care", provides greater clinical effectiveness for primary and
secondary outcome measures over a six-month time frame.
ness measures (at least 20% improvement in pain, and at least
20% improvement in pain and either stiffness or function) were
consistent with those from the primary effectiveness measure. The
prevalence of local adverse events attributed as related to hylan
G-F 20 in any knee during the first course was 1.7% and 2.9% in
the second course.
Although this study was neither designed nor powered to examine
the effect of one course compared to two courses or more, the
subgroup analysis results support the effectiveness and safety of
multiple courses of hylan G-F 20 for treating patients with knee OA.
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RELIABILITY, VALIDITY AND RESPONSIVENESS OF A
SIMPLE INDEX FOR MEASUREMENT OF TREATMENT
EFFECTS IN LONGITUDINAL CLINICAL TRIALS OF
OSTEOARTHRITIS TREATMENTS
LO Brooks, M Rolfe, PA Cheras, SP Myers
AustralianCentre for ComplementaryMedicineEducationand
Research, UniversityofQueensland(Brisbane)and Southern
Cross University(Lismore),Australia.
Aim: To construct a simple, reliable and valid index of the severity
of osteoarthritis (OA) symptoms that is responsive to treatment
effects,statistically tractable and yields suitable power for analyses
in the context of longitudinal structural equation and hierarchical
linear models.
Agreement (pre) Agreement (post)Physical examination (scale)
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Methods: The proposed new instrument (COAT: comprehensive
OA test) consists of four 100mm VAS response scales for pain,
stiffness, difficulties with physical activities, and overall severity of
OA symptoms. Both the WOMAC instrument and the new COAT
instrument were completed by 125 subjects with clinical and x-ray
evidence of OA of the hips or knees in 3 treatment conditions each
week for 12 weeks. Cronbach's alpha coefficients were calculated
to assess the internal consistencies of the various scales. Con-
firmatory factor analyses were fit to assess the utility of the
WOMAC and COAT total scales in structural equation models.
Correlation coefficients between the WOMAC and COAT scales
were calculated to assess the validity of COAT against WOMAC.
Hierarchical linear models (observations within subjects, random
intercepts and slopes) were fit to compare the responsiveness of
the WOMAC and COAT total scales.
Results: The total WOMAC scale had a mean alpha of 0.98 and
the total COAT scale had a mean alpha of 0.97. In confirmatory
factor analyses, the COAT total scale fitted well to the data
(non-significant chi-squares and minimum goodness of fit index of
0.94), but the WOMAC total scale did not (chi-squares highly
significant and maximum GFI of 0.50). The mean correlation
between the WOMAC and COAT total scales was 0.92. The mean
improvement in the most active treatment was 34.7% (p=.013) and
27.1% (p=.022) for the COAT and WOMAC total scales respect-
ively. The focal treatment by time effect was also more highly
significant for COAT than WOMAC (p=0.00007 versus 0.00014).
Conclusions: All scales and sub-scales tested were highly inter-
nally consistent. The COAT but not the WOMAC total scale would
be expected to perform well in a structural equation model. High
correlations with the 'gold standard' WOMAC scales indicate that
the COAT scales are valid measures of OA symptom severity. The
COAT total scale was more responsive to treatment effects than
the WOMAC total scale.
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EVALUATION THE FACTORS THAT EFFECT THE SEVERITY
AND FUNCTIONAL ABILITY OF IRAQI ARAB PATIENTS WITH
PRIMARY KNEE OSTEOARTHRITIS
Sami Salman, Mahdi S. Hazim,
Departmentof Rheumatology,FacultyofMedicine, Universityof
Baghdad- IRAQ
Objective: to investigate the influences of age, sex, body mass
index (BMI), the Kellgren Lawrence Radiological Osteoarthritis
index (KLOAI) on the severity and functional ability of Iraqi Arab
patients with primary knee osteoarthritis (PKO).
Methods: 70 patients, 60 female, 10 male from our outpatient
clinic diagnosed as PKO according to American College of Rheu-
matology were involved in the study. Bilateral standing AP knee
radiography of all patients were taken and evaluated according to
the KLOAI. BMI was calculated as the weight in Kg divided by the
square of the height in meters.
Lequesne index (L1), painless walking distance (PWD), painless
walking duration (PWD1) were used to estimate the severity and
functional ability of the PKO.
Results: both women and men of high BMI had significant
association with the severity and functional ability of PKO. Severity
of PKO increased with age in both sexes. KLOAI greater than 2
has moderate association with PKO.
Conclusion: these data suggest that age, BMI are more important
factors than KLOAI in evaluation the severity and functional ability
of PKO.
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MUSCLE FUNCTION AND HIP MUSCLE CROSS-SECTIONAL
AREA IN MEN WITH AND WITHOUT HIP OSTEOARTHRITIS
MH Arokoski#, JPA Arokoski#, M Haara#, M Vesterinen#,
L Niemitukialf, HJ Helminen'
Departmentsof#Physicaland RehabilitationMedicine, flGlinical
RadiologyKuopioUniversityHospitaland 'Departmentof
AnatomyKuopioUniversity,Kuopio, Finland
Aims of the study: To study muscle function, hip muscle strength
and cross-sectional area (CSA) in men with osteoarthritis (OA)
compared to healthy controls.
Methods: Twenty-seven men (aged 47-64 years) with unilateral or
bilateral hip OA and 30 age-matched randomly selected healthy
men were studied. According to the side of the highest radio-
graphic score from the patients with clinical hip OA, 29.6% had
grade 1, 29.6% grade 2, and 40.8% grade 3 OA. The range of
motion (ROM) of the hip joint was measured with goniometry and
the Western Ontario and McMaster Universities (WOMAC) OA
index was determined. Musculoskeletal function was assessed by
ascending and descending stairs and 25 meter walk test. The
isokinetic hip flexion and extension strength (peak torque (Nm))
was determined using angular velocities 60o/sec and 120o/sec.
The CSA of the pelvic and thigh muscles was measured from
magnetic resonance images.
Results: The hip isokinetic flexion strength was 18-22% lower
(p<0.01) in OA SUbjects than in controls, but extension strength did
not differ between groups. In OA subjects, the hip flexion and
extension isokinetic strength values were 13-17% (p<0.05) lower in
the more deteriorated hip compared to the better hip side. The
CSA of the pelvic and thigh muscles did not differ between the
groups. However, in OA subjects, the CSA of the pelvic and thigh
muscles was 6-13% lower (p<0.05 - p<0.001) in the more severely
affected hip compared to the better hip side. Hip flexion, extension,
inner and outer rotation movements were 13%, 52%, 51% and
49% lower in the OA group than in the controls, respectively. In
WOMAC OA index both stiffness and function, but not pain were
positively related with radiographic severity of OA. The walking
speed was 15-19% lower (p<0.01) in the OA group than in the
control group.
Conclusions: Men with hip OA have significantly lower flexion
muscle strength than the age- and sex-matched controls. The
decrease of muscle size and hip pain may contribute to the
decrease of muscle strength in hip OA. The physical function tests
and WOMAC OA index are useful measures in evaluation of the
hip OA patients.
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INCREASED FEMORAL NECK BONE MINERAL CONTENT
AND BONE SIZE IN WOMEN WITH PRIMARY
OSTEOARTHRITIS
L Sandini', JPA Arokoski#, J Jurvelinlf, H Kroger'
Departmentsof 'Surgery, #Physicaland RehabilitationMedicine,
flGlinicalPhysiologyKuopioUniversityHospitaland Kuopio
University,Kuopio, Finland
Aims of the study: Bone changes are thought to be an important
etiological element in the pathogenesis of osteoarthritis (OA). Even
though clinical findings support the idea that primary OA (POA) is
associated with increased bone mineral density (BMD), the SUbject
remains controversial. Therefore the present study was initiated to
investigate the relationship between the primary POA and femoral
BMD.
Methods: The study population was a subgroup of the population-
based Kuopio Osteoporosis Risk Factor and Prevention Study
(OSTPRE) (n=13100), which contains dual x-ray absorptiometry
(DXA) measurements (bone mineral content (BMC), areal BMD
(BMDareal), and bone area) of the femoral neck of 2950 women
aged 47-56 years. The measurements were made twice, in
1989-91 (baseline), and 1994-97 (5-years follow-up). In 10-year
follow-up questionnaire (1999-2001), the medical history and cur-
rent diagnosis were asked. The diagnosis of POA was based on
medical records. Using the data from the validation of the diagno-
sis of the POA, the BMD data from baseline and 5-year follow-up
were obtained in 107 POA patients and 2316 healthy controls. The
BMD results were compared between the POA and the control
group using a general linear model with adjustment for age and
body mass index (BMI).
Results: After correction for age and BMI, we found no significant
difference in the femoral neck BMDareal of the POA patients when
compared to controls. However, in baseline the femoral neck BMC
was significantly higher (7.4%, p<0.01) in POA group than in
controls. The femoral neck area was also significantly higher
(3.8-4.1 %, p<0.001) in baseline and 5-year follow in POA group
than in controls.
Conclusions: The results suggest that women with POA do not
have increased BMD. However, they have larger femoral neck size
and consequently higher BMC compared to healthy controls.
PS134
TREATMENT OF OSTEOARTHRITIS IN THE PGH ARTHRITIS
CLINIC BEFORE AND AFTER PUBLICATION OF THE 1995
AMERICAN COLLEGE OF RHEUMATOLOGY GUIDELINES
EG Penserga, AA Lucero, IC Rivera
Sectioriof Rheumatology,Departmentof MedicineUniversityof
the Philippines-PhilippineGeneral Hospital,Manila, Philippines
Objective: To compare OA treatment before and after the publi-
cation of the 1995 treatment guidelines for OA of the hips, knees
and hands.
Methods: This is a descriptive, retrospective study, including
charts of patients who fulfilled the ACR clinical criteria for diagnosis
of hips, knees and hands OA, seen at the Arthritis Clinic of
UP-PGH in 1994 and 1999. Patients with secondary OA were
excluded. For 1994, only 44 charts were retrieved out of a total of
111 charts (43%), while for 1999, only 62 charts out of a total of 132
charts were retrieved (47%).
Demographic data and management strategies were compared
using a data collection form. Statistical difference was analyzed
using difference of two binomial proportions.
Results: In the post guideline era, patient education increased
(p<O.05), use of oral NSAIDs (p<O.05) and topical analgesics
(p<O.05) decreased, paracetamol prescription did not change but
more prescribed the opioid analgesic tramadol, although not
statistically significant, and there was an increase in the use of
intraarticular steroids (p<0.05) and drugs like glucosamine sulfate
and ginger extract HMP33.
Conclusion: There was a change in the treatment practices of the
physicians handling OA cases in UP-PGH. Whether these
changes are due to the effect of the ACR treatment guide-
lines cannot be made conclusively at this point because of the
limitations brought about by the study.
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THE ECONOMIC BURDEN OF OSTEOARTHRITIS IN THE
UNIVERSITY OF THE PHILIPPINES-PHILIPPINE GENERAL
HOSPITAL SETTING
EG Penserga, EO Salida, RN Eullaran
Sectionof Rheumatology,DepartmentofMedicine, Universityof
the Philippines-PhilippineGeneral Hospital, Manila, Philippines
Objective: The aim of this study is to quantify the direct and
indirect medical costs of the care of uncomplicated osteoarthritis in
the University of the Philippines-Philippine General Hospital.
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Methods: Review of charts, interviews of actual patients from the
Arthritis Clinic of the Philippine General Hospital using a question-
naire, cases taken from the Osteoarthritis Study Group Database,
hospital construction costs and cost of laboratory tests and medi-
cines provided data to generate a model on direct and indirect
costs of treatment. Direct costs of treatment include drug and
non-drug treatment modalities received by the patients and labora-
tory tests. Indirect costs include capital outlay, maintenance and
operating expenses of the physical plant, wages lost and other
costs like food and transportation expenses incurred.
Results: Fifty-one consecutive osteoarthritis patients seen at the
Arthritis Clinic of the Philippine General Hospital were interviewed.
The OA Study group Database showed that an average of 60 new
osteoarthritis cases were seen each year in the same clinic.
Indirect costs of treatment amounted to P803,854.23 (US$
16,077.00), mainly from maintenance and operating expenses and
capital outlay of the clinics. Meals of the patients and accompany-
ing persons came next and last were the cost of transportation.
Direct costs amounted to P647,016.00 (US$12,940.00) with a
large part (90%) spent on medicines, and the rest on laboratory
tests. The annual cost of treating uncomplicated osteoarthritis in
the Philippine General Hospital Arthritis Clinic is P1, 450,870.20
(US$29,017) or P28, 448.43 (US$ 569.00) per patient.
Conclusion: The economic burden of osteoarthritis is substantial.
Using a COPCORD prevalence data of osteoarthritis in a Philip-
pine urban setting of 4.1 % and the Philippine population of 76.4
million as of 2001 , the estimated osteoarthritis cases is 3.3 million.
This translates to enormous expenditure for uncomplicated oste-
oarthritis in a country like the Philippines. Contributors to indirect
costs as seen in other countries like, wages lost, is uniquely absent
from our data. Our population of patients is consistent with Filipino
family structure where a member or so is not gainfully employed
and is able to accompany the patient to the doctor's clinic. Also
not computed are incremental costs attributable to disease
progression.
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VALIDATION OF THE MULTIDIMENSIONAL HEALTH
ASSESSMENT QUESTIONNAIRE IN MEASURING QUALITY
OF LIFE OF FILIPINO PATIENTS WITH OSTEOARTHRITIS
EG Penserga, AT Dytan
PhilippineRegionalClinicalEpidemiologyResourceand Training
Center, Department of Medicine, Universityof the Philippines,
Manila, Philippines
Objectives: This study aims to validate the Multidimensional
Health Assessment Questionnaire (MDHAQ), in measuring the
quality of life profile of Filipino patients with osteoarthritis.
Methods: The MDHAQ was tested for content validity among
Filipino patients with osteoarthritis by transtlation of the MDHAQ
into Filipino by the Sentro ng Wikang Filipinoof the University of
the Philippines and back translated. The Filipino questionnaire was
administered by a Rheumatology fellow-in-training to 79 cases of
osteoarthritis (ACR). Patients were instructed to answer the ques-
tionnaire and given the choice not to answer or mark the specific
question or activity which he thinks is not part of his daily activities.
Note was taken if any of the items was inappropriate, difficult to
answer, or not fully understood. Statistical analysis for Domain 1
(18 items) and Domain 2 (8 items), tested for internal consistency
or homogeneity of scale, using item-total correlation and Cron-
bach's alpha.
Results: Seventy nine- patients were included in the study. For
Domain 1, 2 items, #13 (Drive a car 5 miles from your home) and
# 14 (participate in sports and games as you would like) had the
most number of missing values (patient chose not to answer). Two
strategies were used to assess internal consistency of the Domain
1items: 1) items 13 and 14 included and 2) items 13 and 14
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excluded. Using the 2nd strategy, Domain 1 consisted of 16 items
having a scale-reliability coefficient of 83%. All items of Domain 2
were answered. Item-correlation and Cronbach's alpha analysis
showed a reliability coefficient of 78%. The VAS for pain showed a
mean of 4.1 +1- 3.2 cms and that for fatigue was 5.2+1-3.5.
Conclusion: A 26-item modified health assessment questionnaire
for Filipino patients with osteoarthritis was generated in this study.
Domain 1 has a reliability coefficient of 83% and Domain 2, 78%.
This questionnaire will be utilized in quality of life studies to be
undertaken.
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THE COMPARATIVE EFFICACY OF DIFFERENT SCHEMES
OF OSTEOARTHRITIS TREATMENT
VM Kovalenko, NM Shuba, OP Bortkevich, LB Sholokhova
M.D.StrazheskoInstituteof cardiologyofAMS of Ukraine,
UkrainianRheumatologicCentre, Kyiv
Aim of the study: to compare efficacy of NSAID (diclofenac) with
combination of NSAID (diclofenac) with chondroprotector (alflutop)
and oral enzyme (flogenzym) in the treatment of osteoarthritis.
Methods: 57 patients with II-III stage gonarthrosis (12 men, 45
women; mean age 57, 1±7,2, mean disease duration 5,8±2,2) were
included in the study. The pts were divided in 3 groups: 20 pts of
the first one (AFD-group) took alflutop (1 ml i/a every other day 5
then 1 ml/day i/m for 15 days), flogenzim 3 tab tid and diclofenac
50 mg bid for 3 weeks; 20 pts of the 2nd group (FD-group) took
f10genzim and diclofenac as above described; 17 pts of the 3'd
group (D-group) took diclofenac 100 mg/day for 21 days. For
efficacy assessment we used before and after treatment and then
every three months for half a year algofunctional indexes, VAS of
pain, range of motion, quality of life index EuroQol-5D, standart
blood analysis.
Results: After 3 weeks of treatment we documented the best
results in AFD- and FD-groups (p<O,OI); in the D-group results
were less significant (p<0,05). The long-period (0,5 year) obser-
vation of pts has showed that in the pts of 1st group, those were
received the most complex therapy, the distant results of the
treatment were the best. There was observed the optimal "keep-
ing" of achieved clinical improvement, while in the 3rd group such
"keeping' was practically absent (the investigated parameters
were not distinguished from initial levels by the 6 months of
observation). The analysis of quality of life index EuroQol-5D
showed the statistically significant improvement of the OA patients'
quality of life under the complex treatment by chondroprotectors,
oral enzymes and NSAIDs.
Conclusions: The "triple" therapy of the osteoarthritis (chondro-
protectors, oral enzyme and NSAIDs) is the optimal method of
such patients treatment.
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THE ESTIMATION OF ANTLINFLAMMATORY AND
IMMUNOMODULATORY ACTIVITY OF SYSTEMIC
ENZYMOTHERAPY (SE) IN PATIENTS WITH
OSTEOARTHRITIS
Kovalenko VN', Pishak OV, Shuba NM'
M.D.StrazheskoInstituteof Cardiology',Kyiv, BukovinskaState
MedicalAcademy, Tchernovtsy,Ukraine
Aim of the study: to optimize the complex treatment of pts with
OA by application of SE and to determine clinical efficacy of SE
(course and long-period treatment by medications Wobenzym or
Phlogenzym) by the data of investigation of SE action' mecha-
nisms, including immunomodulatory and anti inflammatory.
Methods: By the data of experimental, byochemical, immunologi-
cal and cell investigations we have evaluated the clinical efficacy of
SE in OA pts. There were determined in biological fluids of these
pts (synovial fluid, blood) such laboratory parameters, as IL-IB,
TNF-, TGF-B1, the activity of antioxidative enzymes, the functional
activity of cell and humoral factors of nonspecific reactivity of
organism.
Results: In the early period of experimental OA increase of IL-I B
in targeted tissues is associated with mechanisms of synoviocy1es'
and chondrocy1es' damage, whereas application of SE (Phlogen-
zym, Wobenzym) leads to significant increase of TGF-B1 levels,
and decrease of IL-1 BTNF-Ievels, as well as normalize of plasma
IgA, M, G, and functional activity of cell and humoral factors of
nonspecific reactivity of organism. The optimal regimens of
SE-treatment was elaborated depending on clinical course of OA.
It was determined also, that under the treatment by Wobenzym
clinical course of OA is modified (clear 4 periods: initial exacer-
bation, following by unstable remission, than secondary exacer-
bation and finally - the stable remission.
Conclusions: Application of SE in complex treatment of OA is
effective and safe method of disease-modifying therapy. SE may
be used in long-period treatment of OA.
PS139
PROGNOSIS OF NSAID5-INDUCED GASTROTOXICITY AND
ITS CORRECTION WITH DIMEPHOSPHONE
Ziganshina LE, Titarenko AF, Valeeva ICh,
Chaziachmetova VN and Ziganshin AU
Kazan State MedicalAcademy,
Kazan State MedicalUniversity,Russia
The objective of the study was to evaluate changes in lipid
peroxidation (LP) and anti-oxidant system (AS) of osteoarthritis
patients and healthy volunteers after acute indometacin pharma-
cological test with the a.im of developing prognosis criteria of
NSAIDs-induced gastrotoxicity. The effectiveness of dimephos-
phone was evaluated. Dimephosphone is a newly developed
Russian monophosphonate - medicine with antioxidant and
chondrocyte protective effects.
Method: 30 volunteers and 35 osteoarthritis patients were enrolled
in the study. The age of all the participants was 17 - 70 years.
Acute pharmacological Indometacin test (PhIT), dimephosphone
and placebo treatment as well as endoscopic examination were
carried out after obtaining written informed consent. LP and AS
characteristics were measured in venous blood before and after
indometacin 75 mg ingestion.
Results: On the basis of the LP and AS changes after PhlT the
patients were divided into 2 groups - "resistant" and "vulnerable".
Gastro-duodenallesions were detected in "vulnerable" patients. In
the group of "resistant" patients and in healthy "resistant" volun-
teers PhlT caused activation of glutathion buffer. Dimephosphone
treatment of osteoarthritis patients (being treated with NSAIDs for
years) caused decrease of intensity of LP, activation of glutathion
system and enhancement of resistance towards NSAIDs-induced
gastrotoxicity with simultaneous healing of gastro-duodenal
lesions.
Conclusion: PhlT is a sensitive and specific prognostic test for the
risk of development of NSAIDs-induced gastrotoxicity and dime-
phosphone can be used for prophylaxis of gastro-intestinal lesions
caused by NSAIDs.
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TRIAMCINOLONE HEXACETONIDE THERAPY COMPARED
TO NIMESULID IN KNEE OSTEOARTHRITIS
CONCLUSION: Consequently RBF was not effected from the long
term administration of therapeutic doses of these two NSAIDs
-<:elecoxib 200 mglday and tenoxicam 20 mg/day- when assessed
using a sensitive and reproducible CDS technique.
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EFFECT OF CELECOXIB VERSUS TENOXICAM ON RENAL
BLOOD FLOW IN PATIENTS WITH KNEE OSTEOARTHRITIS
o Ardicoglu. E Kocakoc, S Ozgocmen, A Ardicoglu, H Gudul,
Z Bozgeyik
Dept. ofPM&R, Divisionof Rheumatology,Depts. of Radiology,
Urology, Firat University,FacultyofMedicine, Elazig, Turkey
OBJECTIVES: Adverse renal events associated with the use of
NSAIDs are based on inhibition of prostaglandin (PG) formation
and the potential of COX-2 inhibitors to cause these events
depends on the relative role of COX-2 in the formation of renal
PGs. We proposed to assess the effect of celecoxib and a
conventional NSAID -tenoxicam- on renal blood flow (RBF) of
patients with knee osteoarthritis (OA).
METHODS: A total of 33 patients with knee OA included into the
study. Patients who had evidence of renal dysfunction and
history of diabetes, hypertention or drug history effecting renal
hemodynamics were excluded. Patients randomly assigned as
celecoxib (C) and tenoksicam (T) groups. C group consisted 17
patients (14 F, 3 M; mean age 54.8+/-10.0, and mean disease
duration 6.5+/-6.3 years) received 200 mg celecoxib once daily.
T group 16 patients (13 F, 3 M; mean age 52.6+/-7.1, and mean
disease duration 4.4+/-3.3 years) received 20 mg tenoxicam
once daily. Patients underwent color doppler sonographic (CDS)
examination following blood chemistry and urine analysis. Left
and right renal CDS (from both upper and lower poles) studies
were performed in the morning and in a fasting state with the
patieJlts in decubitus position. All of the patients were examined
by the same radiologist using a 3.5 MHz convex probe was
used. Maximum systolic velocity (SV), end diastolic velocity (DV),
and indices of pulsatility (PI=(SV-DV)/mean velocity) and resis-
tivity (RI=(SV- DV)/maximum systolic velocity) were measured
without angular correction at the beginning and at the fourth
week of treatment.
RESULTS: None of the parameters measured at the beginning
and fourth week of the treatment was significantly changed both in
C group and T-group. There was also no significant difference in
these measurements between groups (Table I).
C 0.62 0.62 1.1
T 0.62 0.63 1.1
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EVALUATION OF CHRONIC LOW BACK PAIN THERAPY
WITH ETORICOXIB USING THE ROLAND-MORRIS
DISABILITY QUESTIONNAIRE.
from June 2000 to October 2001. Patients were divided in two
groups. First group included 27 patients treated with Nimesulid 100
mg twice a day, Ranitidin 150 mg once a day and physical therapy
during three weeks. Second group included 15 patients treated
with intra-articular injection of 40 mg Triamcinolone hexacetonide
and physical therapy during three weeks.
RESULTS: According to establish criteria at 2 (7,45) patients
treated with Nimesulid at first week there was no therapy's effect,
after three weeks 5 (18,5%) patients and after 3 months 15
(55,5%) had recidivate of disease, and 5 (18,5%) patients felt good
after 6 months. At 1 (6,6%) of patient treated with Triamcinolone
hexacetonide after 3 weeks, at 2 (13,3%) patients after 3 and 6
months observed receive of disease. But 10 (66,6%) patients felt
good after 6 months, also.
CONCLUSION: Our study showed that intra-articular injection of
Trimamcinolone hexacetonide is better than Nimesulid therapy, in
combination with physical therapy.
GP Geba1 , NR Bohidarl, WL Straus1 , I Noblel, and RA
Petruschke1
1Merck and Co., Inc., West Point, PA (USA).
We evaluated the efficacy of etoricoxib 60 mg and 90 mg for the
treatment of chronic low back pain (LBP) using the Roland-
Morris Disability Questionnaire (RMDQ). The RMDQ contains 24
questions validated for assessing functional status achieved with
therapy for LBP. A total of 644 patients were assigned to receive
daily etoricoxib 60 mg (n=212) or 90 mg (n=213), or placebo
(n=219) in two randomized, placebo-controlled 3 month trials.
The RMDQ was included as a secondary endpoint administered
during office visits at baseline and 1, 2, 4, 8, and 12 weeks.
Patients answered "yes" or "no" to 24 questions, with the global
score analyzed as a time weighted average ranging from 0 (no
pain) to 24 (unbearable pain). An additional analysis was per-
formed to evaluate patient's response to each of the 24 individual
questions on the RMDQ. Demographics were similar among the
treatment groups. The average duration of LBP was 12 years.
Reduction in RMDQ score over the 12 week study was greater
with etoricoxib 60 mg and 90 mg than with placebo. Treatment
difference from placebo was significant (P<0.001) for etoricoxib
60 mg and 90 mg . Clinically significant differences were
observed between placebo and etoricoxib 60 mg and 90 mg by
Week 1, which were maintained throughout the study. The
improvement observed with etoricoxib on each of the 24 ques-
tions on the RMDQ was consistent with summarized global
scores. Etoricoxib at doses of 60 and 90 mg daily provided
significant improvement in functional status assessed with the
Roland-Morris Disability Questionnaire. Improvement was
observed as early as 1 week after initiation of therapy and was
maintained over the 3 months of the trial.
PI2
1.1
1.1
Left
RI2 PI1
0.62 0.61 1.1
0.61 0.62 1.1
PI2 RI1
1.1
1.1
Right
RI2 PI1RI1
Nenad Prodanovic, Biljana Bozic', Dejan Miljkovic, Ljiljana
Petrovic Rackov, Ljubisa Arsic, Rajko Popovic, Ivan Zgradic
MilitaryMedicalAcademy, Clinicof rheumatologyand clinical
immunology,Institutefor medicalresearch, Belgrade
OBJECTIVES: Gonarthritis is a slOWly evolving disease of knee
cartilage degeneration characterized by gradual development of
knee joint pain, crepitus, limitation on motion and stiffness less
than 30 minutes.
METHODS: Our study included 42 patients, average age was 67
years (from 52-77) with visual analog scale (VAS) score of pain on
motion of 40 mm and Lawrence radiographic score of great II-III,
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DAILY ACTIVITIES OF OSTEOARTHRITIS PATIENTS ON
ETORICOXIB VERSUS NAPROXEN
E Hunsche, 0 Geling, SX Kong, OJ Watson
OutcomesResearch, Merck & Co. Inc., WhitehouseStation,
New Jersey;RutgersUniversity,Piscataway,New Jersey;and
Merck Research Laboratories,West Point, Pennsylvania,USA
Aim of study: To evaluate the improvements of daily activities
according to the items of the physical functioning subscale of
WOMAC in OA patients treated with etoricoxib, naproxen or
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placebo in the 12-week portion of two 1-year phase III clinical
efficacy trials in OA.
Methods: Data were from two replicate (one multinational and one
US-based), multicenter, randomized, parallel-group, double-blind
clinical trials enrolling patients with OA of the knee or hip who had
worsening symptoms (flare) upon discontinuation of prior NSAID
therapy. Patients were randomized to etoricoxib 60mg once daily
(N=436), naproxen 500mg twice daily (N=435) or placebo
(N=108). The physical functioning questions (WOMAC) were
assessed by the patient on a 100-mm VAS scale ranging from "no
difficulty" to "extreme difficulty". Analyses were done on all
patients randomized (except those without baseline or post-
baseline observations). Semilog regression analyses were per-
formed to estimate how much less difficulty in performing daily
activities was reported at week 12 by patients on etoricoxib and
naproxen compared to those on placebo, after adjusting for
baseline values.
Results: There were no significant differences at baseline in the
distribution of answers to the individual items of the physical
functioning subscale (WOMAC). At week 12, the percent decrease
in the difficulty of performing daily activities with both etoricoxib and
naproxen was statistically significantly better than placebo for all
17 measured activities.
Conclusion: Both active treatments resulted in significant
improvement in the ability to perform daily activities compared with
placebo. There was greater reduction in difficulty of performing
daily activities with etoricoxib than with naproxen in 11 of the 17
physical functioning items, although these differences were not
statistically significant.
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THE SOCIAL AND EMOTIONAL WELLBEING OF
OSTEOARTHRmS PATIENTS IS IMPROVED BY ETORICOXIB
AND NAPROXEN
E Hunsche, 0 Geling, SX Kong, DJ Watson
OutcomesResearch, Merck & Co. Inc., WhitehouseStation,
New Jersey;RutgersUniversity,Piscataway,New Jersey;and
Merck Research Laboratories,West Point, Pennsylvania,USA
Aim of study: To evaluate improvements in OA patients treated
with etoricoxib, naproxen or placebo on individual items of the
social functioning, role-emotional and vitality subscales of the
SF-36 in the 12-week portion of two 1-year phase III trials
in OA.
Methods: Data were from two multicenter, randomized, parallel-
group, double-blind clinical trials enrolling patients with OA of the
knee or hip who had worsening symptoms (flare) upon discon-
tinuation of prior NSAID therapy. Patients were randomized to
etoricoxib 60mg once daily (N=436), naproxen 500mg twice daily
(N=435) or placebo (N=108). SF-36 data were collected at
baseline, week 4 and week 12. Analyses were done on all
patients randomized (except those without any baseline or post-
baseline observations). For all individual items, the percentage of
patients who improved at least one category at week 12 from
baseline was used as the key outcome measure. Categories
were based on a 5-point Likert scale for social functioning,
6-point Likert scale for vitality and yes/no-categories with regard
to role-emotional.
Results: There were no significant differences in the baseline
distribution of answers to the individual items of the SF-36.
Patients on etoricoxib and naproxen had numerically greater
improvements than those on placebo in all 9 measures and
statistically significant improvements in 6 and 5 of the measures,
respectively.
Conclusion: Etoricoxib and naproxen significantly reduced the
impact of patients' emotional problems on work, daily activities and
social life compared to placebo. In addition, both treatments
increased the vitality of the patients compared to placebo. The
results of these specific outcomes are important from the perspec-
tive the patient and may be more meaningful than the analysis of
aggregated QoL subscales.
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THE PHYSICAL FUNCTIONING OF OSTEOARTHRITIS
PATIENTS ON ETORICOXIB AND NAPROXEN
E Hunsche, 0 Geling, SX Kong, DJ Watson
OutcomesResearch, Merck & Co. Inc., WhitehouseStation,
New Jersey;Rutgers University,Piscataway, New Jersey;and
Merck Research Laboratories,West Point, Pennsylvania,USA
Aim of study: To evaluate improvements of individual items of
the physical functioning and role-physical subscales of the SF-36
in OA patients treated with etoricoxib, naproxen or placebo in the
12-week portion of two 1-year phase III clinical efficacy trials
in OA.
Methods: Data were from two replicate (one multinational and
one US- based), multicenter, randomized, parallel-group, double-
blind clinical trials enrolling patients with OA of the knee or hip
who had worsening symptoms (flare) upon discontinuation of
prior NSAID therapy. Patients were then randomized to etoricoxib
60mg once daily (N=436), naproxen 500mg twice daily (N=435)
or placebo (N=108). SF-36 data were collected at baseline, week
4 and week 12. Analyses were done on all patients randomized
(except those without any baseline or post-baseline observa-
tions). For each individual item of the subscales analyzed, the
percentage of patients who improved at least one category at
week 12 from baseline was used as the key outcome measure.
Categories were "a lot limited", "a little limited", "not limited" or
"yes", "no".
Results: There were no significant differences in the baseline
distribution of answers to the individual items of the SF-36.
Patients on etoricoxib and naproxen had numerically greater
improvements in all 14activity measures than placebo. The differ-
ences in improvement between etoricoxib and placebo and
between naproxen and placebo were statistically significant in 12
of the 14 measures (p < 0.05).
Conclusion: Etoricoxib and naproxen significantly improved
SF-36 physical functioning and role-physical domain scores
indicative of patient daily physical activities compared to placebo.
The impact of etoricoxib on specific physical activities and the
ability to work are important for the patient.
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ROFECOXIB IMPROVES QUALITY OF LIFE IN HIP AND
KNEE OA PATIENTS
R Theilerl, H Bischoff, M Goodl, D UebelharP
Depts ofRheum. & PMR, City HospitalTriemli'and University
Hospitaf,Zurich/Switzerland,Div of Rheum., Immunologyand
Allergy,Brighamand Women~ Hospital, Boston/USA2 •
The primary aim of this study was to test the hypothesis that
. patients with activated OA pain flares due to knee or hip OA not
sufficiently responding to conventional NSAID therapy can be
adequately treated with rofecoxib 25mg/day with further improve-
ment of their quality of life. Secondary aims were to measure the
effects of NSAID treatment and to quantify the percentage of
patients who require concomitant gastroprotective medication
such as PPl's during the drug treatment period. Finally a new
electronic version of the WOMAC 3.1.LK should be validated in a
multisite setting.
Methods: A total of 134 elderly patients, mean age 69.1 +/- 8 yrs,
with symptomatic hip or knee OA were intially included, then
screened and those fulfilling the inclusion criteria were switched
from conventional NSAID therapy to rofecoxib 25mg daily for 3
weeks. Patients were instructed to record their consumption of
paracetamol or any other analgesic rescue medication as well as
gastroprotective medication in a diary. At each control visit (day
7,14,21), a clinical examination and a self-assessment by filling out
the SF-12 and the WOMAC 3.1 LK questionnaire were performed.
Half of the study sites (10/20) used additionally the electronic
WOMAC version. Two weeks after the end of the drug therapy with
rofecoxib, a telephone survey was done to record the ongoing drug
consumption.
Results: Quality of life measured by the SF-12 physical function
score significantly improved. The relative treatment effect after 3
weeks of treatment was 29 % for pain, 25 % for stiffness and 24 %
for function. At the end of the study 54% of patients continued the
drug therapy with rofecoxib, where as 31% switched back to
another drug (mostly diclofenac). Only 8 % of patients needed
comedication due to adverse GI-symptoms. A high agreement was
observed between both the paper and the computer format of the
e-WOMAC and all users were able to handle the computerized
interview quite well.
Conplusions: In this 3-week duration study, rofecoxib im-
proved the quality of life of hip and knee OA patients not
responding to conventional NSAID therapy. In addition, the
e-WOMAC appears to be a suitable tool to assess OA patient in
clinical trials.
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LOCALIZATION OF EXOGENOUS GLUCOSAMINE IN
CULTURED CHONDROCYTES
Kathryn Evans and Sunetra Ekanayake;
Ocean NutritionCanada Ltd., 1721 Lower Water Street, Halifax,
Nova Scotia, Canada B3J 1S5
Glucosamine is widely used as a treatment for osteoarthritis. A
recently published clinical study indicates a structure-modifying
effect of glucosamine on joint cartilage (Reginster et al. (2001)
Lancet, 357:251-6). Glucosamine is a structurally important mol-
ecule in cartilage as it is a building block of certain glycosaminogly-
cans including hyaluronic acid. In addition, glucosamine may have
inhibitory effects on aggrecanase, an enzyme that breaks down
proteoglycans (aggrecan) of cartilage (Sandy et al. (1998) Bio-
chem. J. 335: 59-66). However, actual mechanism of action of
glucosamine in reducing arthritic symptoms is not fully understood.
To examine whether exogenous glucosamine is selectively utilized
by chondrocytes in building cartilage tissue, we compared the
localization of radio-labelled glucosamine and glucose in cultured
chondrocytes using micro-autoradiographic methods. Our results
indicate that glucosamine is rapidly absorbed by chondrocytes and
utilized in the synthesis of cartilage extracellular matrix.
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ORAL CHONDROITIN SULPHATE IN KNEE OA PATIENTS:
RADIOGRAPHIC AND DENSITOMETRIC OUTCOMES OF A
TWO-YEAR PROSPECTIVE STUDY
D Uebelhart1, D Hauser1, G Goerres2 , E Vignon3 ,
F de Vathaire4 , D Frey1, HJ Hauselmann1, G Stucki1,
P BrOhlmann 1, BA Michel 1
1) Dept. of Rheumatology,InstituteofPhys. Med., 2) Div. of
NuclearMedicine, UniversityHospital,Zurich, CH 3) Dept. of
Rheumatology,CHU Lyon-Sud,Pierre Benite, F 4) INSERM Unit
521, Gustave RoussyInstitute,UniversityofParis XI, Villejuif,F
Aims of the study: 1°) to evaluate the efficacy of chondroitin
sulphate (CS, Chondrosulf~ 800, tablets) as a Structure Modifying
Drug in knee OA (SMOAD), 2°) to assess the effects of CS on the
evolution of spinal and femoral bone mineral density (BMD) in
knee OA patients.
Methods: One-centre, randomised, double-blind, placebo-
controlled (PBO), two-year prospective (Phase III) clinical trial. A
total of 300 patients of both gender, aged > 40 with clinically
symptomatic knee OA, Kellgren & Lawrence score I-III, were
recruited and randomly allocated to CS or PBO groups. Both
knees were radiographed in standard upright AP and in PA Schuss
20° flexion incidence at entry and after 2 years. The target knee
was defined upon entry. X-rays were blindly measured at the end
of the study using a validated digitized image analysis system.
Spinal and femoral bone mineral density (BMD) was measured by
DEXA upon entry, month 12 and 24 using an Hologic R QDR-4500
densitometer.
Results: A total of 219 patients completed the two-year treatment
period. Data of the femoro-tibial joint space (JS) of the target knee
measured in Schuss incidence are provided. All completers (PP)
with a min. JS width >=1 mmat entry were initially analysed. Both
the min. JS width and the mean JS thickness did significantly
decrease in the PBO group whereas they did not change in the CS
group. The evolution was significantly different between both
groups. The JS surface area showed a trend to decrease in the
PBO group (ns) whereas it did not vary in the CS group. The
evolution between both groups was not significantly different. Data
of the intent-to-treat (ITT) analysis did confirm these results. The
spinal and femoral DEXA analysis is ongoing and will be provided.
Conclusion: The measurement of the femoro-tibial joint space
narrowing (PP and ITT) using quantitative digitised X-ray image
analysis does confirm the efficacy of CS in this 2-year duration trial.
Chondroitin sulphate therefore also qualifies as a Structure Modi-
fying Drug for the treatment of OA (SMOAD). The question of a
potential effect of CS on the evolution of spinal and femoral bone
mineral remains open at this stage.
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EFFECT OF INTRA-ARTICULAR HYLAN GF-20 (SYNVISC)
ON SYNOVIAL FLUID AND CLINICAL PARAMETERS
H.Bagga, D.Burkhardt, D.Morris, P.Ghosh, L.March
InstituteOf & JointResearch, RoyalNorth Shore Hospital,
SydneyAustralia
Aim: To compare the concentration of hyaluronan (HA) and
sulfated Glycosaminoglycans (GAGs) in synovial fluid, pre-, and 3
and 6 months, post intra-articular injection of Hylan G-F20 (Syn-
visc), in 30 subjects with OARSI grade 1 and 2 osteoarthritis of the
knee. Results of the first 8 patients are presented.
Method: 30 patients with OARSI grade 1-2 knee osteoarthritis had
at least 0.5mls of synovial fluid aspirated from the study knee pre
Synvisc injection. Subjects then received 3 x weekly intra-articular
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injections and synovial fluid was aspirated where possible on each
occasion. Subjects were then invited back 3 and 6 months post
injection to undergo repeat synovial fluid aspiration of at least
0.5mls. Primary endpoints included synovial fluid HAconcentration
& molecular weight determination, viscosity & S-GAG levels.
Secondary endpoints included magnetic resonance imaging (MRI)
of the study knee at baseline and 6 months, and blood and urine
was collected at baseline, 3 & 6 months for biomarker analysis.
Results of HA concentration and S-GAG levels are presented for
the first 8 patients. Synovial fluid (HA) concentration was deter-
mined using Uronic acid assay and S- GAG concentration using
the Farndale assay. Pre and post synovial fluid HA and S-GAG
levels were compared using Wilcoxon signed-rank test.
Results: A mean increase from baseline of 21% (median 15%) in
synovial fluid HA concentration was observed over a mean of 3.75
months (p<0.03). A small trend towards an increase in synovial
fluid S-GAG levels was observed over this time, but was not
statistically significant. A median decrease of 58% (P<0.01) in pain
scores on a visual analog scale and a 40% (P<0.02) median
decrease in total WOMAC scores were observed over the same
time period.
Conclusion: Synovial fluid HA concentration was increased by a
median of 15% on baseline levels (p<0.03), 3.75 months post
intra-articular Hylan GF20 injection. This is the first report showing
sustained increases in synovial fluid HA concentration after treat-
ment with intra-articular Hylan. Given the time frame, this is
consistent with increased HA biosynthesis by synovial cells sug-
gesting potential for disease modification with (Synvisc) therapy.
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INTRAARTICULAR INJECTION OF HYALURONAN
SUPPRESS DESTRUCTION OF ARTHRITIC JOINTS IN RA
PATIENTS
M Tsuji, M Tanaka, N Tanabe, Y Itoh, T Nishizawa, K Fujii
Dept ofOrthopaedicSurg. The Jikei Univ. SchoolofMedicine,
Tokyo, JAPAN
The aim of this study was to assess the therapeutic effect of
hyaluronan on rheumatoid joint destruction.
Methods: Hyaluronan (mw. 200kDa) or saline was injected intraar-
ticulary to the finger PIP joints of collagen-induced arthritis (CIA) in
monkeys. Two female patients with rheumatoid arthritis (RA) of the
knee were assigned to receive arthroscopic observation of the
knee joint with synovial biopsy before and after intraarticular
injection of hyaluronan. Paraffin sections of the injected joints were
subject to immunohistochemical study.
Results: Hyaluronan reduced the production of cytokines by
synovial cells and chondrocytes, and the subchondral accumula-
tion of osteoclasts-like cells in monkey CIA. Hyaluronan also
reduced not only the clinical symptoms, but the staining for MMPs
and T cell invasion in synovial tissue of the knee joints in RA
patients.
Conclusion: Intraarticular injection of hyaluronan significantly
suppressed the synovial inflammation and the progression of
osteochondral destruction in CIA and RA. These findings demon-
strate beneficial effects of hyaluronan on the affected joints of RA
patients.
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EFFECTS OF LOW·INTENSITY ULTRASOUND ON THE
UPTAKE OF INJECTED HYALURONATE INTO SYNOVIUM
KH Jang, S-H Park*, SR Park**, C-Z Jin***, S-I Chung,
S-H Min***
Cell and Tissue engineeringLab, Duplogen, Suwon, Korea
Departmentof BiomedicalEngineering,Ajou University,Suwon,
Korea*
DepartmentofPhysiology,Inha University,inchon,Korea**
DepartmentofOrthopedicSurgery,Ajou University,Suwon,
Korea***
Aim of study: The objective of this study was to examine a
possible effects of L1US on the absorption of larger and small HA
molecules into synovium and consequential interaction of
absorbed HA with the synovial tissues.
METHODS: Preparation of fluorescein-labeled HA
High molecular weight HA (3000kDa) and small molecular weight
HA (1000kDa) were supplied from LGCI (Daejon, KOREA).
Labeled HA with fluorescein amine was injected into the joint
cavity of adult New Zealand white rabbits through the patellar
tendon with a needle point placed at patellofemoral joint to avoid
damage to the synovial membrane. The joint of right knee
was stimulated for 10 min every day using continuous wave at
the frequency 1MHz signals with intensity of 400 mW/cm2 for
13day. The left knee joint was exposed to sham ultrasound as a
control.
The measurementof labeledHA in synovialfluid
0.1 ml volume of synovial fluids were collected on the 1st day, 4th,
7th, 10th day after injection of HA. Fluorescence intensity in each
collected sample was measured with a spectrofluoremeter at
400-550 nm.
HIstologicexaminationofsynovIal
SynOVia were removed from certain portions of the medial
parapatella synovium in the knee joints at thirteen days after the
last L1US stimulation. The synovial tissues were fixed and these
samples were embedded in an O.C.T. compound at -80 or
in paraffin. Cryosections were cut at 5by a cryostat, and
fluorescein-labeled HA were observed under fluorescence
microscope. Paraffin sections of the samples were cut at 5 by
microtome. The sections were stained with hematoxylin and
eosin.
P5152
SAFETY AND EFFICACY OF FERMENTATlON·DERIVED HIGH
MOLECULAR WEIGHT SODIUM HYALURONATE - A
CLINICAL TRIAL IN PATIENTS WITH OSTEOARTHRITIS OF
THE KNEE
JI Thompson1, YW Huang2 and R Zaibel3
1DePuy InternationalLtd, Leeds, UK, 2BiotechnologyGeneral
Corp., Iselin, USA, 3BiotechnologyGeneral (Israel) Ltd.,
Rehovot, Israel
Aim of S1udy: To assess the performance of high molecular
weight, fermentation derived sodium hyaluronate as a treatment
for knee osteoarthritis in a randomised, prospective, multi-centre,
double blind, active control clinical trial.
Methods: The 321 patient study was designed to test for non-
inferiority of fermentation derived sodium hyaluronate (NaHA,
20mg / 2ml syringe, average molecular weight 3.0 MDa, DePuy
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improvement for SPS (p<0.05). G6 patients continued to demon-
strate statistically significant improvements (from the three injec-
tions baseline) for SPS by injection five and SPW by injection six
(p<O.05).
ANOVA '(base-3inj/-6inj) p<0.05 *(3inj-6inj) p<0.05
Exercise induced pain was significantly reduced in G6 patients for
both SPS and SPW by the forth injection (p<O.05) and continued to
improve to injection six (p<0.01).
Sodium hyaluronate appears to improve function and load bearing
of osteoarthritic joints by improving the synovial fluid properties.
SUbsequently, improved usage of the joint appears to reduce the
pain associated with mobility. Pain reduction may not be an
appropriate primary measure for SH efficacy.
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INTRAARTICULAR HYALURONIC ACID IMPROVES
SYMPTOMS IN "GOLFER'S TOE"
RJ Petrella, MD DiSilvestro, A Cogliano
Canadian Centre forActivityandAging, Universityof Western
Ontario, London,Canada.
Osteoarthritis of the great toe is common in the older golfer and
can lead to progressive decrease in range of motion and pain at
the first metatarsophalangeal joint. This condition can impact
participation in this popular activity for a significant population at
risk.
We investigated the impact of intraarticular injection of hyaluronic
acid in golfer's presenting with osteoarthritis of the first metatar-
sophalangeal joint. Fifteen consecutive male patients (mean age
73 years; BMI 27.2) referred for pain and loss of range of motion in
the great toe that was interfering with participation in regular golf
activity were recruited. All patients had clinically significant reduc-
tion of range of motion associated with pain at rest and worse with
walking and driving activity during golf in one great toe. All patients
had grades 1-3 hallux rigidus according to the Regnauld classifi-
cation, were currently using non-steroidal anti-inflammatory medi-
cations and continued this treatment throughout the study period.
No other modalities of therapy were used during the study period.
Baseline measures of rest pain using VAS scale, activity level,
metatarsophalangeal joint range of motion, 10-metre tip-toe walk-
ing VAS,
WOMAC-VAS pain, stiffness and function scales and global patient
satisfaction were compared to measures after 4 months. Intraar-
ticular hyaluronate Suplasyn (20mg/ml, 0.5ml) was injected using a
25 gauge needle with the first metatarsophalangeal joint in flexion.
Injections were delivered in unblinded fashion by an experienced
physician once-weekly for 8 consecutive weeks. We used Wil-
coxon paired risk tests to compare outcomes for each grade of
hallux rigidus.
At 4 months, significant improvement (p<0.05) in rest pain, activity
level, tip-toe walking pain, range of motion and global patient
satisfaction was observed for all 3 grades. WOMAC-VAS was
significantly improved for pain and stiffness for grade 1 and 2
hallux rigidus but not grade 3. No change in the WOMAC function
subscale was observed in any group.
Intraarticular hyaluronic acid improved pain and function up to 4
months and appears to be an effective therapy for Golfer's Toe.
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SODIUM HYALURONATE FOR FUNCTIONAL IMPROVEMENT
OF THE OSTEOARTHRITIC KNEE - THREE AND SIX
INJECTIONS
RJ Petrella1, SJ Alkemade2 , VA Salvatori3
1Centre forActivityandAging, U. Western Ontario, London,
Canada:2BioMedEx,Arva, Canada: 3BionicheLife Sciences,
Belleville,Canada
Osteoarthritis of the knee is a debilitating disease that can severely
hinder the mobility of patients. Until recently, continued usage of
the joint was accomplished by decreasing the pain and inflamma-
tion with corticosteroids or long-term therapy with analgesics
and/or nonsteroidal anti-inflammatory drugs (NSAIDs). Viscosup-
plementation with weekly intra-articular injections of sodium
hyaluronate (SH) is currently used as an adjunctive or alternative
treatment to improve the rheological properties of the synovial fluid
and result in an improvement in joint function.
A randomized, double-blind study was conducted to determine the
functional improvement from baseline with three and six injections
of SH (Suplasyn'", Bioniche Life Sciences, Canada). Each patient
was evaluated one week after each injection for self-paced walking
and stepping times (SPW and SPS) and VAS pain associated with
these functions.
There was no statistical difference between the evaluated patients
in either group at baseline (six injections, n=52 and three injec-
tions, n=50 ) with respect to sex, age or osteoarthritic grade.
FollOWing three injections, G3 patients and those receiving three of
the six injections demonstrated a statistically significant improve-
ment for SPW (p<0.05). G6 patients also showed a statistical
•.!--:r---,.---;:---;:---,;:----!12
,.t-----------~
Conclusions: This study has shown that fermentation derived,
high molecular weight sodium hyaluronate is a safe and effective
treatment for osteoarthritis of the knee. Non-inferiority relative to a
current treatment was demonstrated, in conjunction with reduced
usage of escape medication, and a statistically and clinically
significant reduction in knee effusion.
International Ltd.) relative to a widely used animal derived cross-
linked hyaluronate derivative (XLHA, 16mg per 2ml syringe, aver-
age molecular weight 6.0 MDa, Genzyme Biosurgery). In each
case, three weekly intra-articular knee injections were adminis-
tered. The primary performance endpoint was the change in the
mean of five pain parameters at 12-week end-point using the
Western Ontario McMaster University Osteoathritis (WOMAC)
Index on a 0-100 mm horizontal visual analogue scale (VAS).
Consumption of escape medication was assessed as a secondary
outcome measure. Adverse events were monitored throughout
the study.
Results: A statistically significant reduction in pain compared to
baseline was observed for both NaHA and XLHA groups (see
figure). The reduction in pain was greater for the NaHA group,
although this difference was not statistically significant. Signifi-
cantly fewer patients in the NaHA group used escape medication
than in the XLHA group. Thirteen cases of joint effusion were noted
in the XLHA group compared to only one for NaHA (p=0.0015);
other differences in adverse event profile were not significant.
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PREDICTORS OF PREVALENT LUMBAR SPINE
INTERVERTEBRAL DISC DEGENERATION: THE CHINGFORD
STUDY
G Hassett. D J Hart, D V Doyle, N Manek and T D Spector
Twin Research & GeneticEpidemiologyUnit, St Thomas'
Hospital, London, UnitedKingdom
Aim: Few epidemiological studies have reported the prevalence
rates or identified the risk factors for the individual features of
lumbar spine disc degeneration in the general population. We
therefore examined for the prevalence rates and the predictors of
radiographic lumbar spine intervertebral disc degeneration in a
population-based cohort of women.
Method: 796 paired lateral lumbar spine x-rays taken at entry to
the study and at year 9 were examined. The films were read by one
experienced reader for the individual features of anterior osteo-
phytes (AO) and disc space narrowing (DSN) using the Lane
grading score and an overall Kellgren and Lawrence grade (KL) at
each lumbar disc space L1-5. Prevalent cases were defined as the
presence of KL 2+ or a Lane grade of 2+ for either AO or DSN in
at least one of the four disc spaces. Predictors of prevalence
including age, body mass index (BMI), smoking, ERT, physical
activity, back pain, presence of OA at the hip, hand and knee were
examined using logistic regression. In the analysis adjustments
were made for age and BMI.
Results: At entry the mean age was 53.8 ± 6 years and BMI 25.4
± 4.0 kg/m2 . Prevalent cases of AO = 33%, DSN =12% and
KL=56% at entry. There was a significant increase over 9 years in
the prevalence of degeneration of the lumbar spine in both overall
grade and for the individual features, ranging from 14 -22%
(p<0.001). Peak rates of prevalence at entry for AO was L2/3
(17%) and for DSN was L4/5 (7%). PrevalentAO were predicted by
age, BMI (p=0.05), knee osteoarthritis (p=0.05) and back pain
(0.03). Prevalent DSN was predicted by age, knee osteoarthritis
(p=0.01), back pain (p<0.001).
Conclusions: Prevalence rates of lumbar spine disc degeneration
increased significantly with age for the individual features of both
AO and DSN. Risk factors for the individual features of AO and
DSN of lumbar spine intervertebral disc degeneration include age,
BMI, back pain and baseline osteoarthritis at other sites. These
factors appear to be site and feature specific.
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THE PRIORITY SETTING IN OSTEOARTHRITIS PROJECT:
EVIDENCE·BASED HEALTH SECTOR WIDE MODELLING OF
HEALTH OUTCOMES, ECONOMICS, AND QUALITY OF LIFE
L Segall, RH Osborne2 , S Day1, A Chapman1
1Health EconomicsUnit, Centre for Health ProgramEvaluation,
Monash University,Australia.2Centre for RheumaticDiseases,
The UniversityofMelbourne, Royal MelbourneHospital
Introduction: Priority setting in health is necessary for govern-
ment health agencies to ensure limited resources are allocated to
areas of greatest efficiency, thus producing the largest possible
health gain across the population. Little research has been con-
ducted to determine the most appropriate method of priority
setting.
Aims: (1) Establish the appropriate priority setting modelling
methods and, (2) Identify a disease for model application - to test
and refine the model, which has (a) a substantial disease burden
through morbidity and loss in quality of life (QoL) rather than
mortality; (b) imposes a large cost on the health care system, and
(c) has diverse interventions/disease stages.
Results: Osteoarthritis (OA) was chosen for priority setting mod-
elling, using a Health Sector Wide Disease Based Model (HSW-
DBM) -incorporating an expert panel. OA is very common and has
a substantial impact on the health of individuals and on the health
care system. Published evidence of effectiveness of each possible
intervention type (from community health promotion to orthopaed-
ics and covering a range of modalities such as media, education,
prescription drugs, complementary medicines, physical therapies
and surgery) were reviewed. As disease burden largely occurs
through loss of QoL rather than mortality, we explored methods of
comparing outcomes from disparate interventions. The use of
QALYs (quality adjusted life years) was chosen in preference to
the popular DALY (disability adjusted life year) as DALYs were too
insensitive for OA. Conversion of common OA outcome measures
(eg WOMAC &SF-36) to QoL (utility) equivalent scores have been
undertaken for inclusion in cost-utility analyses. The costs of
interventions were determined using published reports and unit
cost information. Marginal programs are identified from the cost-
utility analyses, to find programs with high costs per QALY, that
could be contracted, and those with low costs per QALY that could
be expanded.
Conclusion: Our evidence-based priority setting procedure is able
to identify priority areas for OA treatment, (and those that warrant
contraction). We have also identified gaps in the literature that
suggest priority areas for research.
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3 YEARS DOWN THE TRACK: PATIENT EXPENDITURE AND
OUTCOMES FOLLOWING PRIMARY AND REVISION TOTAL
HIP & KNEE REPLACEMENT
L March, M Cross, H Lapsley, K Tribe, B Courtenay, MJ Cross,
L Pinczewski, S Ruff, M Coolican, M Neale, S Quain,
F Robertson, W Walter, B Zicat, P Brooks
UniversityofSydney, RNSH, St Leonards;Universityof New
South Wales, St Vincent'sCampus, Mater Misericordiae
Hospital, Sydney
OBJECTIVE: To compare out-of-pocket expenditure & health
status of patients undergoing revision hip (rTHR) & knee (rTKR)
replacement with those undergoing primary hip (THR) & knee
(TKR) replacement 3 years post-surgery.
METHOD: 3mth Diaries recording costs for medications, profes-
sional visits, tests, equipment, services, and SF-36 & WOMAC
completed pre-op, and at 1 and 3yrs post-op.
RESULTS: Data were analysed from 52 THR, 19 rTHR, 62 TKR
& 10 rTKR. rTKR were significantly older than TKRs (74.3 vs
69.7yrs). No difference was seen in age between rTHR & THR
(66.8 vs 62.5 yrs). Average out-of pocket expenditure for 3mth
periods leading up to 1 and 3 years post-op: THR $58, $36
(p=0.036), rTHR $43, $43, TKR $97, $210, rTKR $52, $32 -
differences between primary & revisions for mean total costs and
for proportion of patients having no arthritis related expenditure
were not significant. All patients except those with rTKR
improved from pre- to 1year post-op in WOMAC Pain, Stiffness &
Function and there was no further change from 1year to 3years.
Pre-op, no differences were found between primary & revision
WOMAC scores for hips or knees. By 1year post-op, rTKR
reported worse WOMAC Pain and Function than TKR and at
3years rTKR reported worse Stiffness. There was no difference
in WOMAC scores at 1year or 3years between rTHR and THR.
81% of TKR, 50% of rTKR, 81% of THR and 68% of rTHR were
satisfied with the outcome at 3yr follow-up. The majority of
respondents would still have the replacement if they could go
back in time: 84% of TKR, 87% of rTKR, 98% of THR and 74%
of rTHR.
CONCLUSION: Revision hip or knee replacement patients did not
have greater out-of-pocket costs at 1 and 3 years post-surgery
than primaries but rTKR reported worse function 1yr post-op than
their primary peers. Despite this, many revision patients were
satisfied with the outcome & would still go through the replacement
procedure again if they could turn back the clock.
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IMPACT OF "LOCUS OF CONTROL" ON OUTCOMES OF HIP
& KNEE REPLACEMENT (THR & TKR) FOR
OSTEOARTHRITIS
KL Tribe 1, HM Lapsley 1, LM March 2, MJ Cross 2,
B Courtenay 1 & PM Brooks 3
1. DepartmentofMedicine, UniversityofNew South Wales
3.Health Sciences, Universityof Queensland;2. Universityof
Sydney, Dept ofRheumatology,RoyalNorth Shore Hospital,
NSW,/2065, AUSTRALIA
TKR and THR for OA have become some of the most commonly
performed operations in the developed world. While they are
known to be cost-effective procedures, they are placing a rapidly
increasing financial burden on all health systems, thus strategies
for maximising their benefits should be a priority.
The aim of this paper was to explore the association between an
OA patient's perceived locus of control of their disease and their
health outcomes following THR and TKR surgery.
115 people with OA (52 THR & 63 TKR) completed pre &
post-operative SF-36 and WOMAC questionnaires up to 12
months after the operation. A Multi-dimensional Health Locus of
Control questionnaire (MHLC) was also completed.
At 12 months post TKR, patients showed a significant correlation
between higher Internal MHLC scores and lower pain scores
(r=-0.3, p=0.021), better physical function (r=0.3, p=0.013) and
better general health (r=0.3, p=0.027). These patients also tended
to have better mental health and vitality scores pre-operatively but
no difference in pre-operative pain or physical function suggesting
that they may have a greater gain from the surgery than those
with lower internal control scores. The TKR patients with higher
Chance scores were more likely to live alone and showed a trend
towards poorer physical function, general health and mental health
at 12 months post-operatively (r=-0.3, p<0.05) but not pre-
operatively.
Among THR patients higher Internal control scores correlated with
better physical and social function pre-operatively but no signifi-
cant correlations were seen with post-op outcomes. THR patients
who had higher External Control scores were more likely to report
needing help from family and friends and at 12 months post-op
had poorer general health, mental health, social and physical
function and higher pain scores than those with lower External
scores.
Locus of disease control appears to influence health outcomes,
particularly following TKR, showing positive correlations with
higher Internal control scores and better physical function and pain
scores. Those with higher Chance and External scores tended to
have poorer post-op function, general and mental health. This
warrants further investigation if we wish to optimise the benefits
from these important and common interventions.
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TOTAL KNEE REPLACEMENT SURGERY AS AN
INDEPENDENT RISK FACTOR FOR FALLING IN THE FRAIL
ELDERLY
Lyn March, C Chen, J Schwarz, J Zochling, J Makaroff,
A Brnabic, I Cameron, R Cumming, S Lord, P Sambrook
Universityof Sydney Instituteof Bone & JointResearch,
Royal North Shore Hospital, St Leonards2065, AUSTRALIA
Falls are a major problem in the elderly. This large prospective
study is one of few to be conducted in residential care,
where simple measures of risk are urgently required. Knee OA
and joint replacement (TKR) were evaluated as possible such
factors.
Residents of randomly selected nursing homes (NH) and hostels in
Northern Sydney were interviewed. Demographic data, cognitive
status, Implicit Review of General Health and measures of
strength & balance including quadriceps strength (OMS) were
collected. Falls data were recorded prospectively for a minimum of
6 months.
There were 977 residents (458 NH & 519 hostel), with mean age
85 years and 74% females. Almost 2,500 falls were recorded. Fall
rates were not affected by gender or type of residence. There was
no difference in the rate of falls between those with & without OA
knee (1.86 vs 1.93 per person/yr), nor was there any difference in
mean Ouad Strength (OMS) (18.90 vs 19.85). Those with a past
history of TKR had a significantly higher rate of falls than those
without (2.51 vs 1.88/person/yr), not explained by difference in
OMS (18.88 vs 19.56) or age (85.8 vs 84.8 yrs). A Cox proportional
hazards model evaluated the time to first fall. After adjusting for
other known risk factors for falling, history of TKR (Hazard Ratio
(HR) 1.44, 95% CI 1.01-2.08, p=0.047) was an independent
predictor together with past history of falling (HR 1.46, p=O.OOO),
poor general health as judged by nurse Implicit Review (HR 1.75,
p=0.045), age (HR 1.02, p=0.02), lower weight (HR 1.01, p=0.012),
incontinence (HR 1.31, p=0.006), poor cognitive scores (HR 1.02,
p=0.003) and fair/poor balance (HR 1.35, p=0.023) when com-
pared to good balance. Residents unable to stand unaided had a
much lower risk of falling.
A number of readily identifiable factors may prove useful to screen
in this frail elderly population, including a past history of TKR.
Further exploration of what places the knee joint replacement
patient at risk for falling is warranted.
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HIP FRACTURES DUE TO OSTEOPOROSIS DO NOT HAVE
HIPOA
Thorvaldur Ingvarsson1,Olafur Ingimarsson1,2,Elvar Orn Birgisson
1L Stefan Lohmander2
1UniversityHospital,Akureyri,Icelandand2LundUniversity
Hospital,Sweden
Objectives: To describe the prevalence of hip OA in patients,
which have sustained hip fractures due to osteoporosis and
compare that with the expected prevalence of hip OA in the
population.
Patients and Methods: All patients with hip fractures which where
treated at the Hospital in Akureyri Iceland during 1982-1994 where
included in the study. All available radiographs where studied and
the following measurements where made. Type of fracture, Mini-
mal joint space where measured by quantitative and qualitative
methods (mm, K&L and Burnet et al.). The diagnosis of hip OA was
made by minimal joint space (MJSP) less or equal than 2.5 mm or
K&L higher or equal than II.
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Results: Of the 355 patients with hip fractures it was possible to
identify and measure 325 or 650 hips. The mean age of the
patients where 80 years at the time of fracture. The prevalence of
hip OA where 6.2 % compared to the expected prevalence of 26%
(p<0.001). Most of the hips with MJSP 2.5 mm or less, and as such
diagnosed with hip OA had no other signs of hip OA such as
osteophytes or cysts.
Conclusions: The prevalence of Hip OA is significantly less than
expected in the population with hip fractures. The majority of the
OA hips had no other signs of OA. This can strengthen the possible
inverse relationship of hip OA and osteoporosis, which can have
different genetic aetiology.
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CROSS SECTIONAL STUDY OF FACTORS ASSOCIATED
WITH EARLY OSTEOARTHRITIS IN HIP DYSPLASIA
Y-J Kim, D Burstein, D Jaramillo, ML Gray, and MB Millis
Departmentof OrthopaedicSurgery, Children'sHospital,Boston,
MA 02115
Aim: Severity of dysplasia has not been demonstrated to be
predictive of early OA when assessed using plain radiographs. We
have utilized the delayed Gadolinium Enhanced MRI of Cartilage
(dGEMRIC) technique to measure early OA and attempted to
correlate this with measures of dysplasia severity.
Methods: Skeletally mature or nearly mature hips with develop-
mental dysplasia and without prior acetabular osteotomies were
included. Standing pelvic radiographs and false profile views were
obtained. dGEMRIC scans of both hips were obtained after double
dose intravenous injection of Magnevist. The average T1 value of
the acetabular and femoral cartilages was calculated as the
dGEMRIC index (DI). The presence of a labral tear was deter-
mined using the indirect arthrogram effect of the Magnevist injec-
tion. Pain was assessed using the WOMAC questionnaire. The
lateral center-edge (LCE) angle of Wiberg, break in Shenton's line,
anterior center-edge angle of Lequesne (ACE), and minimum joint
space width (JSW) were measured. Two-tailed t-test was used to
determine significance. All values are given as mean ± SD.
Results: 68 hips in 43 patients were imaged. The age ranged from
11 to 47 years with mean age of 29 years. The dysplasia severity
was stratified as follows: normal: LCE > 20, mild: 15 < LCE 20,
moderate: 5 < LCE 15, severe: LCE 5. Normal hips had DI of 573
±91 msec, n=9. Mildly (549 ± 73 msec, n=1 0) and moderately (511
± 104 msec, n=21) dysplastic hips had a decrease in DI, indicating
more OA, but they were not significantly different from normal.
Severely dysplastic hips had a significant decrease (p<0.0001) in
DI (419 ± 82 msec, n=27). The mean age in each group was not
significantly different. When only the hips with labral tears were
compared, the moderately (465 ± 76 msec, n=6) dysplastic hips
had a significant decrease (p<0.05) in DI compared to normals.
The mean age was not significantly different. The presence of a
labral tear in the severely dysplastic group did significantly
(p<0.05) decrease the DI. Surprisingly, the presence of subluxation
did not significantly affect the DI. When the moderately dysplastic
group was stratified into two groups according to age, the older
than 30 years group had a significant decrease in DI (p<0.005) and
JSW (P<0.01) compared to the younger than 30 years group. The
average LCE and ACE did not significantly differ.
Conclusions: The dGEMRIC data seem to suggest that in this
young adult group hips with severe dysplasia and moderate
dysplasia with labral tears have early OA. The presence of a labral
tear is associated with more OA in the severely dysplastic hips.
Moderately dysplastic hips appear to develop more OA with age.
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MINIMAL 5-YEAR RESULTS FOR AN ANATOMIC
CEMENTLESS FEMORAL PROSTHESIS FOR OF A
DEVELOPMENTAL DYSPLASIC HIP IN JAPANESE
Tanzo Sugimori, M.D., Mitsuru Nishino, M.D., Ayumi Kaneuji,
M.D., Tadami Matsumoto, M.D.
Departmentof OrthopedicSurgery, Kanazawa Medical
University,Ishikawa, Japan
Aim of study: The results of 102 total hip arthroplasties (THA) for
osteoarthritis with a minimum follow-up of 5-years, in which a
hydroxyapatite-coated Anatomic femoral prosthesis (Zimmer, War-
saw, IN) was used, were reviewed retrospectively. The purpose of
this study was to analyze radiographic findings and evaluate the
stability of this prosthesis for a developmental dysplasic hip in
Japanese.
Methods: Radiographic evaluation was performed to all 102
patients at the most recent follow up and the Japan Orthopaedic
Association (JOA) score system was incorporated into the clinical
evaluation. In addition, 5 patients were selected for each of three
different types of proximal femoral configuration classified accord-
ing to our method on the preoperative radiographs, that is, typeA:
the configuration is the same as normal, typeB: the posterior cortex
inclines anterior, typeC: the medial cortex is steeper. We investi-
gated the frequency of radiolucency around the component for
each of the three types statistically.
Results: At a mean follow-up interval of 86 months (range, 60-118
months), an improvement was observed in the overall JOA score
with 44 points. Two (2.0%) femoral components were revised
secondary to aseptic loosening. Review of postoperative radio-
graphs revealed spot weld formation in 89 (87.3%) THAs, proximal
stress shielding in 17 (16.7%) THAs. Radiolucent lines were
observed in 12 (11.8%) THAs as a whole; however, lucencies all
around the component were observed in only 2 (2.0%) THAs.
Femoral osteolysis was observed in the proximal region of the
femur in 18 (17.6%) THAs; however, distal femoral osteolysis
observed in only 1 (1.0%) THA. In the frequency of radiolucency
for each of the three different types, radiolucent lines in typeA were
significantly less than in typeB and C in proximal region.
Conclusion: The anatomic cementless femoral component was
well fixed to the femur in Japanese osteoarthritis patients; how-
ever, radiolucent lines in typeB and C were significantly more than
in typeA in proximal region. This suggests that this prosthesis does
not fit some types of femur of developmental displasic hip due to a
deformity of the proximal femoral canal.
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FEMORAL CANAL CLASSIFICATION FOR OSTEOARTHRITIS
SECONDARY TO DEVELOPMENTAL DYSPLASIA OF THE
HIP
Ayumi Kaneuji, Mitsuru Nishino, Tanzo Sugimori, Masataka
Ogawara, Tadami Matsumoto
DepartmentofOrthopaedicSurgery, Kanazawa Medical
University,Ishikawa, Japan
Aim of study: The aim of this study is to clarify the three-
dimensional (3-D) morphological features of femurs secondary to
developmental dysplasia of the hip (DDH).
Methods: One hundred-nine femurs with osteoarthritis (OA)
secondary to DDH (group OA) and thirty-six normal femurs as
control (group N) were the subjects of this study. A 3-D virtual
femur model was produced in each subject from computed
tomography images using a computer aided design system. The
3-D model's inclination angles for each canal line on the frontal
and sagittal planes were measured and cross-sectional plane
shape was identified by moment of inertia. The neck shaft angle,
anteversion angle, neck length and neck off set were also
measured in the 3-D models.
Results: The femoral canal was classified into four types, A, B, C
and D, based on the distribution differences of the proximal
inclination angles in frontal and sagittal planes. Either triangular or
circular shapes were identified at the proximal cross-section. Type
A, which was considered standard type, accounted for 89% of
group N, and for 40% of group OA. Type B, which had a proximal
posterior canal plane inclined strongly towards the anterior,
accounted for 26% of group OA, and had a significantly larger
anteversion angle (P<0.05) and the shortest femoral neck of all the
other femoral canal types (P<0.005). Type C, which had a steep
inclination of the proximal medial canal, accounted for 30% of
group OA, and had a significantly larger neck shaft angle than
other types (P<O.OOOl). Type C had large number of circular shape
in the cross sectional plane of the subjects. Type D, whiCh had the
two special features of both type B and type C, accounted for 4%
of group OA.
Conclusions: The femoral canal with OA secondary to DDH was
classified into four types based on the proximal inclination angles
in frontal and sagittal canal lines. This classification has expressed
not only differences of canal shape but also other features in the
femur with OA secondary to DDH.
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ENDOGENOUS CANNABINOIDS IS ONE OF THE
CANDIDATE FOR LIPID MEDIATOR THAT CAUSE BONE
CEMENT IMPLANTATION SYNDROME
T Motobe, T Hashiguchi, T Uchimura T Onishi, I Maruyama,
S Komiya
Departmentsof OrthopaedicSurgeryand; Laboratoryand
MolecularMedicine, FacultyofMedicine, KagoshimaUniversity,
KagoshimaJapan.
Aim of study: Acute hypotension, hypoxemia, cardiac arrhyth-
mias, cardiac arrest are well recognized complications during
cemented hip arthroplasty procedure, called bone cement
implantation syndrome (BCIS). Cannabinoids are reportedly to be
strong vasodilators, and endocannabinoids are involved in hypo-
tension in hemorrhagic and septic shock. We sought to deter-
mine whether endocannabinoids influence hemodynamic
variables in BCIS.
Methods: 35 hips were assigned to one of two groups. Group 1
consisted of fifteen patients who had the femoral component
inserted without cement, Group 2 comprised sixteen patients who
had the component inserted with a conventional cementing tech-
nique. The serum concentrations of anandamide and
2-arachidonoylglycerol were examined by HPLC.
Result: Time-course analysis revealed a rapid increase in can-
nabinoids levels after femoral component insertion with cement.
Conclusions: We report here for the first time that endogenous
cannabinoids is one of the candidate for lipid mediator that cause
bone cement implantation syndrome.
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BONE MINERAL DENSITY IN PATEINTS WITH KNEE
OSTEOARTHRITIS (OA)
Roya AbharL Sahba Chehrehei, Jafar Forghanizadeh
Iran Universityof medicalSciences, Tehran, Iran
Aim: Osteoarthritis (OA) Osteoporosis are both common disorders
with high prevalence in older age population. It seems that OA
might have protective effect on progression of Osteoporosis. This
875
study is designed to measure Bone Mineral Density (BMD) in
patients with knee OA.
Methods: In a cross sectional study, 50 patients with knee OA
according to the physical examination and x-ray findings were
selected. Patients who has other conditions which affect bone
mineral density were excluded. BMD (AP spine, Femur) measured
by DEXA method for patients who had Knee osteoarthritis.
Results: 94% of patients were female and 6% were male. Their
mean age was 60.5+11 years, mean weight was 63.16+18..9 kg
and mean height was 156.58+9.3 cm. 82% had moderate and 18%
had sever OA. 50% of patients has osteoporosis (T score<-2.5) ,
22% had osteopenia (T score<-l) and 28% of patients had normal
BMD ( T score >-1). There was no significant statistical correlation
between patients' BMDs and severity of OA.
Conclusion: In this study Bone Mineral Density of 72% of patients
with knee osteoarthritis was less than normal values.
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EXTRACORPOREAL SHOCK WAVES TREATMENT OF
RESISTANT CHRONIC TENDINITIS WITH ORTHOSPEC
JG Bloch, V Diebolt, C Kanmacher, D Kieffer, JC Martin,
R Meyer, P Niederberger, C Offner
Enthese Center, Strasbourg,France. E-mail:
dr.jgblochwanadoo.fr
Summary: We have completed an open study of 193 patients
presenting chronic tendinitis not responsive to any medical treat-
ments, treated with extracorporeal shock waves. Evaluation at 1
month showed for all locations 77% excellent and good results,
10% poor results and 13% failures.
Materials and Methods: The study was conducted in the Enthese
Center in Strasbourg. It is equipped with an Orthospec, which is a
hydroelectric system. No X-ray or ultrasound imaging was used.
Local anaesthesia was not needed. The sessions were given at 15
days intervals.
Results: The average age of the 193 patients was 54 years (15 to
88). The average duration of symptoms was 22 months (1 to 240).
The average number of sessions was 3 (1 to 10, SD = 1,28). The
results were as follows:
TOPOGRAPHY/ Excellent Good Poor Nul
RESULTS
ALL LOCATIONS N=193 52% 25% 10% 13 %
SCHOULDER N066 40% 36% 12% 12%
PLANTAR FASCIA N=45 60% 18% 7% 15%
LATERAL EPICONDYLE N=34 47% 24% 15% 14%
ACHILLES'S TENDON N=16 63% 19% 12% 6%
MEDIAL EPICONDYLE N=IO 70% 10% 0% 20%
MEDIUM GLUTEAL N=7 75% 25% 0% 0%
TROCHANTERIC BURSiTIS N=12 67% 8% 17% 8%
PATELLAR TENDON N=3 67% 33% 0% 0%
Discussion: There are differences in the characteristics of the
shock waves produced by the different technologies which deter-
mine whether X-ray or ultrasound imaging is needed for treatment
and whether anaesthesia is required. It is the particularly large
volume characteristic of the Orthospec which enable treatment
without imaging and without anaesthesia.
Conclusion: The results of this open study are good. We have
started in France a multi-centre double blind study randomised
against placebo, for plantar fasciitis with Orthospec which should
provide confirmation.
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VIABLE MENISCAL ALLOGRAFTS IN HUMANS: 101 CASES
WITH A 0.3 TO 12.4 YEARS FOLLOW-UP
P VerdQnk, KF Almqvist, A Demurie, E WitvrQuw, G Vergrugeen
UniversityHospital, Ghent, Belgium
Introduction: In this study the functiQnal results after transplanta-
tiQn Qf human viable fresh allQgenic menisci was evaluated.
Materials and Methods: The survival Qf intact cadaveric human
menisci in in vitroculture belQre their transplantatiQn intQ human
knees was initially investigated. The menisci were cultured in
DulbeccQ's mQdified Eagle's medium supplemented with 20%
human (decQmplemented) serum, L-glutamine and antibiQtics!
antimycQtics. The prQteQglycan synthesis rate Qf these samples
was assessed by the incQrpQratiQn Qf 35S04 in aggrecans.
Results: The clinical results - dQcumented by arthroscQpic, pathQ-
IQgical and MRI fQIIQw-up evaluatiQns - Qf the first 101 in in vitro
cultured meniscal transplants, with a mean fQIIQw-up Qf 6.1 years
(0.3 - 12.4yrs) are rewarding, in that:
- FunctiQnal restQratiQn has been achieved with a significant
increase in the HQspital fQr Special Surgery SCQre,
- At cQntrol arthrQscQpy macrQscQpic evidence Qf revitalized
meniscal tissue was fQund,
- PathQIQgical examinatiQn revealed viable tissue in the biQpsy
specimen,
- NQ clinical rejectiQn reactiQns have Qccured, shQwing gQQd
biQcQmpatibility Qf the viable allQgenic meniscal transplant.
MQreQver, DNA fingerprinting techniques tQ assess fibrochQndrQ-
cyte ingrQwth frQm the recipient intQ the dQnQr meniscus have
revealed progressive incQrpQratiQn Qf the recipient cells intQ the
meniscal bQdy. Surviving dQnQr cells, hQwever, have been prQven
tQ survive at a 3-year fQIIQw-up.
Conclusion: TransplantatiQn Qf in in vitrocultured viable allQgenic
menisci is a gQQd technique with satisfactQry clinical results in 101
cases with a fQIIQw-up periQd Qf 0.3 tQ 12.4 years.
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ADD ON ARTHROSCOPIC LAVAGE (AL) IN
OSTEOARTHRITIS (OA) KNEE: AN OPEN TRIAL
Singh GK, Jain RQhit, Ahmad Parvez, Kumar Ashish,
Singh Kamlesh
CEU, KGMC Instituteof ClinicalEpidemiology,Lucknow,INDIA
Objectives: TQ measure imprQvement after AL in OA Qf knee jQints
and cQmpare it with imprQvement after cQnventiQnal treatment.
Design: Open CQntrQlled Trial.
Setting: Tertiary Care hQspital
Interventions: AL and cQnventiQnal treatment
Participants: 100 knees Qf 83 Patients Qf OA knee attending
QrthQpedics frQm 01.08.0D-31.05.01.Patients whQ sCQred <24 Qn
WOMAC scale were excluded.
Main Outcomes measured: FunctiQnal capacity knee by
WOMAC index and pain by Visual AnalQg Scale (VAS), pretreat-
ment, immediately after start Qf the treatment, at 4, 12 and 4-19
weeks. 59 knees in 48 patients lavaged, 47 knees Qf 37 patients
received cQnventiQnal treatment.
Results: BQth Qn pain and functiQn SCQres cases were WQrst pre
treatment and better Qf PQst treatment at all fQIIQW ups bQth
statistically and clinically. The YQunger, less duration less severely
invQlved (bQth pain and functiQn wise) cQntrQls did cQnsistently and
significantly WQrst Qn all pain and functiQn imprQvement par-
ameters fQr up tQ 19 mQnths fQIIQW up except that Qn WOMAC 12,
walking Qn flat surface the difference did nQt reach statistical
significance. pQsttreatment cQntrQls were cQnsistently wQrstthan
cases bQth functiQnally and pain wise. The results persisted till the
end Qf fQIIQW up periQd Qf 4-19 weeks. The cQmplicatiQn rate Qf
36% in cQntrQls was much higher than 2% in cases.
Conclusions: Cases, initially WQrse than cQntrols, did statistically
and clinically better in terms Qf pain and functiQn up tQ 19 weeks
with lesser cQmplicatiQn rate.
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EFFICIENCY AND SAFETY OF SELECTIVE
CYCLOOXYGENASE -2 (COX 2) INHIBITION (MELOXICAM)
THERAPY IN COMPARISON WITH DICLOFENAC IN
SPONDYLOARTRITIS
M WislQwska
RheumatologyDepartment, CentralClinicalHospital,
137 WoloskaSt, Warsaw, Poland
The aim Qf this study was tQ cQmpare the efficiency and safety Qf
MelQxicam versus DiclQfenac in patients with sPQndylQarthritis.
Methods: The data were based Qn tWQ - week clinical trial. A tQtal
Qf 60 patients with sPQndylQarthritis were divided in twQ grQups (1)
treated with MelQxicam (15 mg daily) and (2) treated with
DiclQfenac (100 mg daily). A 100mm visual analQgue scale
(VAS), which measures pain, was administered at Baseline and
Weeks 2.
Results: MelQdic therapy resulted in better results in cQmparisQn
with DiclQfenac if we used a 100 mm VAS scale. FQr patients
taking MelQdic 6.7% were detected a minQr gastrQintestinal effect
in CQntrast tQ 26.7% in the DiclQfenac grQup.
Conclusions: Selective COX-2 inhibitiQn with MelQdic (15 mg)
was as efficaciQus as DiclQfenac (100 mg) but withQut seriQus
gastrQintestinal adverse event cQmpared with DiclQfenac.
